*********** PTASSAMj00 ******** FILEIN user.vek ../../CSA/PIK_SPRITE/ ULMN 3 3uao_o00 PUTATIVE ISOCHORISMATASE user 1 3 # 1 A 29 ASP A 129 ASP~? 19.06 O1 BME A 300 A 117 LYS A 126 LYS.? 26.12 O1 BME A 300 A 150 CYH A 52 CYH~? 13.74 O1 BME A 300 coo 37.97 47.82 5.46 38.65 48.02 7.40 80.80 42.21 -6.02 80.73 43.57 -7.63 coo 41.02 51.33 13.36 40.18 47.06 9.99 79.50 36.17 1.43 79.74 32.57 -2.57 coo 39.17 42.30 8.54 40.94 44.26 7.78 78.45 45.58 -0.24 81.07 46.23 -0.72 3uao_o00 source 3UAO PUTATIVE ISOCHORISMATASE : 1 hits 3uao_o00 naa= 3 ULMN 4 1btl_c00 BETA-LACTAMASE TEM1 (E.C.3.5.2.6) user 1 4 # 1 70 SER B 71 SER~? 8.60 S2 BME B 301 73 LYS B 73 LYS~? 5.56 C2 BME B 301 130 SER B 57 SER~? 14.27 S2 BME B 301 166 GLU B 70 GLU~? 7.75 C1 BME A 300 coo 9.07 4.77 36.50 9.47 6.77 37.81 71.04 68.14 4.29 73.26 68.66 5.07 coo 4.86 1.62 38.78 8.40 6.54 40.49 66.37 67.01 1.95 66.56 61.98 -0.01 coo 5.59 9.57 39.68 6.91 9.21 37.66 70.33 75.49 -0.10 72.36 74.24 -0.48 coo 11.82 4.41 43.29 12.22 5.15 41.33 72.71 65.28 -0.66 74.40 64.00 -0.70 1btl_c00 source 1btl BETA-LACTAMASE TEM1 (E.C.3.5.2.6) : 1 hits 1btl_c00 naa= 4 ULMN 4 1bzy_c01 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 1 4 # 1 B 133 GLU B 130 GLU.? 21.96 S2 BME B 301 B 134 ASP B 129 ASP.? 27.81 S2 BME B 301 B 137 ASP B 55 ASP~? 19.77 S2 BME B 301 B 165 LYS B 126 LYS.? 28.14 S2 BME B 301 coo -0.78 112.03 42.85 0.95 111.50 41.80 65.89 71.50 -12.95 66.09 70.43 -14.77 coo 2.83 112.32 46.21 3.45 112.93 44.27 64.27 77.57 -15.36 64.19 79.64 -15.85 coo 1.33 120.54 41.38 2.37 122.32 41.83 66.42 77.35 -5.07 66.48 77.29 -7.17 coo -1.54 122.74 46.23 4.22 122.84 44.60 64.27 82.78 -6.16 67.59 84.99 -10.95 1bzy_c01 source 1bzy HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE: 1 hits 1bzy_c01 naa= 4 ULMN 4 1doo_c00 HEAT SHOCK LOCUS U user 1 4 # 1 A 1 THR A 101 THR.? -4.16 C1 BME A 300s A 33 LYS A 81 LYS~? 9.69 C2 BME A 300 A 48 GLY A 98 GLY.? -3.52 S2 BME A 300s A 124 SER A 102 SER.? 8.36 C1 BME A 300 coo 20.60 80.81 78.25 19.93 81.48 80.23 78.82 59.97 0.83 77.48 58.31 0.82 coo 24.21 79.63 86.31 23.19 81.94 80.55 81.93 61.05 10.82 83.04 64.25 6.21 coo 18.07 85.03 84.32 18.49 84.59 84.79 74.17 61.90 8.39 74.00 62.65 8.00 coo 15.73 80.26 75.45 17.95 80.97 75.03 78.79 62.05 -2.37 76.46 61.88 -3.05 ULMN 4 1doo_c00 HEAT SHOCK LOCUS U user 2 4 # 2 A 1 THR B 101 THR.? 7.80 C2 BME B 301 A 33 LYS B 73 LYS~? 5.56 C2 BME B 301 A 48 GLY B 98 GLY.? -3.46 C2 BME B 301s A 124 SER B 102 SER.? 9.52 C2 BME B 301 coo 20.60 80.81 78.25 19.93 81.48 80.23 62.74 59.71 -1.20 64.09 61.32 -1.60 coo 24.21 79.63 86.31 23.19 81.94 80.55 66.37 67.01 1.95 66.56 61.98 -0.01 coo 18.07 85.03 84.32 18.49 84.59 84.79 65.71 59.42 7.74 66.01 58.68 7.45 coo 15.73 80.26 75.45 17.95 80.97 75.03 63.38 56.52 -3.17 65.79 56.15 -3.09 1doo_c00 source 1doo HEAT SHOCK LOCUS U : 2 hits 1doo_c00 naa= 4 ULMN 4 1doo_c01 HEAT SHOCK LOCUS U user 1 4 # 1 B 1 THR A 101 THR.? -4.16 C1 BME A 300s B 33 LYS A 81 LYS~? 9.69 C2 BME A 300 B 48 GLY A 98 GLY.? -3.52 S2 BME A 300s B 124 SER A 102 SER.? 8.36 C1 BME A 300 coo 26.69 108.13 78.57 25.70 107.69 80.43 78.82 59.97 0.83 77.48 58.31 0.82 coo 30.17 110.91 86.31 27.32 111.03 80.63 81.93 61.05 10.82 83.04 64.25 6.21 coo 22.32 108.46 85.29 22.91 108.64 85.71 74.17 61.90 8.39 74.00 62.65 8.00 coo 24.65 103.43 76.04 24.59 105.78 75.60 78.79 62.05 -2.37 76.46 61.88 -3.05 ULMN 4 1doo_c01 HEAT SHOCK LOCUS U user 2 4 # 2 B 1 THR B 101 THR.? 7.80 C2 BME B 301 B 33 LYS B 73 LYS~? 5.56 C2 BME B 301 B 48 GLY B 98 GLY.? -3.46 C2 BME B 301s B 124 SER B 102 SER.? 9.52 C2 BME B 301 coo 26.69 108.13 78.57 25.70 107.69 80.43 62.74 59.71 -1.20 64.09 61.32 -1.60 coo 30.17 110.91 86.31 27.32 111.03 80.63 66.37 67.01 1.95 66.56 61.98 -0.01 coo 22.32 108.46 85.29 22.91 108.64 85.71 65.71 59.42 7.74 66.01 58.68 7.45 coo 24.65 103.43 76.04 24.59 105.78 75.60 63.38 56.52 -3.17 65.79 56.15 -3.09 1doo_c01 source 1doo HEAT SHOCK LOCUS U : 2 hits 1doo_c01 naa= 4 ULMN 4 1doo_c02 HEAT SHOCK LOCUS U user 1 4 # 1 C 1 THR A 101 THR.? -4.16 C1 BME A 300s C 33 LYS A 73 LYS~? -2.81 O1 BME A 300s C 48 GLY A 98 GLY.? -3.52 S2 BME A 300s C 124 SER A 102 SER.? 8.36 C1 BME A 300 coo -5.30 26.59 199.66 -4.98 26.05 197.57 78.82 59.97 0.83 77.48 58.31 0.82 coo -4.62 30.60 191.94 -3.32 28.83 197.07 75.23 53.47 4.59 74.97 57.96 1.35 coo -3.44 22.13 193.22 -3.30 22.85 192.94 74.17 61.90 8.39 74.00 62.65 8.00 coo -8.31 23.03 202.48 -6.18 24.15 202.80 78.79 62.05 -2.37 76.46 61.88 -3.05 ULMN 4 1doo_c02 HEAT SHOCK LOCUS U user 2 4 # 2 C 1 THR A 101 THR.? -4.16 C1 BME A 300s C 33 LYS A 81 LYS~? 9.69 C2 BME A 300 C 48 GLY A 98 GLY.? -3.52 S2 BME A 300s C 124 SER A 102 SER.? 8.36 C1 BME A 300 coo -5.30 26.59 199.66 -4.98 26.05 197.57 78.82 59.97 0.83 77.48 58.31 0.82 coo -4.62 30.60 191.94 -3.32 28.83 197.07 81.93 61.05 10.82 83.04 64.25 6.21 coo -3.44 22.13 193.22 -3.30 22.85 192.94 74.17 61.90 8.39 74.00 62.65 8.00 coo -8.31 23.03 202.48 -6.18 24.15 202.80 78.79 62.05 -2.37 76.46 61.88 -3.05 ULMN 4 1doo_c02 HEAT SHOCK LOCUS U user 3 4 # 3 C 1 THR B 101 THR.? 7.80 C2 BME B 301 C 33 LYS B 73 LYS~? 5.56 C2 BME B 301 C 48 GLY B 98 GLY.? -3.46 C2 BME B 301s C 124 SER B 102 SER.? 9.52 C2 BME B 301 coo -5.30 26.59 199.66 -4.98 26.05 197.57 62.74 59.71 -1.20 64.09 61.32 -1.60 coo -4.62 30.60 191.94 -3.32 28.83 197.07 66.37 67.01 1.95 66.56 61.98 -0.01 coo -3.44 22.13 193.22 -3.30 22.85 192.94 65.71 59.42 7.74 66.01 58.68 7.45 coo -8.31 23.03 202.48 -6.18 24.15 202.80 63.38 56.52 -3.17 65.79 56.15 -3.09 1doo_c02 source 1doo HEAT SHOCK LOCUS U : 3 hits 1doo_c02 naa= 4 ULMN 4 1doo_c03 HEAT SHOCK LOCUS U user 1 4 # 1 D 1 THR A 101 THR.? -4.16 C1 BME A 300s D 33 LYS A 81 LYS~? 9.69 C2 BME A 300 D 48 GLY A 98 GLY.? -3.52 S2 BME A 300s D 124 SER A 102 SER.? 8.36 C1 BME A 300 coo 21.09 18.28 199.42 20.72 17.74 197.38 78.82 59.97 0.83 77.48 58.31 0.82 coo 25.54 20.08 191.91 24.21 17.77 197.54 81.93 61.05 10.82 83.04 64.25 6.21 coo 18.82 14.75 192.32 19.54 14.99 192.16 74.17 61.90 8.39 74.00 62.65 8.00 coo 16.26 18.98 201.87 18.32 18.00 202.67 78.79 62.05 -2.37 76.46 61.88 -3.05 ULMN 4 1doo_c03 HEAT SHOCK LOCUS U user 2 4 # 2 D 1 THR B 101 THR.? 7.80 C2 BME B 301 D 33 LYS B 73 LYS~? 5.56 C2 BME B 301 D 48 GLY B 98 GLY.? -3.46 C2 BME B 301s D 124 SER B 102 SER.? 9.52 C2 BME B 301 coo 21.09 18.28 199.42 20.72 17.74 197.38 62.74 59.71 -1.20 64.09 61.32 -1.60 coo 25.54 20.08 191.91 24.21 17.77 197.54 66.37 67.01 1.95 66.56 61.98 -0.01 coo 18.82 14.75 192.32 19.54 14.99 192.16 65.71 59.42 7.74 66.01 58.68 7.45 coo 16.26 18.98 201.87 18.32 18.00 202.67 63.38 56.52 -3.17 65.79 56.15 -3.09 1doo_c03 source 1doo HEAT SHOCK LOCUS U : 2 hits 1doo_c03 naa= 4 ULMN 4 1dub_c00 2-ENOYL-COA HYDRATASE user 1 4 # 1 A 98 ALA B 110 ALA~? 18.51 S2 BME B 301 A 141 GLY B 107 GLY~? 18.85 C2 BME B 301 A 144 GLU B 108 GLU~? 13.67 C2 BME B 301 A 164 GLU B 111 GLU~? 15.73 S2 BME B 301 coo 58.27 102.60 178.19 59.43 101.66 178.07 54.15 65.71 -4.34 52.84 65.57 -5.07 coo 59.27 103.88 173.55 59.11 104.69 173.45 51.22 61.18 -3.70 52.03 61.10 -3.58 coo 61.78 103.61 169.93 62.63 102.26 171.29 54.86 59.36 -0.28 55.08 57.73 1.04 coo 65.46 104.88 175.81 64.47 105.72 174.12 52.67 66.26 1.65 52.32 64.94 3.26 1dub_c00 source 1dub 2-ENOYL-COA HYDRATASE : 1 hits 1dub_c00 naa= 4 ULMN 4 1dub_c01 2-ENOYL-COA HYDRATASE user 1 4 # 1 B 98 ALA B 110 ALA~? 18.51 S2 BME B 301 B 141 GLY B 107 GLY~? 18.85 C2 BME B 301 B 144 GLU B 108 GLU~? 13.67 C2 BME B 301 B 164 GLU B 111 GLU~? 15.73 S2 BME B 301 coo 93.67 115.22 150.99 93.63 113.90 150.22 54.15 65.71 -4.34 52.84 65.57 -5.07 coo 88.87 114.43 152.30 88.45 115.15 152.32 51.22 61.18 -3.70 52.03 61.10 -3.58 coo 85.20 111.99 152.05 86.60 110.89 150.91 54.86 59.36 -0.28 55.08 57.73 1.04 coo 88.14 113.46 145.73 86.79 113.92 147.30 52.67 66.26 1.65 52.32 64.94 3.26 1dub_c01 source 1dub 2-ENOYL-COA HYDRATASE : 1 hits 1dub_c01 naa= 4 ULMN 4 1dub_c02 2-ENOYL-COA HYDRATASE user 1 4 # 1 C 98 ALA B 110 ALA~? 18.51 S2 BME B 301 C 141 GLY B 107 GLY~? 18.85 C2 BME B 301 C 144 GLU B 108 GLU~? 13.67 C2 BME B 301 C 164 GLU B 111 GLU~? 15.73 S2 BME B 301 coo 53.00 102.79 132.36 53.08 101.42 133.06 54.15 65.71 -4.34 52.84 65.57 -5.07 coo 56.28 104.55 135.84 56.09 105.34 136.05 51.22 61.18 -3.70 52.03 61.10 -3.58 coo 58.46 103.90 139.48 57.57 102.00 139.16 54.86 59.36 -0.28 55.08 57.73 1.04 coo 51.71 102.03 140.09 53.02 103.62 140.54 52.67 66.26 1.65 52.32 64.94 3.26 1dub_c02 source 1dub 2-ENOYL-COA HYDRATASE : 1 hits 1dub_c02 naa= 4 ULMN 4 1dub_c03 2-ENOYL-COA HYDRATASE user 1 4 # 1 D 98 ALA B 110 ALA~? 18.51 S2 BME B 301 D 141 GLY B 107 GLY~? 18.85 C2 BME B 301 D 144 GLU B 108 GLU~? 13.67 C2 BME B 301 D 164 GLU B 111 GLU~? 15.73 S2 BME B 301 coo 88.91 81.99 128.63 88.96 83.34 129.32 54.15 65.71 -4.34 52.84 65.57 -5.07 coo 86.19 80.64 132.77 86.38 79.85 132.93 51.22 61.18 -3.70 52.03 61.10 -3.58 coo 84.75 81.24 136.88 85.62 83.14 136.43 54.86 59.36 -0.28 55.08 57.73 1.04 coo 91.47 83.05 136.24 90.35 81.38 136.84 52.67 66.26 1.65 52.32 64.94 3.26 1dub_c03 source 1dub 2-ENOYL-COA HYDRATASE : 1 hits 1dub_c03 naa= 4 ULMN 4 1dub_c04 2-ENOYL-COA HYDRATASE user 1 4 # 1 E 98 ALA B 110 ALA~? 18.51 S2 BME B 301 E 141 GLY B 107 GLY~? 18.85 C2 BME B 301 E 144 GLU B 108 GLU~? 13.67 C2 BME B 301 E 164 GLU B 111 GLU~? 15.73 S2 BME B 301 coo 91.93 82.37 174.92 90.77 83.36 175.00 54.15 65.71 -4.34 52.84 65.57 -5.07 coo 90.07 81.07 170.50 90.23 80.26 170.38 51.22 61.18 -3.70 52.03 61.10 -3.58 coo 87.05 81.30 167.53 86.38 82.74 168.94 54.86 59.36 -0.28 55.08 57.73 1.04 coo 84.40 80.02 173.80 85.08 79.06 172.03 52.67 66.26 1.65 52.32 64.94 3.26 1dub_c04 source 1dub 2-ENOYL-COA HYDRATASE : 1 hits 1dub_c04 naa= 4 ULMN 4 1dub_c05 2-ENOYL-COA HYDRATASE user 1 4 # 1 F 98 ALA B 110 ALA~? 18.51 S2 BME B 301 F 141 GLY B 107 GLY~? 18.85 C2 BME B 301 F 144 GLU B 108 GLU~? 13.67 C2 BME B 301 F 164 GLU B 111 GLU~? 15.73 S2 BME B 301 coo 52.21 69.79 154.56 52.11 71.07 153.72 54.15 65.71 -4.34 52.84 65.57 -5.07 coo 57.12 70.68 155.10 57.52 69.95 155.02 51.22 61.18 -3.70 52.03 61.10 -3.58 coo 60.62 73.13 154.21 59.05 74.26 153.35 54.86 59.36 -0.28 55.08 57.73 1.04 coo 56.75 71.71 148.46 58.44 71.01 149.54 52.67 66.26 1.65 52.32 64.94 3.26 1dub_c05 source 1dub 2-ENOYL-COA HYDRATASE : 1 hits 1dub_c05 naa= 4 ULMN 4 1fsg_c00 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 1 4 # 1 A 146 GLU B 130 GLU.? 21.96 S2 BME B 301 A 147 ASP B 129 ASP.? 27.81 S2 BME B 301 A 150 ASP B 55 ASP~? 19.77 S2 BME B 301 A 178 LYS B 126 LYS.? 28.14 S2 BME B 301 coo 25.15 35.36 -14.10 25.49 37.13 -15.26 65.89 71.50 -12.95 66.09 70.43 -14.77 coo 24.20 39.15 -10.33 23.35 40.02 -12.02 64.27 77.57 -15.36 64.19 79.64 -15.85 coo 16.21 35.12 -15.07 14.15 35.53 -14.99 66.42 77.35 -5.07 66.48 77.29 -7.17 coo 14.98 32.15 -10.38 13.23 37.46 -12.31 64.27 82.78 -6.16 67.59 84.99 -10.95 1fsg_c00 source 1fsg HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE: 1 hits 1fsg_c00 naa= 4 ULMN 4 1fsg_c01 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 1 4 # 1 C 146 GLU B 130 GLU.? 21.96 S2 BME B 301 C 147 ASP B 129 ASP.? 27.81 S2 BME B 301 C 150 ASP B 55 ASP~? 19.77 S2 BME B 301 C 178 LYS B 126 LYS.? 28.14 S2 BME B 301 coo 21.13 43.45 27.66 22.75 42.66 28.81 65.89 71.50 -12.95 66.09 70.43 -14.77 coo 23.59 40.44 23.80 23.75 39.21 25.49 64.27 77.57 -15.36 64.19 79.64 -15.85 coo 15.48 36.57 28.52 14.54 34.69 28.40 66.42 77.35 -5.07 66.48 77.29 -7.17 coo 12.35 37.47 23.73 15.50 32.82 25.71 64.27 82.78 -6.16 67.59 84.99 -10.95 1fsg_c01 source 1fsg HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE: 1 hits 1fsg_c01 naa= 4 ULMN 4 1glo_c00 CATHEPSIN S user 1 4 # 1 A 19 GLN A 14 GLN~? 31.72 C1 BME A 300 A 25 SER A 10 SER~? 30.56 C1 BME A 300 A 164 HIS A 13 HIS~? 28.57 O1 BME A 300 A 184 ASN A 16 ASN~? 32.74 O1 BME A 300 coo -11.53 38.19 18.47 -9.42 38.35 18.87 84.35 64.05 -24.67 85.91 65.50 -24.63 coo -7.21 36.10 21.15 -5.41 37.65 20.61 88.87 59.13 -21.90 88.60 57.08 -23.12 coo -4.08 38.90 17.01 -5.94 38.04 16.53 85.22 56.20 -22.53 85.38 54.15 -22.09 coo -7.20 34.51 12.46 -6.97 36.44 13.40 81.19 57.34 -27.42 83.03 56.27 -27.56 ULMN 4 1glo_c00 CATHEPSIN S user 2 4 # 2 A 19 GLN B 14 GLN~? 37.86 O1 BME A 300 A 25 SER B 10 SER~? 37.79 S2 BME B 301 A 164 HIS B 13 HIS~? 34.41 S2 BME B 301 A 184 ASN B 16 ASN~? 33.06 S2 BME B 301 coo -11.53 38.19 18.47 -9.42 38.35 18.87 70.99 69.13 -31.36 71.01 67.24 -32.35 coo -7.21 36.10 21.15 -5.41 37.65 20.61 65.36 72.56 -31.08 66.40 74.55 -30.17 coo -4.08 38.90 17.01 -5.94 38.04 16.53 67.07 73.58 -27.21 65.85 74.91 -26.15 coo -7.20 34.51 12.46 -6.97 36.44 13.40 73.64 74.63 -26.43 74.05 74.83 -24.34 1glo_c00 source 1glo CATHEPSIN S : 2 hits 1glo_c00 naa= 4 ULMN 4 1pxv_c00 CYSTEINE PROTEASE INHIBITOR user 1 4 # 1 A 237 GLN B 23 GLN~? 34.60 C1 BME A 300 A 243 ALA B 20 ALA~? 29.68 C1 BME A 300 A 340 HIS B 19 HIS~? 37.21 C1 BME A 300 A 360 ASN B 16 ASN~? 33.06 S2 BME B 301 coo 38.51 5.65 6.75 37.98 5.66 8.79 83.41 73.35 -23.86 85.18 73.53 -25.05 coo 36.90 8.79 10.32 36.44 7.64 11.20 78.90 71.32 -22.98 77.56 71.08 -22.27 coo 34.70 4.19 13.47 34.73 4.30 11.39 78.85 74.61 -27.69 79.29 75.84 -29.33 coo 30.11 3.11 8.43 31.98 2.38 9.15 73.64 74.63 -26.43 74.05 74.83 -24.34 1pxv_c00 source 1pxv CYSTEINE PROTEASE INHIBITOR : 1 hits 1pxv_c00 naa= 4 ULMN 4 1pxv_c01 CYSTEINE PROTEASE INHIBITOR user 1 4 # 1 B 237 GLN B 23 GLN~? 34.60 C1 BME A 300 B 243 ALA B 20 ALA~? 29.68 C1 BME A 300 B 340 HIS B 19 HIS~? 37.21 C1 BME A 300 B 360 ASN B 16 ASN~? 33.06 S2 BME B 301 coo 4.68 3.74 -9.39 5.24 2.86 -11.31 83.41 73.35 -23.86 85.18 73.53 -25.05 coo 6.24 5.41 -13.65 6.53 4.09 -14.24 78.90 71.32 -22.98 77.56 71.08 -22.27 coo 8.35 0.07 -15.30 8.40 0.85 -13.38 78.85 74.61 -27.69 79.29 75.84 -29.33 coo 12.91 0.42 -10.35 11.06 -0.44 -10.73 73.64 74.63 -26.43 74.05 74.83 -24.34 1pxv_c01 source 1pxv CYSTEINE PROTEASE INHIBITOR : 1 hits 1pxv_c01 naa= 4 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 1 3 # 1 142 TRP A 62 TRP.? 13.96 C2 BME A 300 223 ASP B 84 ASP^? 10.28 C2 BME B 301 258 LYS A 73 LYS~? -2.81 O1 BME A 300s coo 127.19 33.46 26.14 126.78 36.79 28.15 72.00 48.24 13.73 75.57 46.89 14.64 coo 126.95 41.66 23.38 128.48 40.72 24.51 64.49 54.82 11.77 62.58 54.12 11.40 coo 138.83 37.95 25.17 133.50 36.37 26.52 75.23 53.47 4.59 74.97 57.96 1.35 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 2 3 # 2 142 TRP B 62 TRP.? 13.85 S2 BME B 301 223 ASP A 84 ASP^? 10.85 S2 BME A 300 258 LYS B 73 LYS~? 5.56 C2 BME B 301 coo 127.19 33.46 26.14 126.78 36.79 28.15 68.29 74.36 9.74 64.89 76.31 9.74 coo 126.95 41.66 23.38 128.48 40.72 24.51 75.39 67.64 11.32 77.43 68.14 11.09 coo 138.83 37.95 25.17 133.50 36.37 26.52 66.37 67.01 1.95 66.56 61.98 -0.01 1aam_c01 source 1aam ASPARTATE AMINOTRANSFERASE : 2 hits 1aam_c01 naa= 3 ULMN 3 1akd_c01 CYTOCHROME P450CAM user 1 3 # 1 252 THR B 101 THR.? 7.80 C2 BME B 301 350 PHE B 76 PHE~? 11.05 S2 BME B 301 357 CYH B 74 CYH~? -2.15 S2 BME B 301s coo 17.85 20.47 14.62 16.85 19.84 12.80 62.74 59.71 -1.20 64.09 61.32 -1.60 coo 7.92 21.96 13.27 8.57 20.30 15.42 62.48 70.31 3.16 62.78 73.09 2.84 coo 8.82 20.77 7.90 10.59 19.75 9.80 66.79 65.33 5.35 68.26 63.59 7.03 1akd_c01 source 1akd CYTOCHROME P450CAM : 1 hits 1akd_c01 naa= 3 ULMN 3 1amo_c00 NADPH-CYTOCHROME P450 REDUCTASE user 1 3 # 1 A 457 SER A 57 SER~? 13.02 O1 BME A 300 A 630 CYH A 52 CYH~? 13.74 O1 BME A 300 A 675 ASP A 55 ASP~? 17.20 O1 BME A 300 coo 2.70 -0.05 22.31 2.42 1.39 24.24 71.70 44.22 4.13 69.75 45.17 3.03 coo 0.87 7.55 27.28 1.82 5.91 25.24 78.45 45.58 -0.24 81.07 46.23 -0.72 coo 0.10 3.62 28.03 1.23 2.44 26.67 76.53 41.69 0.56 76.82 41.16 -1.46 ULMN 3 1amo_c00 NADPH-CYTOCHROME P450 REDUCTASE user 2 3 # 2 A 457 SER A 128 SER~? 18.41 O1 BME A 300 A 630 CYH A 52 CYH~? 13.74 O1 BME A 300 A 675 ASP A 55 ASP~? 17.20 O1 BME A 300 coo 2.70 -0.05 22.31 2.42 1.39 24.24 77.93 38.84 -4.13 76.71 40.95 -4.16 coo 0.87 7.55 27.28 1.82 5.91 25.24 78.45 45.58 -0.24 81.07 46.23 -0.72 coo 0.10 3.62 28.03 1.23 2.44 26.67 76.53 41.69 0.56 76.82 41.16 -1.46 ULMN 3 1amo_c00 NADPH-CYTOCHROME P450 REDUCTASE user 3 3 # 3 A 457 SER B 57 SER~? 14.27 S2 BME B 301 A 630 CYH B 52 CYH~? 17.21 S2 BME B 301 A 675 ASP B 55 ASP~? 19.77 S2 BME B 301 coo 2.70 -0.05 22.31 2.42 1.39 24.24 70.33 75.49 -0.10 72.36 74.24 -0.48 coo 0.87 7.55 27.28 1.82 5.91 25.24 64.37 73.52 -5.35 61.67 73.37 -6.12 coo 0.10 3.62 28.03 1.23 2.44 26.67 66.42 77.35 -5.07 66.48 77.29 -7.17 ULMN 3 1amo_c00 NADPH-CYTOCHROME P450 REDUCTASE user 4 3 # 4 A 457 SER B 128 SER.? 21.18 S2 BME B 301 A 630 CYH B 52 CYH~? 17.21 S2 BME B 301 A 675 ASP B 55 ASP~? 19.77 S2 BME B 301 coo 2.70 -0.05 22.31 2.42 1.39 24.24 65.44 78.54 -10.74 66.24 76.31 -10.20 coo 0.87 7.55 27.28 1.82 5.91 25.24 64.37 73.52 -5.35 61.67 73.37 -6.12 coo 0.10 3.62 28.03 1.23 2.44 26.67 66.42 77.35 -5.07 66.48 77.29 -7.17 1amo_c00 source 1amo NADPH-CYTOCHROME P450 REDUCTASE : 4 hits 1amo_c00 naa= 3 ULMN 3 1amo_c01 NADPH-CYTOCHROME P450 REDUCTASE user 1 3 # 1 B 457 SER A 57 SER~? 13.02 O1 BME A 300 B 630 CYH A 52 CYH~? 13.74 O1 BME A 300 B 675 ASP A 55 ASP~? 17.20 O1 BME A 300 coo 48.68 26.05 22.04 49.09 24.42 23.79 71.70 44.22 4.13 69.75 45.17 3.03 coo 50.83 17.98 26.05 49.75 19.82 24.27 78.45 45.58 -0.24 81.07 46.23 -0.72 coo 51.67 21.81 27.15 50.44 23.13 26.00 76.53 41.69 0.56 76.82 41.16 -1.46 ULMN 3 1amo_c01 NADPH-CYTOCHROME P450 REDUCTASE user 2 3 # 2 B 457 SER A 128 SER~? 18.41 O1 BME A 300 B 630 CYH A 52 CYH~? 13.74 O1 BME A 300 B 675 ASP A 55 ASP~? 17.20 O1 BME A 300 coo 48.68 26.05 22.04 49.09 24.42 23.79 77.93 38.84 -4.13 76.71 40.95 -4.16 coo 50.83 17.98 26.05 49.75 19.82 24.27 78.45 45.58 -0.24 81.07 46.23 -0.72 coo 51.67 21.81 27.15 50.44 23.13 26.00 76.53 41.69 0.56 76.82 41.16 -1.46 ULMN 3 1amo_c01 NADPH-CYTOCHROME P450 REDUCTASE user 3 3 # 3 B 457 SER B 57 SER~? 14.27 S2 BME B 301 B 630 CYH B 52 CYH~? 17.21 S2 BME B 301 B 675 ASP B 55 ASP~? 19.77 S2 BME B 301 coo 48.68 26.05 22.04 49.09 24.42 23.79 70.33 75.49 -0.10 72.36 74.24 -0.48 coo 50.83 17.98 26.05 49.75 19.82 24.27 64.37 73.52 -5.35 61.67 73.37 -6.12 coo 51.67 21.81 27.15 50.44 23.13 26.00 66.42 77.35 -5.07 66.48 77.29 -7.17 ULMN 3 1amo_c01 NADPH-CYTOCHROME P450 REDUCTASE user 4 3 # 4 B 457 SER B 128 SER.? 21.18 S2 BME B 301 B 630 CYH B 52 CYH~? 17.21 S2 BME B 301 B 675 ASP B 55 ASP~? 19.77 S2 BME B 301 coo 48.68 26.05 22.04 49.09 24.42 23.79 65.44 78.54 -10.74 66.24 76.31 -10.20 coo 50.83 17.98 26.05 49.75 19.82 24.27 64.37 73.52 -5.35 61.67 73.37 -6.12 coo 51.67 21.81 27.15 50.44 23.13 26.00 66.42 77.35 -5.07 66.48 77.29 -7.17 1amo_c01 source 1amo NADPH-CYTOCHROME P450 REDUCTASE : 4 hits 1amo_c01 naa= 3 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 1 3 # 1 179 ASP A 55 ASP~? 17.20 O1 BME A 300 214 ASP B 44 ASP~? 23.69 S2 BME B 301 289 ASP A 68 ASP~? 9.92 C1 BME B 301 coo -0.62 65.95 29.97 0.31 67.47 31.05 76.53 41.69 0.56 76.82 41.16 -1.46 coo 26.86 59.76 46.36 25.42 58.23 45.92 59.88 65.23 -14.80 60.45 65.24 -16.84 coo 9.42 68.07 30.27 7.35 68.27 30.10 67.14 48.96 2.96 66.44 50.60 4.08 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 2 3 # 2 179 ASP B 55 ASP~? 19.77 S2 BME B 301 214 ASP A 44 ASP~? 20.39 O1 BME A 300 289 ASP B 68 ASP~? 10.36 S2 BME B 301 coo -0.62 65.95 29.97 0.31 67.47 31.05 66.42 77.35 -5.07 66.48 77.29 -7.17 coo 26.86 59.76 46.36 25.42 58.23 45.92 83.66 51.21 -11.72 83.67 49.16 -12.23 coo 9.42 68.07 30.27 7.35 68.27 30.10 74.86 70.68 0.81 74.63 68.81 1.72 1amy_c01 source 1amy ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE (ALPHA-AMY: 2 hits 1amy_c01 naa= 3 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 1 3 # 1 179 ASP A 68 ASP~? 9.92 C1 BME B 301 227 GLU B 70 GLU~? 7.75 C1 BME A 300 289 ASP B 84 ASP^? 10.28 C2 BME B 301 coo -0.62 65.95 29.97 0.31 67.47 31.05 67.14 48.96 2.96 66.44 50.60 4.08 coo 3.96 55.76 41.24 4.83 57.69 41.17 72.71 65.28 -0.66 74.40 64.00 -0.70 coo 9.42 68.07 30.27 7.35 68.27 30.10 64.49 54.82 11.77 62.58 54.12 11.40 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 2 3 # 2 179 ASP A 68 ASP~? 9.92 C1 BME B 301 227 GLU B 108 GLU~? 13.67 C2 BME B 301 289 ASP B 84 ASP^? 10.28 C2 BME B 301 coo -0.62 65.95 29.97 0.31 67.47 31.05 67.14 48.96 2.96 66.44 50.60 4.08 coo 3.96 55.76 41.24 4.83 57.69 41.17 54.86 59.36 -0.28 55.08 57.73 1.04 coo 9.42 68.07 30.27 7.35 68.27 30.10 64.49 54.82 11.77 62.58 54.12 11.40 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 3 3 # 3 179 ASP A 84 ASP^? 10.85 S2 BME A 300 227 GLU A 108 GLU~? 11.49 C1 BME A 300 289 ASP B 68 ASP~? 10.36 S2 BME B 301 coo -0.62 65.95 29.97 0.31 67.47 31.05 75.39 67.64 11.32 77.43 68.14 11.09 coo 3.96 55.76 41.24 4.83 57.69 41.17 87.15 61.55 3.86 85.80 63.08 4.38 coo 9.42 68.07 30.27 7.35 68.27 30.10 74.86 70.68 0.81 74.63 68.81 1.72 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 4 3 # 4 179 ASP A 129 ASP~? 19.06 O1 BME A 300 227 GLU A 70 GLU~? 7.34 C1 BME B 301 289 ASP A 44 ASP~? 20.39 O1 BME A 300 coo -0.62 65.95 29.97 0.31 67.47 31.05 80.80 42.21 -6.02 80.73 43.57 -7.63 coo 3.96 55.76 41.24 4.83 57.69 41.17 68.92 53.57 0.58 67.76 55.17 -0.17 coo 9.42 68.07 30.27 7.35 68.27 30.10 83.66 51.21 -11.72 83.67 49.16 -12.23 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 5 3 # 5 179 ASP B 84 ASP^? 10.28 C2 BME B 301 227 GLU B 108 GLU~? 13.67 C2 BME B 301 289 ASP A 68 ASP~? 9.92 C1 BME B 301 coo -0.62 65.95 29.97 0.31 67.47 31.05 64.49 54.82 11.77 62.58 54.12 11.40 coo 3.96 55.76 41.24 4.83 57.69 41.17 54.86 59.36 -0.28 55.08 57.73 1.04 coo 9.42 68.07 30.27 7.35 68.27 30.10 67.14 48.96 2.96 66.44 50.60 4.08 1amy_c06 source 1amy ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE (ALPHA-AMY: 5 hits 1amy_c06 naa= 3 ULMN 3 1ax4_c04 TRYPTOPHANASE user 1 3 # 1 A 130 PHE B 76 PHE~? 11.05 S2 BME B 301 A 223 ASP B 55 ASP~? 19.77 S2 BME B 301 A 265 LYS B 2 LYS.? 15.81 C1 BME A 300 coo 39.74 52.86 65.74 41.15 55.14 66.52 62.48 70.31 3.16 62.78 73.09 2.84 coo 30.70 47.50 67.53 29.83 49.47 67.39 66.42 77.35 -5.07 66.48 77.29 -7.17 coo 19.99 54.53 64.11 20.55 58.78 68.33 75.93 68.83 -9.78 80.88 67.42 -7.25 ULMN 3 1ax4_c04 TRYPTOPHANASE user 2 3 # 2 A 130 PHE B 76 PHE~? 11.05 S2 BME B 301 A 223 ASP B 55 ASP~? 19.77 S2 BME B 301 A 265 LYS B 3 LYS^? 16.28 S2 BME B 301 coo 39.74 52.86 65.74 41.15 55.14 66.52 62.48 70.31 3.16 62.78 73.09 2.84 coo 30.70 47.50 67.53 29.83 49.47 67.39 66.42 77.35 -5.07 66.48 77.29 -7.17 coo 19.99 54.53 64.11 20.55 58.78 68.33 73.79 67.72 -12.74 69.00 65.74 -10.30 ULMN 3 1ax4_c04 TRYPTOPHANASE user 3 3 # 3 A 130 PHE B 76 PHE~? 11.05 S2 BME B 301 A 223 ASP B 68 ASP~? 10.36 S2 BME B 301 A 265 LYS B 3 LYS^? 16.28 S2 BME B 301 coo 39.74 52.86 65.74 41.15 55.14 66.52 62.48 70.31 3.16 62.78 73.09 2.84 coo 30.70 47.50 67.53 29.83 49.47 67.39 74.86 70.68 0.81 74.63 68.81 1.72 coo 19.99 54.53 64.11 20.55 58.78 68.33 73.79 67.72 -12.74 69.00 65.74 -10.30 ULMN 3 1ax4_c04 TRYPTOPHANASE user 4 3 # 4 A 130 PHE B 109 PHE~? 13.55 S2 BME B 301 A 223 ASP B 44 ASP~? 23.69 S2 BME B 301 A 265 LYS A 3 LYS.? 20.23 O1 BME A 300 coo 39.74 52.86 65.74 41.15 55.14 66.52 58.13 62.45 -4.76 60.66 63.28 -5.67 coo 30.70 47.50 67.53 29.83 49.47 67.39 59.88 65.23 -14.80 60.45 65.24 -16.84 coo 19.99 54.53 64.11 20.55 58.78 68.33 68.61 55.34 -21.58 71.21 56.20 -15.92 ULMN 3 1ax4_c04 TRYPTOPHANASE user 5 3 # 5 A 130 PHE B 109 PHE~? 13.55 S2 BME B 301 A 223 ASP B 44 ASP~? 23.69 S2 BME B 301 A 265 LYS B 3 LYS^? 16.28 S2 BME B 301 coo 39.74 52.86 65.74 41.15 55.14 66.52 58.13 62.45 -4.76 60.66 63.28 -5.67 coo 30.70 47.50 67.53 29.83 49.47 67.39 59.88 65.23 -14.80 60.45 65.24 -16.84 coo 19.99 54.53 64.11 20.55 58.78 68.33 73.79 67.72 -12.74 69.00 65.74 -10.30 ULMN 3 1ax4_c04 TRYPTOPHANASE user 6 3 # 6 A 130 PHE B 119 PHE~? 15.49 S2 BME B 301 A 223 ASP B 55 ASP~? 19.77 S2 BME B 301 A 265 LYS B 2 LYS.? 15.81 C1 BME A 300 coo 39.74 52.86 65.74 41.15 55.14 66.52 60.93 76.25 3.98 63.24 76.98 5.43 coo 30.70 47.50 67.53 29.83 49.47 67.39 66.42 77.35 -5.07 66.48 77.29 -7.17 coo 19.99 54.53 64.11 20.55 58.78 68.33 75.93 68.83 -9.78 80.88 67.42 -7.25 1ax4_c04 source 1ax4 TRYPTOPHANASE : 6 hits 1ax4_c04 naa= 3 ULMN 3 1ax4_c05 TRYPTOPHANASE user 1 3 # 1 B 130 PHE B 76 PHE~? 11.05 S2 BME B 301 B 223 ASP B 55 ASP~? 19.77 S2 BME B 301 B 265 LYS B 2 LYS.? 15.81 C1 BME A 300 coo 7.48 54.94 99.62 7.67 52.27 100.42 62.48 70.31 3.16 62.78 73.09 2.84 coo 10.43 61.66 91.81 9.80 60.04 90.61 66.42 77.35 -5.07 66.48 77.29 -7.17 coo 5.43 58.06 80.08 8.57 53.00 79.37 75.93 68.83 -9.78 80.88 67.42 -7.25 ULMN 3 1ax4_c05 TRYPTOPHANASE user 2 3 # 2 B 130 PHE B 76 PHE~? 11.05 S2 BME B 301 B 223 ASP B 55 ASP~? 19.77 S2 BME B 301 B 265 LYS B 3 LYS^? 16.28 S2 BME B 301 coo 7.48 54.94 99.62 7.67 52.27 100.42 62.48 70.31 3.16 62.78 73.09 2.84 coo 10.43 61.66 91.81 9.80 60.04 90.61 66.42 77.35 -5.07 66.48 77.29 -7.17 coo 5.43 58.06 80.08 8.57 53.00 79.37 73.79 67.72 -12.74 69.00 65.74 -10.30 ULMN 3 1ax4_c05 TRYPTOPHANASE user 3 3 # 3 B 130 PHE B 76 PHE~? 11.05 S2 BME B 301 B 223 ASP B 68 ASP~? 10.36 S2 BME B 301 B 265 LYS B 3 LYS^? 16.28 S2 BME B 301 coo 7.48 54.94 99.62 7.67 52.27 100.42 62.48 70.31 3.16 62.78 73.09 2.84 coo 10.43 61.66 91.81 9.80 60.04 90.61 74.86 70.68 0.81 74.63 68.81 1.72 coo 5.43 58.06 80.08 8.57 53.00 79.37 73.79 67.72 -12.74 69.00 65.74 -10.30 ULMN 3 1ax4_c05 TRYPTOPHANASE user 4 3 # 4 B 130 PHE B 109 PHE~? 13.55 S2 BME B 301 B 223 ASP B 44 ASP~? 23.69 S2 BME B 301 B 265 LYS A 3 LYS.? 20.23 O1 BME A 300 coo 7.48 54.94 99.62 7.67 52.27 100.42 58.13 62.45 -4.76 60.66 63.28 -5.67 coo 10.43 61.66 91.81 9.80 60.04 90.61 59.88 65.23 -14.80 60.45 65.24 -16.84 coo 5.43 58.06 80.08 8.57 53.00 79.37 68.61 55.34 -21.58 71.21 56.20 -15.92 ULMN 3 1ax4_c05 TRYPTOPHANASE user 5 3 # 5 B 130 PHE B 109 PHE~? 13.55 S2 BME B 301 B 223 ASP B 44 ASP~? 23.69 S2 BME B 301 B 265 LYS B 3 LYS^? 16.28 S2 BME B 301 coo 7.48 54.94 99.62 7.67 52.27 100.42 58.13 62.45 -4.76 60.66 63.28 -5.67 coo 10.43 61.66 91.81 9.80 60.04 90.61 59.88 65.23 -14.80 60.45 65.24 -16.84 coo 5.43 58.06 80.08 8.57 53.00 79.37 73.79 67.72 -12.74 69.00 65.74 -10.30 ULMN 3 1ax4_c05 TRYPTOPHANASE user 6 3 # 6 B 130 PHE B 119 PHE~? 15.49 S2 BME B 301 B 223 ASP B 55 ASP~? 19.77 S2 BME B 301 B 265 LYS B 2 LYS.? 15.81 C1 BME A 300 coo 7.48 54.94 99.62 7.67 52.27 100.42 60.93 76.25 3.98 63.24 76.98 5.43 coo 10.43 61.66 91.81 9.80 60.04 90.61 66.42 77.35 -5.07 66.48 77.29 -7.17 coo 5.43 58.06 80.08 8.57 53.00 79.37 75.93 68.83 -9.78 80.88 67.42 -7.25 1ax4_c05 source 1ax4 TRYPTOPHANASE : 6 hits 1ax4_c05 naa= 3 ULMN 3 1ax4_c06 TRYPTOPHANASE user 1 3 # 1 C 130 PHE B 76 PHE~? 11.05 S2 BME B 301 C 223 ASP B 55 ASP~? 19.77 S2 BME B 301 C 265 LYS B 2 LYS.? 15.81 C1 BME A 300 coo -6.55 73.45 23.60 -6.77 71.48 21.66 62.48 70.31 3.16 62.78 73.09 2.84 coo -9.52 75.74 33.62 -8.85 73.74 33.93 66.42 77.35 -5.07 66.48 77.29 -7.17 coo -4.44 67.20 42.32 -7.50 62.41 40.49 75.93 68.83 -9.78 80.88 67.42 -7.25 ULMN 3 1ax4_c06 TRYPTOPHANASE user 2 3 # 2 C 130 PHE B 76 PHE~? 11.05 S2 BME B 301 C 223 ASP B 55 ASP~? 19.77 S2 BME B 301 C 265 LYS B 3 LYS^? 16.28 S2 BME B 301 coo -6.55 73.45 23.60 -6.77 71.48 21.66 62.48 70.31 3.16 62.78 73.09 2.84 coo -9.52 75.74 33.62 -8.85 73.74 33.93 66.42 77.35 -5.07 66.48 77.29 -7.17 coo -4.44 67.20 42.32 -7.50 62.41 40.49 73.79 67.72 -12.74 69.00 65.74 -10.30 ULMN 3 1ax4_c06 TRYPTOPHANASE user 3 3 # 3 C 130 PHE B 76 PHE~? 11.05 S2 BME B 301 C 223 ASP B 68 ASP~? 10.36 S2 BME B 301 C 265 LYS B 3 LYS^? 16.28 S2 BME B 301 coo -6.55 73.45 23.60 -6.77 71.48 21.66 62.48 70.31 3.16 62.78 73.09 2.84 coo -9.52 75.74 33.62 -8.85 73.74 33.93 74.86 70.68 0.81 74.63 68.81 1.72 coo -4.44 67.20 42.32 -7.50 62.41 40.49 73.79 67.72 -12.74 69.00 65.74 -10.30 ULMN 3 1ax4_c06 TRYPTOPHANASE user 4 3 # 4 C 130 PHE B 109 PHE~? 13.55 S2 BME B 301 C 223 ASP B 44 ASP~? 23.69 S2 BME B 301 C 265 LYS A 3 LYS.? 20.23 O1 BME A 300 coo -6.55 73.45 23.60 -6.77 71.48 21.66 58.13 62.45 -4.76 60.66 63.28 -5.67 coo -9.52 75.74 33.62 -8.85 73.74 33.93 59.88 65.23 -14.80 60.45 65.24 -16.84 coo -4.44 67.20 42.32 -7.50 62.41 40.49 68.61 55.34 -21.58 71.21 56.20 -15.92 ULMN 3 1ax4_c06 TRYPTOPHANASE user 5 3 # 5 C 130 PHE B 109 PHE~? 13.55 S2 BME B 301 C 223 ASP B 44 ASP~? 23.69 S2 BME B 301 C 265 LYS B 3 LYS^? 16.28 S2 BME B 301 coo -6.55 73.45 23.60 -6.77 71.48 21.66 58.13 62.45 -4.76 60.66 63.28 -5.67 coo -9.52 75.74 33.62 -8.85 73.74 33.93 59.88 65.23 -14.80 60.45 65.24 -16.84 coo -4.44 67.20 42.32 -7.50 62.41 40.49 73.79 67.72 -12.74 69.00 65.74 -10.30 ULMN 3 1ax4_c06 TRYPTOPHANASE user 6 3 # 6 C 130 PHE B 119 PHE~? 15.49 S2 BME B 301 C 223 ASP B 55 ASP~? 19.77 S2 BME B 301 C 265 LYS B 2 LYS.? 15.81 C1 BME A 300 coo -6.55 73.45 23.60 -6.77 71.48 21.66 60.93 76.25 3.98 63.24 76.98 5.43 coo -9.52 75.74 33.62 -8.85 73.74 33.93 66.42 77.35 -5.07 66.48 77.29 -7.17 coo -4.44 67.20 42.32 -7.50 62.41 40.49 75.93 68.83 -9.78 80.88 67.42 -7.25 1ax4_c06 source 1ax4 TRYPTOPHANASE : 6 hits 1ax4_c06 naa= 3 ULMN 3 1ax4_c07 TRYPTOPHANASE user 1 3 # 1 D 130 PHE B 76 PHE~? 11.05 S2 BME B 301 D 223 ASP B 55 ASP~? 19.77 S2 BME B 301 D 265 LYS B 2 LYS.? 15.81 C1 BME A 300 coo -38.60 55.38 52.70 -40.06 57.72 53.04 62.48 70.31 3.16 62.78 73.09 2.84 coo -29.46 51.67 48.51 -28.63 53.31 49.56 66.42 77.35 -5.07 66.48 77.29 -7.17 coo -18.87 56.53 54.79 -19.47 62.22 53.03 75.93 68.83 -9.78 80.88 67.42 -7.25 ULMN 3 1ax4_c07 TRYPTOPHANASE user 2 3 # 2 D 130 PHE B 76 PHE~? 11.05 S2 BME B 301 D 223 ASP B 55 ASP~? 19.77 S2 BME B 301 D 265 LYS B 3 LYS^? 16.28 S2 BME B 301 coo -38.60 55.38 52.70 -40.06 57.72 53.04 62.48 70.31 3.16 62.78 73.09 2.84 coo -29.46 51.67 48.51 -28.63 53.31 49.56 66.42 77.35 -5.07 66.48 77.29 -7.17 coo -18.87 56.53 54.79 -19.47 62.22 53.03 73.79 67.72 -12.74 69.00 65.74 -10.30 ULMN 3 1ax4_c07 TRYPTOPHANASE user 3 3 # 3 D 130 PHE B 76 PHE~? 11.05 S2 BME B 301 D 223 ASP B 68 ASP~? 10.36 S2 BME B 301 D 265 LYS B 3 LYS^? 16.28 S2 BME B 301 coo -38.60 55.38 52.70 -40.06 57.72 53.04 62.48 70.31 3.16 62.78 73.09 2.84 coo -29.46 51.67 48.51 -28.63 53.31 49.56 74.86 70.68 0.81 74.63 68.81 1.72 coo -18.87 56.53 54.79 -19.47 62.22 53.03 73.79 67.72 -12.74 69.00 65.74 -10.30 ULMN 3 1ax4_c07 TRYPTOPHANASE user 4 3 # 4 D 130 PHE B 109 PHE~? 13.55 S2 BME B 301 D 223 ASP B 44 ASP~? 23.69 S2 BME B 301 D 265 LYS A 3 LYS.? 20.23 O1 BME A 300 coo -38.60 55.38 52.70 -40.06 57.72 53.04 58.13 62.45 -4.76 60.66 63.28 -5.67 coo -29.46 51.67 48.51 -28.63 53.31 49.56 59.88 65.23 -14.80 60.45 65.24 -16.84 coo -18.87 56.53 54.79 -19.47 62.22 53.03 68.61 55.34 -21.58 71.21 56.20 -15.92 ULMN 3 1ax4_c07 TRYPTOPHANASE user 5 3 # 5 D 130 PHE B 109 PHE~? 13.55 S2 BME B 301 D 223 ASP B 44 ASP~? 23.69 S2 BME B 301 D 265 LYS B 3 LYS^? 16.28 S2 BME B 301 coo -38.60 55.38 52.70 -40.06 57.72 53.04 58.13 62.45 -4.76 60.66 63.28 -5.67 coo -29.46 51.67 48.51 -28.63 53.31 49.56 59.88 65.23 -14.80 60.45 65.24 -16.84 coo -18.87 56.53 54.79 -19.47 62.22 53.03 73.79 67.72 -12.74 69.00 65.74 -10.30 ULMN 3 1ax4_c07 TRYPTOPHANASE user 6 3 # 6 D 130 PHE B 119 PHE~? 15.49 S2 BME B 301 D 223 ASP B 55 ASP~? 19.77 S2 BME B 301 D 265 LYS B 2 LYS.? 15.81 C1 BME A 300 coo -38.60 55.38 52.70 -40.06 57.72 53.04 60.93 76.25 3.98 63.24 76.98 5.43 coo -29.46 51.67 48.51 -28.63 53.31 49.56 66.42 77.35 -5.07 66.48 77.29 -7.17 coo -18.87 56.53 54.79 -19.47 62.22 53.03 75.93 68.83 -9.78 80.88 67.42 -7.25 1ax4_c07 source 1ax4 TRYPTOPHANASE : 6 hits 1ax4_c07 naa= 3 ULMN 3 1ay4_c02 AROMATIC AMINO ACID AMINOTRANSFERASEuser 1 3 # 1 A 140 TRP A 62 TRP.? 13.96 C2 BME A 300 A 222 ASP B 84 ASP^? 10.28 C2 BME B 301 A 258 LYS A 73 LYS~? -2.81 O1 BME A 300s coo 89.83 15.40 0.01 90.61 18.86 1.71 72.00 48.24 13.73 75.57 46.89 14.64 coo 82.92 20.43 2.47 84.82 20.45 1.55 64.49 54.82 11.77 62.58 54.12 11.40 coo 89.09 24.00 -8.81 89.39 20.33 -4.16 75.23 53.47 4.59 74.97 57.96 1.35 ULMN 3 1ay4_c02 AROMATIC AMINO ACID AMINOTRANSFERASEuser 2 3 # 2 A 140 TRP B 62 TRP.? 13.85 S2 BME B 301 A 222 ASP A 84 ASP^? 10.85 S2 BME A 300 A 258 LYS B 73 LYS~? 5.56 C2 BME B 301 coo 89.83 15.40 0.01 90.61 18.86 1.71 68.29 74.36 9.74 64.89 76.31 9.74 coo 82.92 20.43 2.47 84.82 20.45 1.55 75.39 67.64 11.32 77.43 68.14 11.09 coo 89.09 24.00 -8.81 89.39 20.33 -4.16 66.37 67.01 1.95 66.56 61.98 -0.01 1ay4_c02 source 1ay4 AROMATIC AMINO ACID AMINOTRANSFERASE : 2 hits 1ay4_c02 naa= 3 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 1 3 # 1 B 140 TRP A 62 TRP.? 13.96 C2 BME A 300 B 222 ASP B 84 ASP^? 10.28 C2 BME B 301 B 258 LYS A 73 LYS~? -2.81 O1 BME A 300s coo 103.45 44.39 16.20 102.66 41.02 14.32 72.00 48.24 13.73 75.57 46.89 14.64 coo 110.10 38.66 15.58 108.40 39.41 14.53 64.49 54.82 11.77 62.58 54.12 11.40 coo 107.51 45.54 4.76 105.41 44.51 10.25 75.23 53.47 4.59 74.97 57.96 1.35 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 2 3 # 2 B 140 TRP B 62 TRP.? 13.85 S2 BME B 301 B 222 ASP A 84 ASP^? 10.85 S2 BME A 300 B 258 LYS B 73 LYS~? 5.56 C2 BME B 301 coo 103.45 44.39 16.20 102.66 41.02 14.32 68.29 74.36 9.74 64.89 76.31 9.74 coo 110.10 38.66 15.58 108.40 39.41 14.53 75.39 67.64 11.32 77.43 68.14 11.09 coo 107.51 45.54 4.76 105.41 44.51 10.25 66.37 67.01 1.95 66.56 61.98 -0.01 1ay4_c03 source 1ay4 AROMATIC AMINO ACID AMINOTRANSFERASE : 2 hits 1ay4_c03 naa= 3 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 1 3 # 1 A 109 ASP A 44 ASP~? 20.39 O1 BME A 300 A 182 GLU A 7 GLU^? 21.08 O1 BME A 300 A 286 ASN A 46 ASN~? 11.04 O1 BME A 300 coo 26.03 44.66 108.90 25.67 42.61 108.82 83.66 51.21 -11.72 83.67 49.16 -12.23 coo 18.06 44.02 105.38 18.08 45.37 107.03 82.55 57.05 -16.50 82.95 55.46 -15.17 coo 25.47 38.28 112.06 27.26 39.30 111.54 78.74 53.91 -7.24 78.48 55.71 -6.12 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 2 3 # 2 A 109 ASP B 44 ASP~? 23.69 S2 BME B 301 A 182 GLU B 7 GLU^? 27.97 S2 BME B 301 A 286 ASN B 40 ASN~? 22.06 C2 BME B 301 coo 26.03 44.66 108.90 25.67 42.61 108.82 59.88 65.23 -14.80 60.45 65.24 -16.84 coo 18.06 44.02 105.38 18.08 45.37 107.03 64.21 70.19 -21.03 62.19 70.66 -20.57 coo 25.47 38.28 112.06 27.26 39.30 111.54 59.67 59.12 -17.42 60.89 58.88 -15.71 1b57_c00 source 1b57 FRUCTOSE-BISPHOSPHATE ALDOLASE II : 2 hits 1b57_c00 naa= 3 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 1 3 # 1 B 109 ASP A 44 ASP~? 20.39 O1 BME A 300 B 182 GLU A 7 GLU^? 21.08 O1 BME A 300 B 286 ASN A 46 ASN~? 11.04 O1 BME A 300 coo 13.82 69.26 132.27 11.87 70.14 132.51 83.66 51.21 -11.72 83.67 49.16 -12.23 coo 8.74 63.05 136.42 9.87 62.19 134.79 82.55 57.05 -16.50 82.95 55.46 -15.17 coo 8.26 72.60 129.22 10.14 73.45 129.80 78.74 53.91 -7.24 78.48 55.71 -6.12 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 2 3 # 2 B 109 ASP B 44 ASP~? 23.69 S2 BME B 301 B 182 GLU B 7 GLU^? 27.97 S2 BME B 301 B 286 ASN B 40 ASN~? 22.06 C2 BME B 301 coo 13.82 69.26 132.27 11.87 70.14 132.51 59.88 65.23 -14.80 60.45 65.24 -16.84 coo 8.74 63.05 136.42 9.87 62.19 134.79 64.21 70.19 -21.03 62.19 70.66 -20.57 coo 8.26 72.60 129.22 10.14 73.45 129.80 59.67 59.12 -17.42 60.89 58.88 -15.71 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 3 3 # 3 B 109 ASP B 44 ASP~? 23.69 S2 BME B 301 B 182 GLU B 7 GLU^? 27.97 S2 BME B 301 B 286 ASN B 46 ASN~? 13.59 C2 BME B 301 coo 13.82 69.26 132.27 11.87 70.14 132.51 59.88 65.23 -14.80 60.45 65.24 -16.84 coo 8.74 63.05 136.42 9.87 62.19 134.79 64.21 70.19 -21.03 62.19 70.66 -20.57 coo 8.26 72.60 129.22 10.14 73.45 129.80 64.66 62.99 -9.32 64.25 61.47 -7.89 1b57_c01 source 1b57 FRUCTOSE-BISPHOSPHATE ALDOLASE II : 3 hits 1b57_c01 naa= 3 ULMN 3 1b5d_c00 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 1 3 # 1 A 148 CYH A 74 CYH~? 2.95 S2 BME A 300s A 179 ASP B 84 ASP^? 10.28 C2 BME B 301 A 183 GLN B 83 GLN.? 5.96 S2 BME B 301 coo 21.87 3.71 21.27 20.32 3.55 23.64 74.14 55.73 7.46 71.82 57.29 7.21 coo 17.09 11.24 20.19 17.85 10.05 21.76 64.49 54.82 11.77 62.58 54.12 11.40 coo 19.54 13.23 15.90 21.64 12.89 15.61 64.75 61.63 10.87 66.37 62.95 11.30 ULMN 3 1b5d_c00 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 2 3 # 2 A 148 CYH B 74 CYH~? -2.15 S2 BME B 301s A 179 ASP A 84 ASP^? 10.85 S2 BME A 300 A 183 GLN A 83 GLN.? 6.18 S2 BME A 300 coo 21.87 3.71 21.27 20.32 3.55 23.64 66.79 65.33 5.35 68.26 63.59 7.03 coo 17.09 11.24 20.19 17.85 10.05 21.76 75.39 67.64 11.32 77.43 68.14 11.09 coo 19.54 13.23 15.90 21.64 12.89 15.61 74.98 60.65 12.18 73.13 59.63 12.17 ULMN 3 1b5d_c00 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 3 3 # 3 A 148 CYH B 74 CYH~? -2.15 S2 BME B 301s A 179 ASP A 84 ASP^? 10.85 S2 BME A 300 A 183 GLN A 99 GLN.? -7.63 C2 BME A 300s coo 21.87 3.71 21.27 20.32 3.55 23.64 66.79 65.33 5.35 68.26 63.59 7.03 coo 17.09 11.24 20.19 17.85 10.05 21.76 75.39 67.64 11.32 77.43 68.14 11.09 coo 19.54 13.23 15.90 21.64 12.89 15.61 79.03 63.02 8.04 78.48 65.04 8.42 1b5d_c00 source 1b5d DEOXYCYTIDYLATE HYDROXYMETHYLASE : 3 hits 1b5d_c00 naa= 3 ULMN 3 1b5d_c01 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 1 3 # 1 B 148 CYH A 74 CYH~? 2.95 S2 BME A 300s B 179 ASP B 84 ASP^? 10.28 C2 BME B 301 B 183 GLN B 83 GLN.? 5.96 S2 BME B 301 coo 30.30 0.93 3.58 31.01 1.18 0.88 74.14 55.73 7.46 71.82 57.29 7.21 coo 26.42 -6.51 0.59 28.13 -5.32 0.24 64.49 54.82 11.77 62.58 54.12 11.40 coo 24.68 -8.53 5.16 25.68 -8.09 7.00 64.75 61.63 10.87 66.37 62.95 11.30 ULMN 3 1b5d_c01 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 2 3 # 2 B 148 CYH B 74 CYH~? -2.15 S2 BME B 301s B 179 ASP A 84 ASP^? 10.85 S2 BME A 300 B 183 GLN A 83 GLN.? 6.18 S2 BME A 300 coo 30.30 0.93 3.58 31.01 1.18 0.88 66.79 65.33 5.35 68.26 63.59 7.03 coo 26.42 -6.51 0.59 28.13 -5.32 0.24 75.39 67.64 11.32 77.43 68.14 11.09 coo 24.68 -8.53 5.16 25.68 -8.09 7.00 74.98 60.65 12.18 73.13 59.63 12.17 ULMN 3 1b5d_c01 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 3 3 # 3 B 148 CYH B 74 CYH~? -2.15 S2 BME B 301s B 179 ASP A 84 ASP^? 10.85 S2 BME A 300 B 183 GLN A 99 GLN.? -7.63 C2 BME A 300s coo 30.30 0.93 3.58 31.01 1.18 0.88 66.79 65.33 5.35 68.26 63.59 7.03 coo 26.42 -6.51 0.59 28.13 -5.32 0.24 75.39 67.64 11.32 77.43 68.14 11.09 coo 24.68 -8.53 5.16 25.68 -8.09 7.00 79.03 63.02 8.04 78.48 65.04 8.42 1b5d_c01 source 1b5d DEOXYCYTIDYLATE HYDROXYMETHYLASE : 3 hits 1b5d_c01 naa= 3 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 1 3 # 1 A 88 PHE A 119 PHE~? 14.57 O1 BME A 300 A 159 ASP A 55 ASP~? 17.20 O1 BME A 300 A 188 LYS A 73 LYS~? -2.81 O1 BME A 300s coo 13.91 34.58 14.67 12.95 36.00 12.47 80.27 45.41 9.73 77.88 44.61 10.94 coo 20.97 28.40 16.26 20.19 30.15 15.34 76.53 41.69 0.56 76.82 41.16 -1.46 coo 22.55 41.65 15.60 18.92 37.20 14.63 75.23 53.47 4.59 74.97 57.96 1.35 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 2 3 # 2 A 88 PHE B 119 PHE~? 15.49 S2 BME B 301 A 159 ASP B 55 ASP~? 19.77 S2 BME B 301 A 188 LYS B 73 LYS~? 5.56 C2 BME B 301 coo 13.91 34.58 14.67 12.95 36.00 12.47 60.93 76.25 3.98 63.24 76.98 5.43 coo 20.97 28.40 16.26 20.19 30.15 15.34 66.42 77.35 -5.07 66.48 77.29 -7.17 coo 22.55 41.65 15.60 18.92 37.20 14.63 66.37 67.01 1.95 66.56 61.98 -0.01 1b9h_c02 source 1b9h 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHASE : 2 hits 1b9h_c02 naa= 3 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 A 137 ARG B 47 ARG~? 23.93 S2 BME B 301 A 141 THR A 35 THR^? 22.22 O1 BME A 300 A 235 ASP B 55 ASP~? 19.77 S2 BME B 301 coo 6.21 93.81 36.58 4.58 96.33 37.17 65.24 66.71 -15.28 63.33 68.13 -17.26 coo 6.80 92.87 28.33 4.91 92.74 27.40 72.00 65.36 -18.45 71.15 64.17 -16.85 coo 12.98 90.36 47.57 11.26 89.62 46.62 66.42 77.35 -5.07 66.48 77.29 -7.17 1bd3_c00 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 1 hits 1bd3_c00 naa= 3 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 D 137 ARG B 47 ARG~? 23.93 S2 BME B 301 D 141 THR A 35 THR^? 22.22 O1 BME A 300 D 235 ASP B 55 ASP~? 19.77 S2 BME B 301 coo -8.33 92.80 100.06 -7.71 95.33 98.44 65.24 66.71 -15.28 63.33 68.13 -17.26 coo -9.24 93.49 108.77 -7.37 94.21 109.61 72.00 65.36 -18.45 71.15 64.17 -16.85 coo -14.64 87.74 89.51 -12.89 87.43 90.65 66.42 77.35 -5.07 66.48 77.29 -7.17 1bd3_c01 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 1 hits 1bd3_c01 naa= 3 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 C 137 ARG B 47 ARG~? 23.93 S2 BME B 301 C 141 THR A 35 THR^? 22.22 O1 BME A 300 C 235 ASP B 55 ASP~? 19.77 S2 BME B 301 coo -5.79 67.26 36.83 -4.57 64.58 37.74 65.24 66.71 -15.28 63.33 68.13 -17.26 coo -6.81 68.31 28.28 -4.82 68.47 27.57 72.00 65.36 -18.45 71.15 64.17 -16.85 coo -13.01 70.96 47.58 -11.44 71.65 46.34 66.42 77.35 -5.07 66.48 77.29 -7.17 1bd3_c02 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 1 hits 1bd3_c02 naa= 3 ULMN 3 1bf2_c00 ISOAMYLASE user 1 3 # 1 375 ASP B 129 ASP.? 27.81 S2 BME B 301 435 GLU B 130 GLU.? 21.96 S2 BME B 301 510 ASP B 55 ASP~? 19.77 S2 BME B 301 coo 88.62 69.90 41.16 89.05 70.67 43.04 64.27 77.57 -15.36 64.19 79.64 -15.85 coo 89.52 76.11 40.17 89.01 75.16 41.97 65.89 71.50 -12.95 66.09 70.43 -14.77 coo 84.89 77.60 46.67 85.63 75.79 46.03 66.42 77.35 -5.07 66.48 77.29 -7.17 1bf2_c00 source 1bf2 ISOAMYLASE : 1 hits 1bf2_c00 naa= 3 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 1 3 # 1 B 382 ARG B 39 ARG.? 27.37 S2 BME B 301 B 451 GLU B 130 GLU.? 21.96 S2 BME B 301 B 540 GLU B 7 GLU^? 27.97 S2 BME B 301 coo 82.21 41.07 119.14 83.95 40.66 116.59 61.31 65.86 -19.69 59.13 67.99 -19.83 coo 86.52 35.28 112.74 87.08 36.38 110.99 65.89 71.50 -12.95 66.09 70.43 -14.77 coo 83.38 41.19 112.55 85.47 40.59 112.72 64.21 70.19 -21.03 62.19 70.66 -20.57 1bhg_c05 source 1bhg BETA-GLUCURONIDASE : 1 hits 1bhg_c05 naa= 3 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 1 3 # 1 118 ARG B 39 ARG.? 27.37 S2 BME B 301 183 LYS A 2 LYS.? 28.68 O1 BME A 300 317 ARG A 39 ARG.? 14.17 O1 BME A 300 coo 76.57 109.19 73.41 73.86 110.26 72.16 61.31 65.86 -19.69 59.13 67.99 -19.83 coo 82.09 117.51 66.37 80.60 114.32 71.44 66.36 53.41 -23.99 71.31 50.47 -23.66 coo 65.21 120.62 58.76 63.62 123.14 59.66 79.32 60.12 -11.34 77.45 58.25 -9.78 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 2 3 # 2 118 ARG B 39 ARG.? 27.37 S2 BME B 301 183 LYS B 48 LYS~? 21.20 S2 BME B 301 317 ARG A 39 ARG.? 14.17 O1 BME A 300 coo 76.57 109.19 73.41 73.86 110.26 72.16 61.31 65.86 -19.69 59.13 67.99 -19.83 coo 82.09 117.51 66.37 80.60 114.32 71.44 62.47 69.43 -9.84 56.65 72.06 -9.69 coo 65.21 120.62 58.76 63.62 123.14 59.66 79.32 60.12 -11.34 77.45 58.25 -9.78 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 3 3 # 3 118 ARG B 39 ARG.? 27.37 S2 BME B 301 183 LYS B 48 LYS~? 21.20 S2 BME B 301 317 ARG B 103 ARG.? 9.89 C2 BME B 301 coo 76.57 109.19 73.41 73.86 110.26 72.16 61.31 65.86 -19.69 59.13 67.99 -19.83 coo 82.09 117.51 66.37 80.60 114.32 71.44 62.47 69.43 -9.84 56.65 72.06 -9.69 coo 65.21 120.62 58.76 63.62 123.14 59.66 63.00 51.98 -1.39 64.93 51.92 1.00 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 4 3 # 4 118 ARG B 39 ARG.? 27.37 S2 BME B 301 183 LYS B 48 LYS~? 21.20 S2 BME B 301 317 ARG B 105 ARG~? 19.36 C2 BME B 301 coo 76.57 109.19 73.41 73.86 110.26 72.16 61.31 65.86 -19.69 59.13 67.99 -19.83 coo 82.09 117.51 66.37 80.60 114.32 71.44 62.47 69.43 -9.84 56.65 72.06 -9.69 coo 65.21 120.62 58.76 63.62 123.14 59.66 52.95 54.23 -2.38 52.26 51.27 -1.82 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 5 3 # 5 118 ARG B 58 ARG~? 19.35 S2 BME B 301 183 LYS B 2 LYS.? 15.81 C1 BME A 300 317 ARG B 39 ARG.? 27.37 S2 BME B 301 coo 76.57 109.19 73.41 73.86 110.26 72.16 73.30 78.23 -5.33 71.23 76.59 -6.88 coo 82.09 117.51 66.37 80.60 114.32 71.44 75.93 68.83 -9.78 80.88 67.42 -7.25 coo 65.21 120.62 58.76 63.62 123.14 59.66 61.31 65.86 -19.69 59.13 67.99 -19.83 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 6 3 # 6 118 ARG B 103 ARG.? 9.89 C2 BME B 301 183 LYS A 73 LYS~? -2.81 O1 BME A 300s 317 ARG A 39 ARG.? 14.17 O1 BME A 300 coo 76.57 109.19 73.41 73.86 110.26 72.16 63.00 51.98 -1.39 64.93 51.92 1.00 coo 82.09 117.51 66.37 80.60 114.32 71.44 75.23 53.47 4.59 74.97 57.96 1.35 coo 65.21 120.62 58.76 63.62 123.14 59.66 79.32 60.12 -11.34 77.45 58.25 -9.78 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 7 3 # 7 118 ARG B 103 ARG.? 9.89 C2 BME B 301 183 LYS A 73 LYS~? -2.81 O1 BME A 300s 317 ARG A 132 ARG~? 22.65 O1 BME A 300 coo 76.57 109.19 73.41 73.86 110.26 72.16 63.00 51.98 -1.39 64.93 51.92 1.00 coo 82.09 117.51 66.37 80.60 114.32 71.44 75.23 53.47 4.59 74.97 57.96 1.35 coo 65.21 120.62 58.76 63.62 123.14 59.66 77.21 40.15 -9.68 74.83 40.81 -11.52 1bib_c00 source 1bib BIRA BIFUNCTIONAL PROTEIN (ACTS AS BIOTIN OPER: 7 hits 1bib_c00 naa= 3 ULMN 3 1boo_c00 N-4 CYTOSINE-SPECIFIC METHYLTRANSFERuser 1 3 # 1 A 53 SER A 42 SER~? 18.41 C1 BME A 300 A 54 PRO B 31 PRO.? 19.97 C1 BME A 300 A 96 ASP A 44 ASP~? 20.39 O1 BME A 300 coo -9.03 45.15 44.45 -7.51 43.26 44.28 83.78 56.74 -9.93 84.51 54.83 -11.21 coo -12.82 46.62 43.11 -11.69 44.75 42.79 84.07 59.66 -12.81 85.19 61.47 -13.46 coo -5.86 47.39 44.34 -4.55 46.60 42.83 83.66 51.21 -11.72 83.67 49.16 -12.23 1boo_c00 source 1boo N-4 CYTOSINE-SPECIFIC METHYLTRANSFERASE PVU II: 1 hits 1boo_c00 naa= 3 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 1 3 # 1 A 109 PHE A 76 PHE~? 9.74 O1 BME A 300 A 205 ASP A 129 ASP~? 19.06 O1 BME A 300 A 236 LYS A 126 LYS.? 26.12 O1 BME A 300 coo 4.14 2.10 36.34 6.69 3.08 36.92 78.83 50.67 7.29 78.71 47.88 7.60 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 80.80 42.21 -6.02 80.73 43.57 -7.63 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 79.50 36.17 1.43 79.74 32.57 -2.57 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 2 3 # 2 A 109 PHE A 94 PHE^? 15.72 S2 BME B 301 A 205 ASP B 84 ASP^? 10.28 C2 BME B 301 A 236 LYS B 81 LYS~? 11.51 C2 BME B 301 coo 4.14 2.10 36.34 6.69 3.08 36.92 66.81 69.50 17.94 66.87 71.80 19.56 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 64.49 54.82 11.77 62.58 54.12 11.40 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 58.04 61.64 8.69 57.58 55.47 6.95 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 3 3 # 3 A 109 PHE A 119 PHE~? 14.57 O1 BME A 300 A 205 ASP A 129 ASP~? 19.06 O1 BME A 300 A 236 LYS A 126 LYS.? 26.12 O1 BME A 300 coo 4.14 2.10 36.34 6.69 3.08 36.92 80.27 45.41 9.73 77.88 44.61 10.94 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 80.80 42.21 -6.02 80.73 43.57 -7.63 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 79.50 36.17 1.43 79.74 32.57 -2.57 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 4 3 # 4 A 109 PHE B 94 PHE^? 12.77 O1 BME B 301 A 205 ASP A 84 ASP^? 10.85 S2 BME A 300 A 236 LYS A 81 LYS~? 9.69 C2 BME A 300 coo 4.14 2.10 36.34 6.69 3.08 36.92 71.58 57.30 18.86 71.41 60.08 19.10 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 75.39 67.64 11.32 77.43 68.14 11.09 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 81.93 61.05 10.82 83.04 64.25 6.21 1bs0_c01 source 1bs0 8-AMINO-7-OXONANOATE SYNTHASE : 4 hits 1bs0_c01 naa= 3 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 1 3 # 1 A 50 GLN A 37 GLN^? 16.20 O1 BME A 300 A 91 LEU B 4 LEU^? 24.17 C1 BME A 300 A 133 GLU A 38 GLU^? 20.48 C1 BME A 300 coo 43.58 43.67 66.73 42.32 42.78 68.15 75.99 64.37 -11.97 74.53 63.06 -11.11 coo 38.58 45.09 70.44 38.28 45.21 72.59 74.36 70.83 -16.40 75.83 71.99 -15.35 coo 44.05 36.87 70.65 43.15 38.64 69.97 80.67 68.42 -11.46 82.73 68.27 -11.88 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 2 3 # 2 A 50 GLN B 37 GLN^? 22.79 C1 BME B 301 A 91 LEU A 4 LEU^? 29.02 O1 BME A 300 A 133 GLU B 38 GLU^? 31.80 C2 BME B 301 coo 43.58 43.67 66.73 42.32 42.78 68.15 67.31 60.31 -19.68 67.74 59.93 -17.63 coo 38.58 45.09 70.44 38.28 45.21 72.59 72.63 56.21 -23.96 71.72 55.67 -25.81 coo 44.05 36.87 70.65 43.15 38.64 69.97 61.52 60.14 -24.13 60.63 59.15 -25.77 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 3 3 # 3 A 50 GLN B 37 GLN^? 22.79 C1 BME B 301 A 91 LEU B 43 LEU~? 21.14 C2 BME B 301 A 133 GLU B 38 GLU^? 31.80 C2 BME B 301 coo 43.58 43.67 66.73 42.32 42.78 68.15 67.31 60.31 -19.68 67.74 59.93 -17.63 coo 38.58 45.09 70.44 38.28 45.21 72.59 63.43 61.24 -14.88 64.66 62.40 -16.26 coo 44.05 36.87 70.65 43.15 38.64 69.97 61.52 60.14 -24.13 60.63 59.15 -25.77 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 4 3 # 4 A 50 GLN B 99 GLN.? 8.04 C2 BME B 301 A 91 LEU B 80 LEU~? 11.70 S2 BME B 301 A 133 GLU B 108 GLU~? 13.67 C2 BME B 301 coo 43.58 43.67 66.73 42.32 42.78 68.15 60.99 58.35 6.64 61.25 56.53 7.71 coo 38.58 45.09 70.44 38.28 45.21 72.59 56.76 64.71 5.48 56.13 66.38 4.27 coo 44.05 36.87 70.65 43.15 38.64 69.97 54.86 59.36 -0.28 55.08 57.73 1.04 1bs4_c00 source 1bs4 PEPTIDE DEFORMYLASE : 4 hits 1bs4_c00 naa= 3 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 1 3 # 1 B 550 GLN A 37 GLN^? 16.20 O1 BME A 300 B 591 LEU B 4 LEU^? 24.17 C1 BME A 300 B 633 GLU A 38 GLU^? 20.48 C1 BME A 300 coo 88.06 44.34 57.19 89.06 45.53 55.74 75.99 64.37 -11.97 74.53 63.06 -11.11 coo 86.70 48.66 52.61 87.15 48.69 50.51 74.36 70.83 -16.40 75.83 71.99 -15.35 coo 95.42 44.52 54.43 93.46 45.31 54.70 80.67 68.42 -11.46 82.73 68.27 -11.88 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 2 3 # 2 B 550 GLN B 37 GLN^? 22.79 C1 BME B 301 B 591 LEU A 4 LEU^? 29.02 O1 BME A 300 B 633 GLU B 38 GLU^? 31.80 C2 BME B 301 coo 88.06 44.34 57.19 89.06 45.53 55.74 67.31 60.31 -19.68 67.74 59.93 -17.63 coo 86.70 48.66 52.61 87.15 48.69 50.51 72.63 56.21 -23.96 71.72 55.67 -25.81 coo 95.42 44.52 54.43 93.46 45.31 54.70 61.52 60.14 -24.13 60.63 59.15 -25.77 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 3 3 # 3 B 550 GLN B 37 GLN^? 22.79 C1 BME B 301 B 591 LEU B 43 LEU~? 21.14 C2 BME B 301 B 633 GLU B 38 GLU^? 31.80 C2 BME B 301 coo 88.06 44.34 57.19 89.06 45.53 55.74 67.31 60.31 -19.68 67.74 59.93 -17.63 coo 86.70 48.66 52.61 87.15 48.69 50.51 63.43 61.24 -14.88 64.66 62.40 -16.26 coo 95.42 44.52 54.43 93.46 45.31 54.70 61.52 60.14 -24.13 60.63 59.15 -25.77 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 4 3 # 4 B 550 GLN B 99 GLN.? 8.04 C2 BME B 301 B 591 LEU B 80 LEU~? 11.70 S2 BME B 301 B 633 GLU B 108 GLU~? 13.67 C2 BME B 301 coo 88.06 44.34 57.19 89.06 45.53 55.74 60.99 58.35 6.64 61.25 56.53 7.71 coo 86.70 48.66 52.61 87.15 48.69 50.51 56.76 64.71 5.48 56.13 66.38 4.27 coo 95.42 44.52 54.43 93.46 45.31 54.70 54.86 59.36 -0.28 55.08 57.73 1.04 1bs4_c01 source 1bs4 PEPTIDE DEFORMYLASE : 4 hits 1bs4_c01 naa= 3 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 1 3 # 1 C1050 GLN A 37 GLN^? 16.20 O1 BME A 300 C1091 LEU B 4 LEU^? 24.17 C1 BME A 300 C1133 GLU A 38 GLU^? 20.48 C1 BME A 300 coo 68.29 34.44 43.03 66.67 34.74 44.37 75.99 64.37 -11.97 74.53 63.06 -11.11 coo 65.83 38.95 47.05 65.46 38.90 49.20 74.36 70.83 -16.40 75.83 71.99 -15.35 coo 63.14 29.39 46.25 63.84 31.31 45.74 80.67 68.42 -11.46 82.73 68.27 -11.88 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 2 3 # 2 C1050 GLN B 37 GLN^? 22.79 C1 BME B 301 C1091 LEU A 4 LEU^? 29.02 O1 BME A 300 C1133 GLU B 38 GLU^? 31.80 C2 BME B 301 coo 68.29 34.44 43.03 66.67 34.74 44.37 67.31 60.31 -19.68 67.74 59.93 -17.63 coo 65.83 38.95 47.05 65.46 38.90 49.20 72.63 56.21 -23.96 71.72 55.67 -25.81 coo 63.14 29.39 46.25 63.84 31.31 45.74 61.52 60.14 -24.13 60.63 59.15 -25.77 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 3 3 # 3 C1050 GLN B 37 GLN^? 22.79 C1 BME B 301 C1091 LEU B 43 LEU~? 21.14 C2 BME B 301 C1133 GLU B 38 GLU^? 31.80 C2 BME B 301 coo 68.29 34.44 43.03 66.67 34.74 44.37 67.31 60.31 -19.68 67.74 59.93 -17.63 coo 65.83 38.95 47.05 65.46 38.90 49.20 63.43 61.24 -14.88 64.66 62.40 -16.26 coo 63.14 29.39 46.25 63.84 31.31 45.74 61.52 60.14 -24.13 60.63 59.15 -25.77 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 4 3 # 4 C1050 GLN B 99 GLN.? 8.04 C2 BME B 301 C1091 LEU B 80 LEU~? 11.70 S2 BME B 301 C1133 GLU B 108 GLU~? 13.67 C2 BME B 301 coo 68.29 34.44 43.03 66.67 34.74 44.37 60.99 58.35 6.64 61.25 56.53 7.71 coo 65.83 38.95 47.05 65.46 38.90 49.20 56.76 64.71 5.48 56.13 66.38 4.27 coo 63.14 29.39 46.25 63.84 31.31 45.74 54.86 59.36 -0.28 55.08 57.73 1.04 1bs4_c02 source 1bs4 PEPTIDE DEFORMYLASE : 4 hits 1bs4_c02 naa= 3 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 1 3 # 1 A 50 GLN B 37 GLN^? 22.79 C1 BME B 301 A 91 LEU A 4 LEU^? 29.02 O1 BME A 300 A 133 GLU B 38 GLU^? 31.80 C2 BME B 301 coo 38.23 53.34 67.59 38.84 53.87 69.56 67.31 60.31 -19.68 67.74 59.93 -17.63 coo 35.40 53.22 73.30 35.37 54.87 74.74 72.63 56.21 -23.96 71.72 55.67 -25.81 coo 45.08 56.04 70.60 43.15 55.19 70.77 61.52 60.14 -24.13 60.63 59.15 -25.77 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 2 3 # 2 A 50 GLN B 37 GLN^? 22.79 C1 BME B 301 A 91 LEU B 43 LEU~? 21.14 C2 BME B 301 A 133 GLU B 38 GLU^? 31.80 C2 BME B 301 coo 38.23 53.34 67.59 38.84 53.87 69.56 67.31 60.31 -19.68 67.74 59.93 -17.63 coo 35.40 53.22 73.30 35.37 54.87 74.74 63.43 61.24 -14.88 64.66 62.40 -16.26 coo 45.08 56.04 70.60 43.15 55.19 70.77 61.52 60.14 -24.13 60.63 59.15 -25.77 1bsj_c00 source 1bsj PEPTIDE DEFORMYLASE : 2 hits 1bsj_c00 naa= 3 ULMN 3 1bu7_c02 CYTOCHROME P450 user 1 3 # 1 A 268 THR A 101 THR.? -4.16 C1 BME A 300s A 393 PHE A 76 PHE~? 9.74 O1 BME A 300 A 400 CYH A 74 CYH~? 2.95 S2 BME A 300s coo 45.81 71.19 43.26 47.70 70.19 43.25 78.82 59.97 0.83 77.48 58.31 0.82 coo 48.54 63.17 48.16 46.74 64.99 49.22 78.83 50.67 7.29 78.71 47.88 7.60 coo 53.76 64.39 46.87 52.06 66.55 47.33 74.14 55.73 7.46 71.82 57.29 7.21 ULMN 3 1bu7_c02 CYTOCHROME P450 user 2 3 # 2 A 268 THR B 101 THR.? 7.80 C2 BME B 301 A 393 PHE B 76 PHE~? 11.05 S2 BME B 301 A 400 CYH B 74 CYH~? -2.15 S2 BME B 301s coo 45.81 71.19 43.26 47.70 70.19 43.25 62.74 59.71 -1.20 64.09 61.32 -1.60 coo 48.54 63.17 48.16 46.74 64.99 49.22 62.48 70.31 3.16 62.78 73.09 2.84 coo 53.76 64.39 46.87 52.06 66.55 47.33 66.79 65.33 5.35 68.26 63.59 7.03 1bu7_c02 source 1bu7 CYTOCHROME P450 : 2 hits 1bu7_c02 naa= 3 ULMN 3 1bu7_c03 CYTOCHROME P450 user 1 3 # 1 B 268 THR A 101 THR.? -4.16 C1 BME A 300s B 393 PHE A 76 PHE~? 9.74 O1 BME A 300 B 400 CYH A 74 CYH~? 2.95 S2 BME A 300s coo 37.20 116.32 52.00 35.18 117.07 52.13 78.82 59.97 0.83 77.48 58.31 0.82 coo 33.81 121.65 59.26 35.49 119.55 59.81 78.83 50.67 7.29 78.71 47.88 7.60 coo 28.79 121.15 57.00 30.51 118.99 56.70 74.14 55.73 7.46 71.82 57.29 7.21 ULMN 3 1bu7_c03 CYTOCHROME P450 user 2 3 # 2 B 268 THR B 101 THR.? 7.80 C2 BME B 301 B 393 PHE B 76 PHE~? 11.05 S2 BME B 301 B 400 CYH B 74 CYH~? -2.15 S2 BME B 301s coo 37.20 116.32 52.00 35.18 117.07 52.13 62.74 59.71 -1.20 64.09 61.32 -1.60 coo 33.81 121.65 59.26 35.49 119.55 59.81 62.48 70.31 3.16 62.78 73.09 2.84 coo 28.79 121.15 57.00 30.51 118.99 56.70 66.79 65.33 5.35 68.26 63.59 7.03 1bu7_c03 source 1bu7 CYTOCHROME P450 : 2 hits 1bu7_c03 naa= 3 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 1 3 # 1 A 325 ASP B 129 ASP.? 27.81 S2 BME B 301 A 354 GLU B 130 GLU.? 21.96 S2 BME B 301 A 421 ASP B 44 ASP~? 23.69 S2 BME B 301 coo 31.05 49.37 64.51 31.97 51.11 63.85 64.27 77.57 -15.36 64.19 79.64 -15.85 coo 29.07 50.42 58.36 29.02 52.18 59.49 65.89 71.50 -12.95 66.09 70.43 -14.77 coo 30.82 59.76 58.47 31.12 59.02 60.40 59.88 65.23 -14.80 60.45 65.24 -16.84 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 2 3 # 2 A 325 ASP B 129 ASP.? 27.81 S2 BME B 301 A 354 GLU B 130 GLU.? 21.96 S2 BME B 301 A 421 ASP B 55 ASP~? 19.77 S2 BME B 301 coo 31.05 49.37 64.51 31.97 51.11 63.85 64.27 77.57 -15.36 64.19 79.64 -15.85 coo 29.07 50.42 58.36 29.02 52.18 59.49 65.89 71.50 -12.95 66.09 70.43 -14.77 coo 30.82 59.76 58.47 31.12 59.02 60.40 66.42 77.35 -5.07 66.48 77.29 -7.17 1bvz_c08 source 1bvz ALPHA-AMYLASE II : 2 hits 1bvz_c08 naa= 3 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 1 3 # 1 B 325 ASP A 44 ASP~? 20.39 O1 BME A 300 B 354 GLU A 7 GLU^? 21.08 O1 BME A 300 B 421 ASP B 27 ASP.? 24.30 C1 BME A 300 coo 25.90 8.19 53.87 25.36 6.97 52.29 83.66 51.21 -11.72 83.67 49.16 -12.23 coo 27.87 10.66 47.95 27.82 8.60 48.27 82.55 57.05 -16.50 82.95 55.46 -15.17 coo 26.02 1.87 43.38 25.90 1.97 45.49 90.17 63.25 -14.89 91.44 62.76 -13.27 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 2 3 # 2 B 325 ASP A 68 ASP~? 9.92 C1 BME B 301 B 354 GLU A 70 GLU~? 7.34 C1 BME B 301 B 421 ASP B 84 ASP^? 10.28 C2 BME B 301 coo 25.90 8.19 53.87 25.36 6.97 52.29 67.14 48.96 2.96 66.44 50.60 4.08 coo 27.87 10.66 47.95 27.82 8.60 48.27 68.92 53.57 0.58 67.76 55.17 -0.17 coo 26.02 1.87 43.38 25.90 1.97 45.49 64.49 54.82 11.77 62.58 54.12 11.40 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 3 3 # 3 B 325 ASP B 129 ASP.? 27.81 S2 BME B 301 B 354 GLU B 130 GLU.? 21.96 S2 BME B 301 B 421 ASP B 44 ASP~? 23.69 S2 BME B 301 coo 25.90 8.19 53.87 25.36 6.97 52.29 64.27 77.57 -15.36 64.19 79.64 -15.85 coo 27.87 10.66 47.95 27.82 8.60 48.27 65.89 71.50 -12.95 66.09 70.43 -14.77 coo 26.02 1.87 43.38 25.90 1.97 45.49 59.88 65.23 -14.80 60.45 65.24 -16.84 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 4 3 # 4 B 325 ASP B 129 ASP.? 27.81 S2 BME B 301 B 354 GLU B 130 GLU.? 21.96 S2 BME B 301 B 421 ASP B 55 ASP~? 19.77 S2 BME B 301 coo 25.90 8.19 53.87 25.36 6.97 52.29 64.27 77.57 -15.36 64.19 79.64 -15.85 coo 27.87 10.66 47.95 27.82 8.60 48.27 65.89 71.50 -12.95 66.09 70.43 -14.77 coo 26.02 1.87 43.38 25.90 1.97 45.49 66.42 77.35 -5.07 66.48 77.29 -7.17 1bvz_c09 source 1bvz ALPHA-AMYLASE II : 4 hits 1bvz_c09 naa= 3 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 1 3 # 1 229 ASP A 68 ASP~? 9.92 C1 BME B 301 264 GLU A 122 GLU~? 20.27 C2 BME A 300 328 ASP A 55 ASP~? 17.20 O1 BME A 300 coo 45.62 80.42 43.69 45.65 82.01 45.07 67.14 48.96 2.96 66.44 50.60 4.08 coo 59.69 92.71 39.85 58.53 92.03 41.47 83.94 41.43 11.78 84.52 42.47 13.54 coo 45.39 90.72 40.63 45.07 89.14 41.90 76.53 41.69 0.56 76.82 41.16 -1.46 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 2 3 # 2 229 ASP B 55 ASP~? 19.77 S2 BME B 301 264 GLU A 38 GLU^? 20.48 C1 BME A 300 328 ASP B 68 ASP~? 10.36 S2 BME B 301 coo 45.62 80.42 43.69 45.65 82.01 45.07 66.42 77.35 -5.07 66.48 77.29 -7.17 coo 59.69 92.71 39.85 58.53 92.03 41.47 80.67 68.42 -11.46 82.73 68.27 -11.88 coo 45.39 90.72 40.63 45.07 89.14 41.90 74.86 70.68 0.81 74.63 68.81 1.72 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 3 3 # 3 229 ASP B 68 ASP~? 10.36 S2 BME B 301 264 GLU B 122 GLU~? 20.09 S2 BME B 301 328 ASP B 55 ASP~? 19.77 S2 BME B 301 coo 45.62 80.42 43.69 45.65 82.01 45.07 74.86 70.68 0.81 74.63 68.81 1.72 coo 59.69 92.71 39.85 58.53 92.03 41.47 58.24 80.53 4.30 58.07 79.83 6.28 coo 45.39 90.72 40.63 45.07 89.14 41.90 66.42 77.35 -5.07 66.48 77.29 -7.17 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 4 3 # 4 229 ASP B 129 ASP.? 27.81 S2 BME B 301 264 GLU B 70 GLU~? 7.75 C1 BME A 300 328 ASP B 55 ASP~? 19.77 S2 BME B 301 coo 45.62 80.42 43.69 45.65 82.01 45.07 64.27 77.57 -15.36 64.19 79.64 -15.85 coo 59.69 92.71 39.85 58.53 92.03 41.47 72.71 65.28 -0.66 74.40 64.00 -0.70 coo 45.39 90.72 40.63 45.07 89.14 41.90 66.42 77.35 -5.07 66.48 77.29 -7.17 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 5 3 # 5 229 ASP B 129 ASP.? 27.81 S2 BME B 301 264 GLU B 122 GLU~? 20.09 S2 BME B 301 328 ASP B 55 ASP~? 19.77 S2 BME B 301 coo 45.62 80.42 43.69 45.65 82.01 45.07 64.27 77.57 -15.36 64.19 79.64 -15.85 coo 59.69 92.71 39.85 58.53 92.03 41.47 58.24 80.53 4.30 58.07 79.83 6.28 coo 45.39 90.72 40.63 45.07 89.14 41.90 66.42 77.35 -5.07 66.48 77.29 -7.17 1cdg_c00 source 1cdg CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.C.2.4.1.19: 5 hits 1cdg_c00 naa= 3 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 1 3 # 1 A 198 GLY A 54 GLY~? 12.91 O1 BME A 300 A 228 SER A 128 SER~? 18.41 O1 BME A 300 A 549 ASP A 129 ASP~? 19.06 O1 BME A 300 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 73.25 45.16 -0.27 73.90 44.96 0.21 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 77.93 38.84 -4.13 76.71 40.95 -4.16 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 80.80 42.21 -6.02 80.73 43.57 -7.63 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 2 3 # 2 A 198 GLY A 98 GLY.? -3.52 S2 BME A 300s A 228 SER B 71 SER~? 8.60 S2 BME B 301 A 549 ASP B 68 ASP~? 10.36 S2 BME B 301 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 74.17 61.90 8.39 74.00 62.65 8.00 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 71.04 68.14 4.29 73.26 68.66 5.07 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 74.86 70.68 0.81 74.63 68.81 1.72 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 3 3 # 3 A 198 GLY B 54 GLY~? 15.43 S2 BME B 301 A 228 SER B 57 SER~? 14.27 S2 BME B 301 A 549 ASP B 68 ASP~? 10.36 S2 BME B 301 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 69.56 73.71 -4.55 68.86 74.06 -4.25 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 70.33 75.49 -0.10 72.36 74.24 -0.48 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 74.86 70.68 0.81 74.63 68.81 1.72 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 4 3 # 4 A 198 GLY B 98 GLY.? -3.46 C2 BME B 301s A 228 SER A 71 SER~? 8.26 C1 BME B 301 A 549 ASP A 68 ASP~? 9.92 C1 BME B 301 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 65.71 59.42 7.74 66.01 58.68 7.45 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 70.10 52.54 6.16 67.71 52.03 6.39 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 67.14 48.96 2.96 66.44 50.60 4.08 1cjy_c00 source 1cjy CYTOSOLIC PHOSPHOLIPASE A2 : 4 hits 1cjy_c00 naa= 3 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 1 3 # 1 B1198 GLY A 54 GLY~? 12.91 O1 BME A 300 B1228 SER A 128 SER~? 18.41 O1 BME A 300 B1549 ASP A 129 ASP~? 19.06 O1 BME A 300 coo 126.34 72.75 125.66 125.95 73.27 126.11 73.25 45.16 -0.27 73.90 44.96 0.21 coo 131.65 74.68 129.41 130.31 72.73 128.82 77.93 38.84 -4.13 76.71 40.95 -4.16 coo 134.72 69.43 130.42 133.03 70.65 130.08 80.80 42.21 -6.02 80.73 43.57 -7.63 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 2 3 # 2 B1198 GLY A 98 GLY.? -3.52 S2 BME A 300s B1228 SER B 71 SER~? 8.60 S2 BME B 301 B1549 ASP B 68 ASP~? 10.36 S2 BME B 301 coo 126.34 72.75 125.66 125.95 73.27 126.11 74.17 61.90 8.39 74.00 62.65 8.00 coo 131.65 74.68 129.41 130.31 72.73 128.82 71.04 68.14 4.29 73.26 68.66 5.07 coo 134.72 69.43 130.42 133.03 70.65 130.08 74.86 70.68 0.81 74.63 68.81 1.72 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 3 3 # 3 B1198 GLY B 98 GLY.? -3.46 C2 BME B 301s B1228 SER A 71 SER~? 8.26 C1 BME B 301 B1549 ASP A 68 ASP~? 9.92 C1 BME B 301 coo 126.34 72.75 125.66 125.95 73.27 126.11 65.71 59.42 7.74 66.01 58.68 7.45 coo 131.65 74.68 129.41 130.31 72.73 128.82 70.10 52.54 6.16 67.71 52.03 6.39 coo 134.72 69.43 130.42 133.03 70.65 130.08 67.14 48.96 2.96 66.44 50.60 4.08 1cjy_c01 source 1cjy CYTOSOLIC PHOSPHOLIPASE A2 : 3 hits 1cjy_c01 naa= 3 ULMN 3 1cns_c00 CHITINASE user 1 3 # 1 A 67 GLU A 38 GLU^? 20.48 C1 BME A 300 A 89 GLU A 7 GLU^? 21.08 O1 BME A 300 A 120 SER A 42 SER~? 18.41 C1 BME A 300 coo -24.35 9.53 67.64 -25.07 11.29 68.60 80.67 68.42 -11.46 82.73 68.27 -11.88 coo -31.18 6.91 75.60 -32.39 8.51 74.91 82.55 57.05 -16.50 82.95 55.46 -15.17 coo -34.73 8.57 68.21 -33.63 9.08 70.28 83.78 56.74 -9.93 84.51 54.83 -11.21 ULMN 3 1cns_c00 CHITINASE user 2 3 # 2 A 67 GLU A 136 GLU~? 27.28 O1 BME A 300 A 89 GLU A 130 GLU~? 23.04 O1 BME A 300 A 120 SER A 128 SER~? 18.41 O1 BME A 300 coo -24.35 9.53 67.64 -25.07 11.29 68.60 81.55 37.42 -15.14 81.99 39.46 -15.20 coo -31.18 6.91 75.60 -32.39 8.51 74.91 84.58 38.87 -3.95 85.40 38.00 -2.18 coo -34.73 8.57 68.21 -33.63 9.08 70.28 77.93 38.84 -4.13 76.71 40.95 -4.16 1cns_c00 source 1cns CHITINASE : 2 hits 1cns_c00 naa= 3 ULMN 3 1ct9_c04 ASPARAGINE SYNTHETASE B user 1 3 # 1 A 1 ALA A 90 ALA.? 16.34 S2 BME B 301 A 74 ASN A 88 ASN.? 14.08 S2 BME B 301 A 75 GLY A 93 GLY.? 15.31 S2 BME B 301 coo -1.80 62.71 122.76 -1.88 63.70 123.92 58.27 73.33 13.07 57.55 72.13 13.66 coo 1.20 66.40 122.20 2.03 64.53 121.46 62.51 69.97 13.22 61.16 70.64 14.74 coo 4.68 65.84 125.52 4.11 65.60 126.05 62.45 69.60 17.87 62.71 70.25 17.36 ULMN 3 1ct9_c04 ASPARAGINE SYNTHETASE B user 2 3 # 2 A 1 ALA A 90 ALA.? 16.34 S2 BME B 301 A 74 ASN A 92 ASN.? 17.57 S2 BME B 301 A 75 GLY A 93 GLY.? 15.31 S2 BME B 301 coo -1.80 62.71 122.76 -1.88 63.70 123.92 58.27 73.33 13.07 57.55 72.13 13.66 coo 1.20 66.40 122.20 2.03 64.53 121.46 58.62 72.30 18.50 57.75 71.24 16.88 coo 4.68 65.84 125.52 4.11 65.60 126.05 62.45 69.60 17.87 62.71 70.25 17.36 ULMN 3 1ct9_c04 ASPARAGINE SYNTHETASE B user 3 3 # 3 A 1 ALA B 90 ALA.? 15.84 C2 BME A 300 A 74 ASN B 88 ASN.? 14.13 C2 BME A 300 A 75 GLY B 93 GLY.? 15.48 C2 BME A 300 coo -1.80 62.71 122.76 -1.88 63.70 123.92 80.35 50.63 18.53 80.97 51.96 18.93 coo 1.20 66.40 122.20 2.03 64.53 121.46 76.46 53.84 16.90 77.36 53.44 18.78 coo 4.68 65.84 125.52 4.11 65.60 126.05 75.52 55.36 20.96 75.34 54.55 20.70 ULMN 3 1ct9_c04 ASPARAGINE SYNTHETASE B user 4 3 # 4 A 1 ALA B 90 ALA.? 15.84 C2 BME A 300 A 74 ASN B 92 ASN.? 17.15 C2 BME A 300 A 75 GLY B 93 GLY.? 15.48 C2 BME A 300 coo -1.80 62.71 122.76 -1.88 63.70 123.92 80.35 50.63 18.53 80.97 51.96 18.93 coo 1.20 66.40 122.20 2.03 64.53 121.46 79.23 53.21 23.13 80.31 54.07 21.53 coo 4.68 65.84 125.52 4.11 65.60 126.05 75.52 55.36 20.96 75.34 54.55 20.70 1ct9_c04 source 1ct9 ASPARAGINE SYNTHETASE B : 4 hits 1ct9_c04 naa= 3 ULMN 3 1ct9_c05 ASPARAGINE SYNTHETASE B user 1 3 # 1 B 1 ALA A 90 ALA.? 16.34 S2 BME B 301 B 74 ASN A 88 ASN.? 14.08 S2 BME B 301 B 75 GLY A 93 GLY.? 15.31 S2 BME B 301 coo 39.21 14.97 27.55 40.19 16.01 27.08 58.27 73.33 13.07 57.55 72.13 13.66 coo 43.06 12.94 25.74 42.26 11.81 27.44 62.51 69.97 13.22 61.16 70.64 14.74 coo 46.38 13.54 29.18 46.14 14.29 29.26 62.45 69.60 17.87 62.71 70.25 17.36 ULMN 3 1ct9_c05 ASPARAGINE SYNTHETASE B user 2 3 # 2 B 1 ALA A 90 ALA.? 16.34 S2 BME B 301 B 74 ASN A 92 ASN.? 17.57 S2 BME B 301 B 75 GLY A 93 GLY.? 15.31 S2 BME B 301 coo 39.21 14.97 27.55 40.19 16.01 27.08 58.27 73.33 13.07 57.55 72.13 13.66 coo 43.06 12.94 25.74 42.26 11.81 27.44 58.62 72.30 18.50 57.75 71.24 16.88 coo 46.38 13.54 29.18 46.14 14.29 29.26 62.45 69.60 17.87 62.71 70.25 17.36 ULMN 3 1ct9_c05 ASPARAGINE SYNTHETASE B user 3 3 # 3 B 1 ALA B 90 ALA.? 15.84 C2 BME A 300 B 74 ASN B 88 ASN.? 14.13 C2 BME A 300 B 75 GLY B 93 GLY.? 15.48 C2 BME A 300 coo 39.21 14.97 27.55 40.19 16.01 27.08 80.35 50.63 18.53 80.97 51.96 18.93 coo 43.06 12.94 25.74 42.26 11.81 27.44 76.46 53.84 16.90 77.36 53.44 18.78 coo 46.38 13.54 29.18 46.14 14.29 29.26 75.52 55.36 20.96 75.34 54.55 20.70 ULMN 3 1ct9_c05 ASPARAGINE SYNTHETASE B user 4 3 # 4 B 1 ALA B 90 ALA.? 15.84 C2 BME A 300 B 74 ASN B 92 ASN.? 17.15 C2 BME A 300 B 75 GLY B 93 GLY.? 15.48 C2 BME A 300 coo 39.21 14.97 27.55 40.19 16.01 27.08 80.35 50.63 18.53 80.97 51.96 18.93 coo 43.06 12.94 25.74 42.26 11.81 27.44 79.23 53.21 23.13 80.31 54.07 21.53 coo 46.38 13.54 29.18 46.14 14.29 29.26 75.52 55.36 20.96 75.34 54.55 20.70 1ct9_c05 source 1ct9 ASPARAGINE SYNTHETASE B : 4 hits 1ct9_c05 naa= 3 ULMN 3 1ct9_c06 ASPARAGINE SYNTHETASE B user 1 3 # 1 C 1 ALA A 90 ALA.? 16.34 S2 BME B 301 C 74 ASN A 88 ASN.? 14.08 S2 BME B 301 C 75 GLY A 93 GLY.? 15.31 S2 BME B 301 coo 16.14 15.08 36.63 15.28 14.65 37.81 58.27 73.33 13.07 57.55 72.13 13.66 coo 11.60 16.13 36.70 12.80 17.74 35.96 62.51 69.97 13.22 61.16 70.64 14.74 coo 10.99 19.23 40.32 11.50 18.77 40.74 62.45 69.60 17.87 62.71 70.25 17.36 ULMN 3 1ct9_c06 ASPARAGINE SYNTHETASE B user 2 3 # 2 C 1 ALA A 90 ALA.? 16.34 S2 BME B 301 C 74 ASN A 92 ASN.? 17.57 S2 BME B 301 C 75 GLY A 93 GLY.? 15.31 S2 BME B 301 coo 16.14 15.08 36.63 15.28 14.65 37.81 58.27 73.33 13.07 57.55 72.13 13.66 coo 11.60 16.13 36.70 12.80 17.74 35.96 58.62 72.30 18.50 57.75 71.24 16.88 coo 10.99 19.23 40.32 11.50 18.77 40.74 62.45 69.60 17.87 62.71 70.25 17.36 ULMN 3 1ct9_c06 ASPARAGINE SYNTHETASE B user 3 3 # 3 C 1 ALA B 90 ALA.? 15.84 C2 BME A 300 C 74 ASN B 88 ASN.? 14.13 C2 BME A 300 C 75 GLY B 93 GLY.? 15.48 C2 BME A 300 coo 16.14 15.08 36.63 15.28 14.65 37.81 80.35 50.63 18.53 80.97 51.96 18.93 coo 11.60 16.13 36.70 12.80 17.74 35.96 76.46 53.84 16.90 77.36 53.44 18.78 coo 10.99 19.23 40.32 11.50 18.77 40.74 75.52 55.36 20.96 75.34 54.55 20.70 ULMN 3 1ct9_c06 ASPARAGINE SYNTHETASE B user 4 3 # 4 C 1 ALA B 90 ALA.? 15.84 C2 BME A 300 C 74 ASN B 92 ASN.? 17.15 C2 BME A 300 C 75 GLY B 93 GLY.? 15.48 C2 BME A 300 coo 16.14 15.08 36.63 15.28 14.65 37.81 80.35 50.63 18.53 80.97 51.96 18.93 coo 11.60 16.13 36.70 12.80 17.74 35.96 79.23 53.21 23.13 80.31 54.07 21.53 coo 10.99 19.23 40.32 11.50 18.77 40.74 75.52 55.36 20.96 75.34 54.55 20.70 1ct9_c06 source 1ct9 ASPARAGINE SYNTHETASE B : 4 hits 1ct9_c06 naa= 3 ULMN 3 1ct9_c07 ASPARAGINE SYNTHETASE B user 1 3 # 1 D 1 ALA A 90 ALA.? 16.34 S2 BME B 301 D 74 ASN A 88 ASN.? 14.08 S2 BME B 301 D 75 GLY A 93 GLY.? 15.31 S2 BME B 301 coo -13.31 41.90 116.45 -13.05 40.39 116.25 58.27 73.33 13.07 57.55 72.13 13.66 coo -16.85 39.36 115.26 -17.55 40.58 116.90 62.51 69.97 13.22 61.16 70.64 14.74 coo -17.65 36.37 119.00 -16.85 36.22 119.00 62.45 69.60 17.87 62.71 70.25 17.36 ULMN 3 1ct9_c07 ASPARAGINE SYNTHETASE B user 2 3 # 2 D 1 ALA A 90 ALA.? 16.34 S2 BME B 301 D 74 ASN A 92 ASN.? 17.57 S2 BME B 301 D 75 GLY A 93 GLY.? 15.31 S2 BME B 301 coo -13.31 41.90 116.45 -13.05 40.39 116.25 58.27 73.33 13.07 57.55 72.13 13.66 coo -16.85 39.36 115.26 -17.55 40.58 116.90 58.62 72.30 18.50 57.75 71.24 16.88 coo -17.65 36.37 119.00 -16.85 36.22 119.00 62.45 69.60 17.87 62.71 70.25 17.36 ULMN 3 1ct9_c07 ASPARAGINE SYNTHETASE B user 3 3 # 3 D 1 ALA B 90 ALA.? 15.84 C2 BME A 300 D 74 ASN B 88 ASN.? 14.13 C2 BME A 300 D 75 GLY B 93 GLY.? 15.48 C2 BME A 300 coo -13.31 41.90 116.45 -13.05 40.39 116.25 80.35 50.63 18.53 80.97 51.96 18.93 coo -16.85 39.36 115.26 -17.55 40.58 116.90 76.46 53.84 16.90 77.36 53.44 18.78 coo -17.65 36.37 119.00 -16.85 36.22 119.00 75.52 55.36 20.96 75.34 54.55 20.70 ULMN 3 1ct9_c07 ASPARAGINE SYNTHETASE B user 4 3 # 4 D 1 ALA B 90 ALA.? 15.84 C2 BME A 300 D 74 ASN B 92 ASN.? 17.15 C2 BME A 300 D 75 GLY B 93 GLY.? 15.48 C2 BME A 300 coo -13.31 41.90 116.45 -13.05 40.39 116.25 80.35 50.63 18.53 80.97 51.96 18.93 coo -16.85 39.36 115.26 -17.55 40.58 116.90 79.23 53.21 23.13 80.31 54.07 21.53 coo -17.65 36.37 119.00 -16.85 36.22 119.00 75.52 55.36 20.96 75.34 54.55 20.70 1ct9_c07 source 1ct9 ASPARAGINE SYNTHETASE B : 4 hits 1ct9_c07 naa= 3 ULMN 3 1cwy_c00 AMYLOMALTASE user 1 3 # 1 A 293 ASP B 129 ASP.? 27.81 S2 BME B 301 A 340 GLU B 130 GLU.? 21.96 S2 BME B 301 A 395 ASP B 55 ASP~? 19.77 S2 BME B 301 coo -48.00 -26.48 6.86 -46.51 -25.94 5.49 64.27 77.57 -15.36 64.19 79.64 -15.85 coo -43.58 -29.03 7.13 -42.45 -27.34 7.75 65.89 71.50 -12.95 66.09 70.43 -14.77 coo -42.28 -26.47 -1.32 -44.06 -25.60 -0.58 66.42 77.35 -5.07 66.48 77.29 -7.17 1cwy_c00 source 1cwy AMYLOMALTASE : 1 hits 1cwy_c00 naa= 3 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 1 3 # 1 A 138 TRP B 127 TRP.? 20.56 S2 BME B 301 A 243 ASP B 55 ASP~? 19.77 S2 BME B 301 A 272 LYS B 48 LYS~? 21.20 S2 BME B 301 coo 18.21 54.75 18.05 19.91 55.17 21.59 60.13 79.81 -6.22 61.23 77.20 -3.48 coo 16.93 55.67 9.65 17.16 54.23 11.19 66.42 77.35 -5.07 66.48 77.29 -7.17 coo 14.13 45.79 13.40 14.25 49.41 18.30 62.47 69.43 -9.84 56.65 72.06 -9.69 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 2 3 # 2 A 138 TRP B 127 TRP.? 20.56 S2 BME B 301 A 243 ASP B 129 ASP.? 27.81 S2 BME B 301 A 272 LYS B 48 LYS~? 21.20 S2 BME B 301 coo 18.21 54.75 18.05 19.91 55.17 21.59 60.13 79.81 -6.22 61.23 77.20 -3.48 coo 16.93 55.67 9.65 17.16 54.23 11.19 64.27 77.57 -15.36 64.19 79.64 -15.85 coo 14.13 45.79 13.40 14.25 49.41 18.30 62.47 69.43 -9.84 56.65 72.06 -9.69 1d7r_c01 source 1d7r 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYRUVATE) : 2 hits 1d7r_c01 naa= 3 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 1 3 # 1 A 145 LYS A 81 LYS~? 9.69 C2 BME A 300 A 177 GLU A 111 GLU~? 14.81 C1 BME A 300 A 201 LEU A 80 LEU~? 9.60 C2 BME A 300 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 81.93 61.05 10.82 83.04 64.25 6.21 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 89.56 55.57 5.81 89.83 56.98 7.35 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 83.70 57.43 9.09 84.12 55.31 8.78 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 2 3 # 2 A 145 LYS B 81 LYS~? 11.51 C2 BME B 301 A 177 GLU B 108 GLU~? 13.67 C2 BME B 301 A 201 LEU B 80 LEU~? 11.70 S2 BME B 301 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 58.04 61.64 8.69 57.58 55.47 6.95 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 54.86 59.36 -0.28 55.08 57.73 1.04 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 56.76 64.71 5.48 56.13 66.38 4.27 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 3 3 # 3 A 145 LYS B 81 LYS~? 11.51 C2 BME B 301 A 177 GLU B 111 GLU~? 15.73 S2 BME B 301 A 201 LEU B 80 LEU~? 11.70 S2 BME B 301 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 58.04 61.64 8.69 57.58 55.47 6.95 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 52.67 66.26 1.65 52.32 64.94 3.26 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 56.76 64.71 5.48 56.13 66.38 4.27 1daa_c00 source 1daa D-AMINO ACID AMINOTRANSFERASE : 3 hits 1daa_c00 naa= 3 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 1 3 # 1 B 145 LYS A 81 LYS~? 9.69 C2 BME A 300 B 177 GLU A 108 GLU~? 11.49 C1 BME A 300 B 201 LEU A 80 LEU~? 9.60 C2 BME A 300 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 81.93 61.05 10.82 83.04 64.25 6.21 coo 27.00 6.35 51.01 26.30 4.53 50.18 87.15 61.55 3.86 85.80 63.08 4.38 coo 23.74 1.68 49.50 22.87 -0.24 49.97 83.70 57.43 9.09 84.12 55.31 8.78 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 2 3 # 2 B 145 LYS A 81 LYS~? 9.69 C2 BME A 300 B 177 GLU A 111 GLU~? 14.81 C1 BME A 300 B 201 LEU A 80 LEU~? 9.60 C2 BME A 300 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 81.93 61.05 10.82 83.04 64.25 6.21 coo 27.00 6.35 51.01 26.30 4.53 50.18 89.56 55.57 5.81 89.83 56.98 7.35 coo 23.74 1.68 49.50 22.87 -0.24 49.97 83.70 57.43 9.09 84.12 55.31 8.78 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 3 3 # 3 B 145 LYS B 81 LYS~? 11.51 C2 BME B 301 B 177 GLU B 111 GLU~? 15.73 S2 BME B 301 B 201 LEU B 80 LEU~? 11.70 S2 BME B 301 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 58.04 61.64 8.69 57.58 55.47 6.95 coo 27.00 6.35 51.01 26.30 4.53 50.18 52.67 66.26 1.65 52.32 64.94 3.26 coo 23.74 1.68 49.50 22.87 -0.24 49.97 56.76 64.71 5.48 56.13 66.38 4.27 1daa_c01 source 1daa D-AMINO ACID AMINOTRANSFERASE : 3 hits 1daa_c01 naa= 3 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 A 57 GLU A 108 GLU~? 11.49 C1 BME A 300 A 226 THR A 121 THR~? 20.71 O1 BME A 300 A 229 LYS A 126 LYS.? 26.12 O1 BME A 300 coo 9.66 102.78 70.07 9.79 101.18 71.42 87.15 61.55 3.86 85.80 63.08 4.38 coo 7.24 97.46 49.60 8.11 95.69 48.80 84.25 40.08 6.83 86.21 40.39 6.13 coo 10.53 97.56 43.71 9.33 93.71 47.17 79.50 36.17 1.43 79.74 32.57 -2.57 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 A 57 GLU A 130 GLU~? 23.04 O1 BME A 300 A 226 THR A 77 THR~? -3.44 C2 BME A 300s A 229 LYS A 81 LYS~? 9.69 C2 BME A 300 coo 9.66 102.78 70.07 9.79 101.18 71.42 84.58 38.87 -3.95 85.40 38.00 -2.18 coo 7.24 97.46 49.60 8.11 95.69 48.80 79.06 56.59 7.66 78.46 57.92 6.11 coo 10.53 97.56 43.71 9.33 93.71 47.17 81.93 61.05 10.82 83.04 64.25 6.21 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 A 57 GLU B 38 GLU^? 31.80 C2 BME B 301 A 226 THR B 101 THR.? 7.80 C2 BME B 301 A 229 LYS B 73 LYS~? 5.56 C2 BME B 301 coo 9.66 102.78 70.07 9.79 101.18 71.42 61.52 60.14 -24.13 60.63 59.15 -25.77 coo 7.24 97.46 49.60 8.11 95.69 48.80 62.74 59.71 -1.20 64.09 61.32 -1.60 coo 10.53 97.56 43.71 9.33 93.71 47.17 66.37 67.01 1.95 66.56 61.98 -0.01 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 A 57 GLU B 61 GLU.? 21.77 S2 BME B 301 A 226 THR A 101 THR.? -4.16 C1 BME A 300s A 229 LYS A 73 LYS~? -2.81 O1 BME A 300s coo 9.66 102.78 70.07 9.79 101.18 71.42 72.49 81.24 7.40 73.27 83.04 8.17 coo 7.24 97.46 49.60 8.11 95.69 48.80 78.82 59.97 0.83 77.48 58.31 0.82 coo 10.53 97.56 43.71 9.33 93.71 47.17 75.23 53.47 4.59 74.97 57.96 1.35 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 A 57 GLU B 108 GLU~? 13.67 C2 BME B 301 A 226 THR B 121 THR~? 23.09 S2 BME B 301 A 229 LYS B 126 LYS.? 28.14 S2 BME B 301 coo 9.66 102.78 70.07 9.79 101.18 71.42 54.86 59.36 -0.28 55.08 57.73 1.04 coo 7.24 97.46 49.60 8.11 95.69 48.80 58.24 81.00 -0.76 56.42 80.96 -1.87 coo 10.53 97.56 43.71 9.33 93.71 47.17 64.27 82.78 -6.16 67.59 84.99 -10.95 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 A 57 GLU B 130 GLU.? 21.96 S2 BME B 301 A 226 THR A 101 THR.? -4.16 C1 BME A 300s A 229 LYS A 73 LYS~? -2.81 O1 BME A 300s coo 9.66 102.78 70.07 9.79 101.18 71.42 65.89 71.50 -12.95 66.09 70.43 -14.77 coo 7.24 97.46 49.60 8.11 95.69 48.80 78.82 59.97 0.83 77.48 58.31 0.82 coo 10.53 97.56 43.71 9.33 93.71 47.17 75.23 53.47 4.59 74.97 57.96 1.35 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 7 3 # 7 A 57 GLU B 130 GLU.? 21.96 S2 BME B 301 A 226 THR B 77 THR~? 5.05 S2 BME B 301 A 229 LYS B 81 LYS~? 11.51 C2 BME B 301 coo 9.66 102.78 70.07 9.79 101.18 71.42 65.89 71.50 -12.95 66.09 70.43 -14.77 coo 7.24 97.46 49.60 8.11 95.69 48.80 61.38 64.71 4.62 63.06 63.57 3.91 coo 10.53 97.56 43.71 9.33 93.71 47.17 58.04 61.64 8.69 57.58 55.47 6.95 1dfo_c04 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 7 hits 1dfo_c04 naa= 3 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 B 57 GLU A 108 GLU~? 11.49 C1 BME A 300 B 226 THR A 121 THR~? 20.71 O1 BME A 300 B 229 LYS A 126 LYS.? 26.12 O1 BME A 300 coo 15.90 87.61 49.61 13.92 86.96 49.36 87.15 61.55 3.86 85.80 63.08 4.38 coo 20.74 95.78 68.68 19.29 96.84 69.83 84.25 40.08 6.83 86.21 40.39 6.13 coo 22.32 101.61 71.64 17.89 98.63 71.55 79.50 36.17 1.43 79.74 32.57 -2.57 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 B 57 GLU A 130 GLU~? 23.04 O1 BME A 300 B 226 THR A 77 THR~? -3.44 C2 BME A 300s B 229 LYS A 81 LYS~? 9.69 C2 BME A 300 coo 15.90 87.61 49.61 13.92 86.96 49.36 84.58 38.87 -3.95 85.40 38.00 -2.18 coo 20.74 95.78 68.68 19.29 96.84 69.83 79.06 56.59 7.66 78.46 57.92 6.11 coo 22.32 101.61 71.64 17.89 98.63 71.55 81.93 61.05 10.82 83.04 64.25 6.21 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 B 57 GLU B 61 GLU.? 21.77 S2 BME B 301 B 226 THR A 101 THR.? -4.16 C1 BME A 300s B 229 LYS A 73 LYS~? -2.81 O1 BME A 300s coo 15.90 87.61 49.61 13.92 86.96 49.36 72.49 81.24 7.40 73.27 83.04 8.17 coo 20.74 95.78 68.68 19.29 96.84 69.83 78.82 59.97 0.83 77.48 58.31 0.82 coo 22.32 101.61 71.64 17.89 98.63 71.55 75.23 53.47 4.59 74.97 57.96 1.35 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 B 57 GLU B 108 GLU~? 13.67 C2 BME B 301 B 226 THR B 121 THR~? 23.09 S2 BME B 301 B 229 LYS B 126 LYS.? 28.14 S2 BME B 301 coo 15.90 87.61 49.61 13.92 86.96 49.36 54.86 59.36 -0.28 55.08 57.73 1.04 coo 20.74 95.78 68.68 19.29 96.84 69.83 58.24 81.00 -0.76 56.42 80.96 -1.87 coo 22.32 101.61 71.64 17.89 98.63 71.55 64.27 82.78 -6.16 67.59 84.99 -10.95 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 B 57 GLU B 130 GLU.? 21.96 S2 BME B 301 B 226 THR A 101 THR.? -4.16 C1 BME A 300s B 229 LYS A 73 LYS~? -2.81 O1 BME A 300s coo 15.90 87.61 49.61 13.92 86.96 49.36 65.89 71.50 -12.95 66.09 70.43 -14.77 coo 20.74 95.78 68.68 19.29 96.84 69.83 78.82 59.97 0.83 77.48 58.31 0.82 coo 22.32 101.61 71.64 17.89 98.63 71.55 75.23 53.47 4.59 74.97 57.96 1.35 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 B 57 GLU B 130 GLU.? 21.96 S2 BME B 301 B 226 THR B 77 THR~? 5.05 S2 BME B 301 B 229 LYS B 81 LYS~? 11.51 C2 BME B 301 coo 15.90 87.61 49.61 13.92 86.96 49.36 65.89 71.50 -12.95 66.09 70.43 -14.77 coo 20.74 95.78 68.68 19.29 96.84 69.83 61.38 64.71 4.62 63.06 63.57 3.91 coo 22.32 101.61 71.64 17.89 98.63 71.55 58.04 61.64 8.69 57.58 55.47 6.95 1dfo_c05 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 6 hits 1dfo_c05 naa= 3 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 C 57 GLU A 108 GLU~? 11.49 C1 BME A 300 C 226 THR A 121 THR~? 20.71 O1 BME A 300 C 229 LYS A 126 LYS.? 26.12 O1 BME A 300 coo 5.43 40.40 61.63 4.27 41.99 60.90 87.15 61.55 3.86 85.80 63.08 4.38 coo 22.16 45.88 73.63 23.23 47.70 73.25 84.25 40.08 6.83 86.21 40.39 6.13 coo 28.90 45.91 73.55 25.22 49.72 72.97 79.50 36.17 1.43 79.74 32.57 -2.57 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 C 57 GLU A 130 GLU~? 23.04 O1 BME A 300 C 226 THR A 77 THR~? -3.44 C2 BME A 300s C 229 LYS A 81 LYS~? 9.69 C2 BME A 300 coo 5.43 40.40 61.63 4.27 41.99 60.90 84.58 38.87 -3.95 85.40 38.00 -2.18 coo 22.16 45.88 73.63 23.23 47.70 73.25 79.06 56.59 7.66 78.46 57.92 6.11 coo 28.90 45.91 73.55 25.22 49.72 72.97 81.93 61.05 10.82 83.04 64.25 6.21 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 C 57 GLU B 61 GLU.? 21.77 S2 BME B 301 C 226 THR A 101 THR.? -4.16 C1 BME A 300s C 229 LYS A 73 LYS~? -2.81 O1 BME A 300s coo 5.43 40.40 61.63 4.27 41.99 60.90 72.49 81.24 7.40 73.27 83.04 8.17 coo 22.16 45.88 73.63 23.23 47.70 73.25 78.82 59.97 0.83 77.48 58.31 0.82 coo 28.90 45.91 73.55 25.22 49.72 72.97 75.23 53.47 4.59 74.97 57.96 1.35 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 C 57 GLU B 108 GLU~? 13.67 C2 BME B 301 C 226 THR B 121 THR~? 23.09 S2 BME B 301 C 229 LYS B 126 LYS.? 28.14 S2 BME B 301 coo 5.43 40.40 61.63 4.27 41.99 60.90 54.86 59.36 -0.28 55.08 57.73 1.04 coo 22.16 45.88 73.63 23.23 47.70 73.25 58.24 81.00 -0.76 56.42 80.96 -1.87 coo 28.90 45.91 73.55 25.22 49.72 72.97 64.27 82.78 -6.16 67.59 84.99 -10.95 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 C 57 GLU B 130 GLU.? 21.96 S2 BME B 301 C 226 THR A 101 THR.? -4.16 C1 BME A 300s C 229 LYS A 73 LYS~? -2.81 O1 BME A 300s coo 5.43 40.40 61.63 4.27 41.99 60.90 65.89 71.50 -12.95 66.09 70.43 -14.77 coo 22.16 45.88 73.63 23.23 47.70 73.25 78.82 59.97 0.83 77.48 58.31 0.82 coo 28.90 45.91 73.55 25.22 49.72 72.97 75.23 53.47 4.59 74.97 57.96 1.35 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 C 57 GLU B 130 GLU.? 21.96 S2 BME B 301 C 226 THR B 77 THR~? 5.05 S2 BME B 301 C 229 LYS B 81 LYS~? 11.51 C2 BME B 301 coo 5.43 40.40 61.63 4.27 41.99 60.90 65.89 71.50 -12.95 66.09 70.43 -14.77 coo 22.16 45.88 73.63 23.23 47.70 73.25 61.38 64.71 4.62 63.06 63.57 3.91 coo 28.90 45.91 73.55 25.22 49.72 72.97 58.04 61.64 8.69 57.58 55.47 6.95 1dfo_c06 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 6 hits 1dfo_c06 naa= 3 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 D 57 GLU A 108 GLU~? 11.49 C1 BME A 300 D 226 THR A 121 THR~? 20.71 O1 BME A 300 D 229 LYS A 126 LYS.? 26.12 O1 BME A 300 coo 26.07 55.89 66.14 25.33 56.50 68.01 87.15 61.55 3.86 85.80 63.08 4.38 coo 11.79 47.62 52.67 10.10 46.51 53.39 84.25 40.08 6.83 86.21 40.39 6.13 coo 10.05 41.79 49.80 7.94 44.71 53.76 79.50 36.17 1.43 79.74 32.57 -2.57 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 D 57 GLU A 130 GLU~? 23.04 O1 BME A 300 D 226 THR A 77 THR~? -3.44 C2 BME A 300s D 229 LYS A 81 LYS~? 9.69 C2 BME A 300 coo 26.07 55.89 66.14 25.33 56.50 68.01 84.58 38.87 -3.95 85.40 38.00 -2.18 coo 11.79 47.62 52.67 10.10 46.51 53.39 79.06 56.59 7.66 78.46 57.92 6.11 coo 10.05 41.79 49.80 7.94 44.71 53.76 81.93 61.05 10.82 83.04 64.25 6.21 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 D 57 GLU B 61 GLU.? 21.77 S2 BME B 301 D 226 THR A 101 THR.? -4.16 C1 BME A 300s D 229 LYS A 73 LYS~? -2.81 O1 BME A 300s coo 26.07 55.89 66.14 25.33 56.50 68.01 72.49 81.24 7.40 73.27 83.04 8.17 coo 11.79 47.62 52.67 10.10 46.51 53.39 78.82 59.97 0.83 77.48 58.31 0.82 coo 10.05 41.79 49.80 7.94 44.71 53.76 75.23 53.47 4.59 74.97 57.96 1.35 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 D 57 GLU B 108 GLU~? 13.67 C2 BME B 301 D 226 THR B 121 THR~? 23.09 S2 BME B 301 D 229 LYS B 126 LYS.? 28.14 S2 BME B 301 coo 26.07 55.89 66.14 25.33 56.50 68.01 54.86 59.36 -0.28 55.08 57.73 1.04 coo 11.79 47.62 52.67 10.10 46.51 53.39 58.24 81.00 -0.76 56.42 80.96 -1.87 coo 10.05 41.79 49.80 7.94 44.71 53.76 64.27 82.78 -6.16 67.59 84.99 -10.95 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 D 57 GLU B 130 GLU.? 21.96 S2 BME B 301 D 226 THR A 101 THR.? -4.16 C1 BME A 300s D 229 LYS A 73 LYS~? -2.81 O1 BME A 300s coo 26.07 55.89 66.14 25.33 56.50 68.01 65.89 71.50 -12.95 66.09 70.43 -14.77 coo 11.79 47.62 52.67 10.10 46.51 53.39 78.82 59.97 0.83 77.48 58.31 0.82 coo 10.05 41.79 49.80 7.94 44.71 53.76 75.23 53.47 4.59 74.97 57.96 1.35 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 D 57 GLU B 130 GLU.? 21.96 S2 BME B 301 D 226 THR B 77 THR~? 5.05 S2 BME B 301 D 229 LYS B 81 LYS~? 11.51 C2 BME B 301 coo 26.07 55.89 66.14 25.33 56.50 68.01 65.89 71.50 -12.95 66.09 70.43 -14.77 coo 11.79 47.62 52.67 10.10 46.51 53.39 61.38 64.71 4.62 63.06 63.57 3.91 coo 10.05 41.79 49.80 7.94 44.71 53.76 58.04 61.64 8.69 57.58 55.47 6.95 1dfo_c07 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 6 hits 1dfo_c07 naa= 3 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 1 3 # 1 A 44 THR A 35 THR^? 22.22 O1 BME A 300 A 45 THR B 5 THR.? 22.65 S2 BME B 301 A 161 LYS A 3 LYS.? 20.23 O1 BME A 300 coo 26.16 88.25 79.16 25.22 89.47 80.71 72.00 65.36 -18.45 71.15 64.17 -16.85 coo 27.73 89.90 76.08 29.24 91.46 75.95 70.08 69.00 -17.47 68.54 67.93 -16.36 coo 33.83 91.15 88.62 31.07 91.06 83.02 68.61 55.34 -21.58 71.21 56.20 -15.92 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 2 3 # 2 A 44 THR B 5 THR.? 22.65 S2 BME B 301 A 45 THR A 35 THR^? 22.22 O1 BME A 300 A 161 LYS B 48 LYS~? 21.20 S2 BME B 301 coo 26.16 88.25 79.16 25.22 89.47 80.71 70.08 69.00 -17.47 68.54 67.93 -16.36 coo 27.73 89.90 76.08 29.24 91.46 75.95 72.00 65.36 -18.45 71.15 64.17 -16.85 coo 33.83 91.15 88.62 31.07 91.06 83.02 62.47 69.43 -9.84 56.65 72.06 -9.69 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 3 3 # 3 A 44 THR B 35 THR^? 22.22 O1 BME A 300 A 45 THR A 35 THR^? 22.22 O1 BME A 300 A 161 LYS A 2 LYS.? 28.68 O1 BME A 300 coo 26.16 88.25 79.16 25.22 89.47 80.71 73.34 60.50 -20.06 72.90 60.27 -17.95 coo 27.73 89.90 76.08 29.24 91.46 75.95 72.00 65.36 -18.45 71.15 64.17 -16.85 coo 33.83 91.15 88.62 31.07 91.06 83.02 66.36 53.41 -23.99 71.31 50.47 -23.66 1dhp_c02 source 1dhp DIHYDRODIPICOLINATE SYNTHASE : 3 hits 1dhp_c02 naa= 3 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 1 3 # 1 B 44 THR A 35 THR^? 22.22 O1 BME A 300 B 45 THR B 5 THR.? 22.65 S2 BME B 301 B 161 LYS A 3 LYS.? 20.23 O1 BME A 300 coo 7.39 128.28 94.56 8.34 126.36 94.79 72.00 65.36 -18.45 71.15 64.17 -16.85 coo 5.75 129.25 91.25 4.29 128.16 90.07 70.08 69.00 -17.47 68.54 67.93 -16.36 coo -0.17 119.75 99.65 2.51 123.83 95.70 68.61 55.34 -21.58 71.21 56.20 -15.92 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 2 3 # 2 B 44 THR B 5 THR.? 22.65 S2 BME B 301 B 45 THR A 35 THR^? 22.22 O1 BME A 300 B 161 LYS B 48 LYS~? 21.20 S2 BME B 301 coo 7.39 128.28 94.56 8.34 126.36 94.79 70.08 69.00 -17.47 68.54 67.93 -16.36 coo 5.75 129.25 91.25 4.29 128.16 90.07 72.00 65.36 -18.45 71.15 64.17 -16.85 coo -0.17 119.75 99.65 2.51 123.83 95.70 62.47 69.43 -9.84 56.65 72.06 -9.69 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 3 3 # 3 B 44 THR B 35 THR^? 22.22 O1 BME A 300 B 45 THR A 35 THR^? 22.22 O1 BME A 300 B 161 LYS A 2 LYS.? 28.68 O1 BME A 300 coo 7.39 128.28 94.56 8.34 126.36 94.79 73.34 60.50 -20.06 72.90 60.27 -17.95 coo 5.75 129.25 91.25 4.29 128.16 90.07 72.00 65.36 -18.45 71.15 64.17 -16.85 coo -0.17 119.75 99.65 2.51 123.83 95.70 66.36 53.41 -23.99 71.31 50.47 -23.66 1dhp_c03 source 1dhp DIHYDRODIPICOLINATE SYNTHASE : 3 hits 1dhp_c03 naa= 3 ULMN 3 1dub_c13 2-ENOYL-COA HYDRATASE user 1 3 # 1 B 141 GLY A 107 GLY~? 15.59 C1 BME A 300 B 144 GLU A 108 GLU~? 11.49 C1 BME A 300 B 164 GLU A 111 GLU~? 14.81 C1 BME A 300 coo 88.87 114.43 152.30 88.45 115.15 152.32 90.64 59.31 1.39 89.81 59.35 1.31 coo 85.20 111.99 152.05 86.60 110.89 150.91 87.15 61.55 3.86 85.80 63.08 4.38 coo 88.14 113.46 145.73 86.79 113.92 147.30 89.56 55.57 5.81 89.83 56.98 7.35 ULMN 3 1dub_c13 2-ENOYL-COA HYDRATASE user 2 3 # 2 B 141 GLY A 107 GLY~? 15.59 C1 BME A 300 B 144 GLU A 111 GLU~? 14.81 C1 BME A 300 B 164 GLU A 108 GLU~? 11.49 C1 BME A 300 coo 88.87 114.43 152.30 88.45 115.15 152.32 90.64 59.31 1.39 89.81 59.35 1.31 coo 85.20 111.99 152.05 86.60 110.89 150.91 89.56 55.57 5.81 89.83 56.98 7.35 coo 88.14 113.46 145.73 86.79 113.92 147.30 87.15 61.55 3.86 85.80 63.08 4.38 ULMN 3 1dub_c13 2-ENOYL-COA HYDRATASE user 3 3 # 3 B 141 GLY B 107 GLY~? 18.85 C2 BME B 301 B 144 GLU B 108 GLU~? 13.67 C2 BME B 301 B 164 GLU B 111 GLU~? 15.73 S2 BME B 301 coo 88.87 114.43 152.30 88.45 115.15 152.32 51.22 61.18 -3.70 52.03 61.10 -3.58 coo 85.20 111.99 152.05 86.60 110.89 150.91 54.86 59.36 -0.28 55.08 57.73 1.04 coo 88.14 113.46 145.73 86.79 113.92 147.30 52.67 66.26 1.65 52.32 64.94 3.26 1dub_c13 source 1dub 2-ENOYL-COA HYDRATASE : 3 hits 1dub_c13 naa= 3 ULMN 3 1dub_c14 2-ENOYL-COA HYDRATASE user 1 3 # 1 C 141 GLY A 107 GLY~? 15.59 C1 BME A 300 C 144 GLU A 108 GLU~? 11.49 C1 BME A 300 C 164 GLU A 111 GLU~? 14.81 C1 BME A 300 coo 56.28 104.55 135.84 56.09 105.34 136.05 90.64 59.31 1.39 89.81 59.35 1.31 coo 58.46 103.90 139.48 57.57 102.00 139.16 87.15 61.55 3.86 85.80 63.08 4.38 coo 51.71 102.03 140.09 53.02 103.62 140.54 89.56 55.57 5.81 89.83 56.98 7.35 ULMN 3 1dub_c14 2-ENOYL-COA HYDRATASE user 2 3 # 2 C 141 GLY A 107 GLY~? 15.59 C1 BME A 300 C 144 GLU A 111 GLU~? 14.81 C1 BME A 300 C 164 GLU A 108 GLU~? 11.49 C1 BME A 300 coo 56.28 104.55 135.84 56.09 105.34 136.05 90.64 59.31 1.39 89.81 59.35 1.31 coo 58.46 103.90 139.48 57.57 102.00 139.16 89.56 55.57 5.81 89.83 56.98 7.35 coo 51.71 102.03 140.09 53.02 103.62 140.54 87.15 61.55 3.86 85.80 63.08 4.38 ULMN 3 1dub_c14 2-ENOYL-COA HYDRATASE user 3 3 # 3 C 141 GLY B 107 GLY~? 18.85 C2 BME B 301 C 144 GLU B 108 GLU~? 13.67 C2 BME B 301 C 164 GLU B 111 GLU~? 15.73 S2 BME B 301 coo 56.28 104.55 135.84 56.09 105.34 136.05 51.22 61.18 -3.70 52.03 61.10 -3.58 coo 58.46 103.90 139.48 57.57 102.00 139.16 54.86 59.36 -0.28 55.08 57.73 1.04 coo 51.71 102.03 140.09 53.02 103.62 140.54 52.67 66.26 1.65 52.32 64.94 3.26 1dub_c14 source 1dub 2-ENOYL-COA HYDRATASE : 3 hits 1dub_c14 naa= 3 ULMN 3 1dub_c15 2-ENOYL-COA HYDRATASE user 1 3 # 1 D 141 GLY A 107 GLY~? 15.59 C1 BME A 300 D 144 GLU A 108 GLU~? 11.49 C1 BME A 300 D 164 GLU A 111 GLU~? 14.81 C1 BME A 300 coo 86.19 80.64 132.77 86.38 79.85 132.93 90.64 59.31 1.39 89.81 59.35 1.31 coo 84.75 81.24 136.88 85.62 83.14 136.43 87.15 61.55 3.86 85.80 63.08 4.38 coo 91.47 83.05 136.24 90.35 81.38 136.84 89.56 55.57 5.81 89.83 56.98 7.35 ULMN 3 1dub_c15 2-ENOYL-COA HYDRATASE user 2 3 # 2 D 141 GLY A 107 GLY~? 15.59 C1 BME A 300 D 144 GLU A 111 GLU~? 14.81 C1 BME A 300 D 164 GLU A 108 GLU~? 11.49 C1 BME A 300 coo 86.19 80.64 132.77 86.38 79.85 132.93 90.64 59.31 1.39 89.81 59.35 1.31 coo 84.75 81.24 136.88 85.62 83.14 136.43 89.56 55.57 5.81 89.83 56.98 7.35 coo 91.47 83.05 136.24 90.35 81.38 136.84 87.15 61.55 3.86 85.80 63.08 4.38 ULMN 3 1dub_c15 2-ENOYL-COA HYDRATASE user 3 3 # 3 D 141 GLY B 107 GLY~? 18.85 C2 BME B 301 D 144 GLU B 108 GLU~? 13.67 C2 BME B 301 D 164 GLU B 111 GLU~? 15.73 S2 BME B 301 coo 86.19 80.64 132.77 86.38 79.85 132.93 51.22 61.18 -3.70 52.03 61.10 -3.58 coo 84.75 81.24 136.88 85.62 83.14 136.43 54.86 59.36 -0.28 55.08 57.73 1.04 coo 91.47 83.05 136.24 90.35 81.38 136.84 52.67 66.26 1.65 52.32 64.94 3.26 1dub_c15 source 1dub 2-ENOYL-COA HYDRATASE : 3 hits 1dub_c15 naa= 3 ULMN 3 1dub_c16 2-ENOYL-COA HYDRATASE user 1 3 # 1 E 141 GLY A 107 GLY~? 15.59 C1 BME A 300 E 144 GLU A 108 GLU~? 11.49 C1 BME A 300 E 164 GLU A 111 GLU~? 14.81 C1 BME A 300 coo 90.07 81.07 170.50 90.23 80.26 170.38 90.64 59.31 1.39 89.81 59.35 1.31 coo 87.05 81.30 167.53 86.38 82.74 168.94 87.15 61.55 3.86 85.80 63.08 4.38 coo 84.40 80.02 173.80 85.08 79.06 172.03 89.56 55.57 5.81 89.83 56.98 7.35 ULMN 3 1dub_c16 2-ENOYL-COA HYDRATASE user 2 3 # 2 E 141 GLY A 107 GLY~? 15.59 C1 BME A 300 E 144 GLU A 111 GLU~? 14.81 C1 BME A 300 E 164 GLU A 108 GLU~? 11.49 C1 BME A 300 coo 90.07 81.07 170.50 90.23 80.26 170.38 90.64 59.31 1.39 89.81 59.35 1.31 coo 87.05 81.30 167.53 86.38 82.74 168.94 89.56 55.57 5.81 89.83 56.98 7.35 coo 84.40 80.02 173.80 85.08 79.06 172.03 87.15 61.55 3.86 85.80 63.08 4.38 ULMN 3 1dub_c16 2-ENOYL-COA HYDRATASE user 3 3 # 3 E 141 GLY B 107 GLY~? 18.85 C2 BME B 301 E 144 GLU B 108 GLU~? 13.67 C2 BME B 301 E 164 GLU B 111 GLU~? 15.73 S2 BME B 301 coo 90.07 81.07 170.50 90.23 80.26 170.38 51.22 61.18 -3.70 52.03 61.10 -3.58 coo 87.05 81.30 167.53 86.38 82.74 168.94 54.86 59.36 -0.28 55.08 57.73 1.04 coo 84.40 80.02 173.80 85.08 79.06 172.03 52.67 66.26 1.65 52.32 64.94 3.26 1dub_c16 source 1dub 2-ENOYL-COA HYDRATASE : 3 hits 1dub_c16 naa= 3 ULMN 3 1dub_c17 2-ENOYL-COA HYDRATASE user 1 3 # 1 F 141 GLY A 107 GLY~? 15.59 C1 BME A 300 F 144 GLU A 108 GLU~? 11.49 C1 BME A 300 F 164 GLU A 111 GLU~? 14.81 C1 BME A 300 coo 57.12 70.68 155.10 57.52 69.95 155.02 90.64 59.31 1.39 89.81 59.35 1.31 coo 60.62 73.13 154.21 59.05 74.26 153.35 87.15 61.55 3.86 85.80 63.08 4.38 coo 56.75 71.71 148.46 58.44 71.01 149.54 89.56 55.57 5.81 89.83 56.98 7.35 ULMN 3 1dub_c17 2-ENOYL-COA HYDRATASE user 2 3 # 2 F 141 GLY A 107 GLY~? 15.59 C1 BME A 300 F 144 GLU A 111 GLU~? 14.81 C1 BME A 300 F 164 GLU A 108 GLU~? 11.49 C1 BME A 300 coo 57.12 70.68 155.10 57.52 69.95 155.02 90.64 59.31 1.39 89.81 59.35 1.31 coo 60.62 73.13 154.21 59.05 74.26 153.35 89.56 55.57 5.81 89.83 56.98 7.35 coo 56.75 71.71 148.46 58.44 71.01 149.54 87.15 61.55 3.86 85.80 63.08 4.38 ULMN 3 1dub_c17 2-ENOYL-COA HYDRATASE user 3 3 # 3 F 141 GLY B 107 GLY~? 18.85 C2 BME B 301 F 144 GLU B 108 GLU~? 13.67 C2 BME B 301 F 164 GLU B 111 GLU~? 15.73 S2 BME B 301 coo 57.12 70.68 155.10 57.52 69.95 155.02 51.22 61.18 -3.70 52.03 61.10 -3.58 coo 60.62 73.13 154.21 59.05 74.26 153.35 54.86 59.36 -0.28 55.08 57.73 1.04 coo 56.75 71.71 148.46 58.44 71.01 149.54 52.67 66.26 1.65 52.32 64.94 3.26 1dub_c17 source 1dub 2-ENOYL-COA HYDRATASE : 3 hits 1dub_c17 naa= 3 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 1 3 # 1 A 229 ALA B 51 ALA~? 18.20 S2 BME B 301 A 257 ALA B 131 ALA.? 20.07 S2 BME B 301 A 328 ASP B 44 ASP~? 23.69 S2 BME B 301 coo 39.84 24.12 8.44 38.50 24.23 9.11 66.36 72.04 -8.23 65.50 72.30 -9.45 coo 43.22 26.73 5.37 41.81 27.09 5.79 62.65 74.33 -10.13 63.22 75.25 -9.05 coo 38.17 34.10 6.67 37.72 32.06 6.84 59.88 65.23 -14.80 60.45 65.24 -16.84 1eo7_c00 source 1eo7 CYCLODEXTRIN GLYCOSYLTRANSFERASE : 1 hits 1eo7_c00 naa= 3 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 1 3 # 1 A 38 THR A 35 THR^? 22.22 O1 BME A 300 A 159 LYS B 2 LYS.? 15.81 C1 BME A 300 A 193 GLU B 70 GLU~? 7.75 C1 BME A 300 coo -2.58 16.31 54.79 -4.02 14.93 55.64 72.00 65.36 -18.45 71.15 64.17 -16.85 coo 2.10 10.68 61.44 -2.14 13.16 60.61 75.93 68.83 -9.78 80.88 67.42 -7.25 coo -5.33 11.71 69.72 -4.62 11.92 67.73 72.71 65.28 -0.66 74.40 64.00 -0.70 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 2 3 # 2 A 38 THR B 5 THR.? 22.65 S2 BME B 301 A 159 LYS B 2 LYS.? 15.81 C1 BME A 300 A 193 GLU B 70 GLU~? 7.75 C1 BME A 300 coo -2.58 16.31 54.79 -4.02 14.93 55.64 70.08 69.00 -17.47 68.54 67.93 -16.36 coo 2.10 10.68 61.44 -2.14 13.16 60.61 75.93 68.83 -9.78 80.88 67.42 -7.25 coo -5.33 11.71 69.72 -4.62 11.92 67.73 72.71 65.28 -0.66 74.40 64.00 -0.70 1et0_c02 source 1et0 4-AMINO-4-DEOXYCHORISMATE LYASE : 2 hits 1et0_c02 naa= 3 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 1 3 # 1 A 34 GLU B 70 GLU~? 7.75 C1 BME A 300 A 260 ARG A 39 ARG.? 14.17 O1 BME A 300 A 270 LYS B 2 LYS.? 15.81 C1 BME A 300 coo 50.99 29.43 12.86 52.11 29.45 14.65 72.71 65.28 -0.66 74.40 64.00 -0.70 coo 39.80 27.50 22.98 42.20 26.56 21.34 79.32 60.12 -11.34 77.45 58.25 -9.78 coo 48.83 21.70 19.50 47.44 24.99 15.25 75.93 68.83 -9.78 80.88 67.42 -7.25 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 2 3 # 2 A 34 GLU B 70 GLU~? 7.75 C1 BME A 300 A 260 ARG A 39 ARG.? 14.17 O1 BME A 300 A 270 LYS B 3 LYS^? 16.28 S2 BME B 301 coo 50.99 29.43 12.86 52.11 29.45 14.65 72.71 65.28 -0.66 74.40 64.00 -0.70 coo 39.80 27.50 22.98 42.20 26.56 21.34 79.32 60.12 -11.34 77.45 58.25 -9.78 coo 48.83 21.70 19.50 47.44 24.99 15.25 73.79 67.72 -12.74 69.00 65.74 -10.30 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 3 3 # 3 A 34 GLU B 70 GLU~? 7.75 C1 BME A 300 A 260 ARG B 47 ARG~? 23.93 S2 BME B 301 A 270 LYS B 2 LYS.? 15.81 C1 BME A 300 coo 50.99 29.43 12.86 52.11 29.45 14.65 72.71 65.28 -0.66 74.40 64.00 -0.70 coo 39.80 27.50 22.98 42.20 26.56 21.34 65.24 66.71 -15.28 63.33 68.13 -17.26 coo 48.83 21.70 19.50 47.44 24.99 15.25 75.93 68.83 -9.78 80.88 67.42 -7.25 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 4 3 # 4 A 34 GLU B 70 GLU~? 7.75 C1 BME A 300 A 260 ARG B 58 ARG~? 19.35 S2 BME B 301 A 270 LYS B 2 LYS.? 15.81 C1 BME A 300 coo 50.99 29.43 12.86 52.11 29.45 14.65 72.71 65.28 -0.66 74.40 64.00 -0.70 coo 39.80 27.50 22.98 42.20 26.56 21.34 73.30 78.23 -5.33 71.23 76.59 -6.88 coo 48.83 21.70 19.50 47.44 24.99 15.25 75.93 68.83 -9.78 80.88 67.42 -7.25 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 5 3 # 5 A 34 GLU B 70 GLU~? 7.75 C1 BME A 300 A 260 ARG B 58 ARG~? 19.35 S2 BME B 301 A 270 LYS B 3 LYS^? 16.28 S2 BME B 301 coo 50.99 29.43 12.86 52.11 29.45 14.65 72.71 65.28 -0.66 74.40 64.00 -0.70 coo 39.80 27.50 22.98 42.20 26.56 21.34 73.30 78.23 -5.33 71.23 76.59 -6.88 coo 48.83 21.70 19.50 47.44 24.99 15.25 73.79 67.72 -12.74 69.00 65.74 -10.30 1euy_c00 source 1euy GLUTAMINYL-TRNA SYNTHETASE : 5 hits 1euy_c00 naa= 3 ULMN 3 1eyi_c00 FRUCTOSE-1,6-BISPHOSPHATASE user 1 3 # 1 A 68 ASP A 55 ASP~? 17.20 O1 BME A 300 A 74 ASP A 129 ASP~? 19.06 O1 BME A 300 A 98 GLU A 130 GLU~? 23.04 O1 BME A 300 coo 17.19 9.05 25.28 15.77 9.98 26.53 76.53 41.69 0.56 76.82 41.16 -1.46 coo 15.99 8.54 17.36 14.96 7.80 19.05 80.80 42.21 -6.02 80.73 43.57 -7.63 coo 16.31 12.85 18.11 16.71 11.79 19.90 84.58 38.87 -3.95 85.40 38.00 -2.18 1eyi_c00 source 1eyi FRUCTOSE-1,6-BISPHOSPHATASE : 1 hits 1eyi_c00 naa= 3 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 A 112 PHE B 94 PHE^? 12.77 O1 BME B 301 A 210 ASP B 84 ASP^? 10.28 C2 BME B 301 A 244 LYS A 73 LYS~? -2.81 O1 BME A 300s coo 9.23 46.77 25.11 11.48 48.39 24.76 71.58 57.30 18.86 71.41 60.08 19.10 coo 10.51 37.86 19.71 9.07 39.38 20.04 64.49 54.82 11.77 62.58 54.12 11.40 coo -1.20 42.34 17.67 3.19 45.13 19.06 75.23 53.47 4.59 74.97 57.96 1.35 1fc4_c02 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 1 hits 1fc4_c02 naa= 3 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 B 112 PHE B 94 PHE^? 12.77 O1 BME B 301 B 210 ASP B 84 ASP^? 10.28 C2 BME B 301 B 244 LYS A 73 LYS~? -2.81 O1 BME A 300s coo 8.76 47.85 34.91 11.08 46.36 35.41 71.58 57.30 18.86 71.41 60.08 19.10 coo 9.06 56.85 40.30 7.71 55.27 39.90 64.49 54.82 11.77 62.58 54.12 11.40 coo -2.38 51.82 41.62 2.07 49.19 40.42 75.23 53.47 4.59 74.97 57.96 1.35 1fc4_c03 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 1 hits 1fc4_c03 naa= 3 ULMN 3 1fdy_c04 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 A 47 SER A 100 SER.? 7.07 C1 BME A 300 A 48 THR A 101 THR.? -4.16 C1 BME A 300s A 165 LYS B 2 LYS.? 15.81 C1 BME A 300 coo -39.09 -83.21 -19.79 -37.33 -83.94 -21.38 76.98 62.85 2.47 76.76 63.82 0.26 coo -41.85 -80.60 -20.11 -42.94 -79.78 -21.77 78.82 59.97 0.83 77.48 58.31 0.82 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 75.93 68.83 -9.78 80.88 67.42 -7.25 ULMN 3 1fdy_c04 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 A 47 SER A 100 SER.? 7.07 C1 BME A 300 A 48 THR A 101 THR.? -4.16 C1 BME A 300s A 165 LYS B 73 LYS~? 5.56 C2 BME B 301 coo -39.09 -83.21 -19.79 -37.33 -83.94 -21.38 76.98 62.85 2.47 76.76 63.82 0.26 coo -41.85 -80.60 -20.11 -42.94 -79.78 -21.77 78.82 59.97 0.83 77.48 58.31 0.82 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 66.37 67.01 1.95 66.56 61.98 -0.01 ULMN 3 1fdy_c04 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 A 47 SER A 102 SER.? 8.36 C1 BME A 300 A 48 THR A 101 THR.? -4.16 C1 BME A 300s A 165 LYS B 2 LYS.? 15.81 C1 BME A 300 coo -39.09 -83.21 -19.79 -37.33 -83.94 -21.38 78.79 62.05 -2.37 76.46 61.88 -3.05 coo -41.85 -80.60 -20.11 -42.94 -79.78 -21.77 78.82 59.97 0.83 77.48 58.31 0.82 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 75.93 68.83 -9.78 80.88 67.42 -7.25 ULMN 3 1fdy_c04 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 A 47 SER A 102 SER.? 8.36 C1 BME A 300 A 48 THR A 101 THR.? -4.16 C1 BME A 300s A 165 LYS B 73 LYS~? 5.56 C2 BME B 301 coo -39.09 -83.21 -19.79 -37.33 -83.94 -21.38 78.79 62.05 -2.37 76.46 61.88 -3.05 coo -41.85 -80.60 -20.11 -42.94 -79.78 -21.77 78.82 59.97 0.83 77.48 58.31 0.82 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 66.37 67.01 1.95 66.56 61.98 -0.01 ULMN 3 1fdy_c04 N-ACETYLNEURAMINATE LYASE user 5 3 # 5 A 47 SER B 100 SER.? 7.38 C2 BME B 301 A 48 THR B 101 THR.? 7.80 C2 BME B 301 A 165 LYS A 73 LYS~? -2.81 O1 BME A 300s coo -39.09 -83.21 -19.79 -37.33 -83.94 -21.38 64.33 57.82 1.68 64.28 55.45 1.01 coo -41.85 -80.60 -20.11 -42.94 -79.78 -21.77 62.74 59.71 -1.20 64.09 61.32 -1.60 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 75.23 53.47 4.59 74.97 57.96 1.35 1fdy_c04 source 1fdy N-ACETYLNEURAMINATE LYASE : 5 hits 1fdy_c04 naa= 3 ULMN 3 1fdy_c05 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 B 47 SER A 100 SER.? 7.07 C1 BME A 300 B 48 THR A 101 THR.? -4.16 C1 BME A 300s B 165 LYS B 2 LYS.? 15.81 C1 BME A 300 coo 0.74 -71.26 -35.87 -0.36 -73.34 -35.30 76.98 62.85 2.47 76.76 63.82 0.26 coo 2.65 -68.72 -33.78 3.66 -68.93 -31.87 78.82 59.97 0.83 77.48 58.31 0.82 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 75.93 68.83 -9.78 80.88 67.42 -7.25 ULMN 3 1fdy_c05 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 B 47 SER A 100 SER.? 7.07 C1 BME A 300 B 48 THR A 101 THR.? -4.16 C1 BME A 300s B 165 LYS B 73 LYS~? 5.56 C2 BME B 301 coo 0.74 -71.26 -35.87 -0.36 -73.34 -35.30 76.98 62.85 2.47 76.76 63.82 0.26 coo 2.65 -68.72 -33.78 3.66 -68.93 -31.87 78.82 59.97 0.83 77.48 58.31 0.82 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 66.37 67.01 1.95 66.56 61.98 -0.01 ULMN 3 1fdy_c05 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 B 47 SER A 102 SER.? 8.36 C1 BME A 300 B 48 THR A 101 THR.? -4.16 C1 BME A 300s B 165 LYS B 2 LYS.? 15.81 C1 BME A 300 coo 0.74 -71.26 -35.87 -0.36 -73.34 -35.30 78.79 62.05 -2.37 76.46 61.88 -3.05 coo 2.65 -68.72 -33.78 3.66 -68.93 -31.87 78.82 59.97 0.83 77.48 58.31 0.82 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 75.93 68.83 -9.78 80.88 67.42 -7.25 ULMN 3 1fdy_c05 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 B 47 SER A 102 SER.? 8.36 C1 BME A 300 B 48 THR A 101 THR.? -4.16 C1 BME A 300s B 165 LYS B 73 LYS~? 5.56 C2 BME B 301 coo 0.74 -71.26 -35.87 -0.36 -73.34 -35.30 78.79 62.05 -2.37 76.46 61.88 -3.05 coo 2.65 -68.72 -33.78 3.66 -68.93 -31.87 78.82 59.97 0.83 77.48 58.31 0.82 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 66.37 67.01 1.95 66.56 61.98 -0.01 ULMN 3 1fdy_c05 N-ACETYLNEURAMINATE LYASE user 5 3 # 5 B 47 SER B 100 SER.? 7.38 C2 BME B 301 B 48 THR B 101 THR.? 7.80 C2 BME B 301 B 165 LYS A 73 LYS~? -2.81 O1 BME A 300s coo 0.74 -71.26 -35.87 -0.36 -73.34 -35.30 64.33 57.82 1.68 64.28 55.45 1.01 coo 2.65 -68.72 -33.78 3.66 -68.93 -31.87 62.74 59.71 -1.20 64.09 61.32 -1.60 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 75.23 53.47 4.59 74.97 57.96 1.35 1fdy_c05 source 1fdy N-ACETYLNEURAMINATE LYASE : 5 hits 1fdy_c05 naa= 3 ULMN 3 1fdy_c06 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 C 47 SER A 100 SER.? 7.07 C1 BME A 300 C 48 THR A 101 THR.? -4.16 C1 BME A 300s C 165 LYS B 2 LYS.? 15.81 C1 BME A 300 coo -15.18 -75.37 -50.42 -16.12 -74.55 -48.34 76.98 62.85 2.47 76.76 63.82 0.26 coo -16.57 -77.65 -53.15 -18.61 -78.18 -53.63 78.82 59.97 0.83 77.48 58.31 0.82 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 75.93 68.83 -9.78 80.88 67.42 -7.25 ULMN 3 1fdy_c06 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 C 47 SER A 100 SER.? 7.07 C1 BME A 300 C 48 THR A 101 THR.? -4.16 C1 BME A 300s C 165 LYS B 73 LYS~? 5.56 C2 BME B 301 coo -15.18 -75.37 -50.42 -16.12 -74.55 -48.34 76.98 62.85 2.47 76.76 63.82 0.26 coo -16.57 -77.65 -53.15 -18.61 -78.18 -53.63 78.82 59.97 0.83 77.48 58.31 0.82 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 66.37 67.01 1.95 66.56 61.98 -0.01 ULMN 3 1fdy_c06 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 C 47 SER A 102 SER.? 8.36 C1 BME A 300 C 48 THR A 101 THR.? -4.16 C1 BME A 300s C 165 LYS B 2 LYS.? 15.81 C1 BME A 300 coo -15.18 -75.37 -50.42 -16.12 -74.55 -48.34 78.79 62.05 -2.37 76.46 61.88 -3.05 coo -16.57 -77.65 -53.15 -18.61 -78.18 -53.63 78.82 59.97 0.83 77.48 58.31 0.82 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 75.93 68.83 -9.78 80.88 67.42 -7.25 ULMN 3 1fdy_c06 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 C 47 SER A 102 SER.? 8.36 C1 BME A 300 C 48 THR A 101 THR.? -4.16 C1 BME A 300s C 165 LYS B 73 LYS~? 5.56 C2 BME B 301 coo -15.18 -75.37 -50.42 -16.12 -74.55 -48.34 78.79 62.05 -2.37 76.46 61.88 -3.05 coo -16.57 -77.65 -53.15 -18.61 -78.18 -53.63 78.82 59.97 0.83 77.48 58.31 0.82 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 66.37 67.01 1.95 66.56 61.98 -0.01 ULMN 3 1fdy_c06 N-ACETYLNEURAMINATE LYASE user 5 3 # 5 C 47 SER B 100 SER.? 7.38 C2 BME B 301 C 48 THR B 101 THR.? 7.80 C2 BME B 301 C 165 LYS A 73 LYS~? -2.81 O1 BME A 300s coo -15.18 -75.37 -50.42 -16.12 -74.55 -48.34 64.33 57.82 1.68 64.28 55.45 1.01 coo -16.57 -77.65 -53.15 -18.61 -78.18 -53.63 62.74 59.71 -1.20 64.09 61.32 -1.60 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 75.23 53.47 4.59 74.97 57.96 1.35 1fdy_c06 source 1fdy N-ACETYLNEURAMINATE LYASE : 5 hits 1fdy_c06 naa= 3 ULMN 3 1fdy_c07 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 D 47 SER A 100 SER.? 7.07 C1 BME A 300 D 48 THR A 101 THR.? -4.16 C1 BME A 300s D 165 LYS B 2 LYS.? 15.81 C1 BME A 300 coo -21.69 -90.39 -8.89 -21.07 -88.29 -10.03 76.98 62.85 2.47 76.76 63.82 0.26 coo -19.38 -93.32 -7.98 -17.24 -93.31 -7.67 78.82 59.97 0.83 77.48 58.31 0.82 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 75.93 68.83 -9.78 80.88 67.42 -7.25 ULMN 3 1fdy_c07 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 D 47 SER A 100 SER.? 7.07 C1 BME A 300 D 48 THR A 101 THR.? -4.16 C1 BME A 300s D 165 LYS B 73 LYS~? 5.56 C2 BME B 301 coo -21.69 -90.39 -8.89 -21.07 -88.29 -10.03 76.98 62.85 2.47 76.76 63.82 0.26 coo -19.38 -93.32 -7.98 -17.24 -93.31 -7.67 78.82 59.97 0.83 77.48 58.31 0.82 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 66.37 67.01 1.95 66.56 61.98 -0.01 ULMN 3 1fdy_c07 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 D 47 SER A 102 SER.? 8.36 C1 BME A 300 D 48 THR A 101 THR.? -4.16 C1 BME A 300s D 165 LYS B 73 LYS~? 5.56 C2 BME B 301 coo -21.69 -90.39 -8.89 -21.07 -88.29 -10.03 78.79 62.05 -2.37 76.46 61.88 -3.05 coo -19.38 -93.32 -7.98 -17.24 -93.31 -7.67 78.82 59.97 0.83 77.48 58.31 0.82 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 66.37 67.01 1.95 66.56 61.98 -0.01 ULMN 3 1fdy_c07 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 D 47 SER B 100 SER.? 7.38 C2 BME B 301 D 48 THR B 101 THR.? 7.80 C2 BME B 301 D 165 LYS A 73 LYS~? -2.81 O1 BME A 300s coo -21.69 -90.39 -8.89 -21.07 -88.29 -10.03 64.33 57.82 1.68 64.28 55.45 1.01 coo -19.38 -93.32 -7.98 -17.24 -93.31 -7.67 62.74 59.71 -1.20 64.09 61.32 -1.60 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 75.23 53.47 4.59 74.97 57.96 1.35 ULMN 3 1fdy_c07 N-ACETYLNEURAMINATE LYASE user 5 3 # 5 D 47 SER B 102 SER.? 9.52 C2 BME B 301 D 48 THR B 101 THR.? 7.80 C2 BME B 301 D 165 LYS A 73 LYS~? -2.81 O1 BME A 300s coo -21.69 -90.39 -8.89 -21.07 -88.29 -10.03 63.38 56.52 -3.17 65.79 56.15 -3.09 coo -19.38 -93.32 -7.98 -17.24 -93.31 -7.67 62.74 59.71 -1.20 64.09 61.32 -1.60 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 75.23 53.47 4.59 74.97 57.96 1.35 1fdy_c07 source 1fdy N-ACETYLNEURAMINATE LYASE : 5 hits 1fdy_c07 naa= 3 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 1 3 # 1 A 45 ARG B 39 ARG.? 27.37 S2 BME B 301 A 136 GLU B 130 GLU.? 21.96 S2 BME B 301 A 246 GLU B 7 GLU^? 27.97 S2 BME B 301 coo 13.48 30.30 107.06 11.75 30.99 109.44 61.31 65.86 -19.69 59.13 67.99 -19.83 coo 9.46 32.37 115.82 8.50 34.20 115.47 65.89 71.50 -12.95 66.09 70.43 -14.77 coo 11.99 34.33 109.92 10.08 34.19 110.77 64.21 70.19 -21.03 62.19 70.66 -20.57 1fhl_c00 source 1fhl BETA-1,4-GALACTANASE : 1 hits 1fhl_c00 naa= 3 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 1 3 # 1 A 45 ARG B 39 ARG.? 27.37 S2 BME B 301 A 136 GLU B 130 GLU.? 21.96 S2 BME B 301 A 246 GLU B 7 GLU^? 27.97 S2 BME B 301 coo 13.94 29.84 106.80 11.67 30.40 108.79 61.31 65.86 -19.69 59.13 67.99 -19.83 coo 9.52 31.97 115.23 8.45 33.74 114.72 65.89 71.50 -12.95 66.09 70.43 -14.77 coo 11.92 33.82 109.35 10.10 33.50 110.39 64.21 70.19 -21.03 62.19 70.66 -20.57 1fob_c00 source 1fob BETA-1,4-GALACTANASE : 1 hits 1fob_c00 naa= 3 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 1 3 # 1 B 317 GLU B 38 GLU^? 31.80 C2 BME B 301 B 319 ASP A 27 ASP.? 37.00 C2 BME B 301 B 359 ARG B 9 ARG.? 31.92 S2 BME B 301 coo 10.77 13.13 40.94 11.03 14.73 39.51 61.52 60.14 -24.13 60.63 59.15 -25.77 coo 3.77 12.64 38.21 3.35 14.53 37.39 61.08 65.65 -30.46 59.02 65.16 -30.45 coo -1.16 15.32 35.60 -3.32 13.56 36.98 61.30 71.84 -25.56 62.82 73.83 -23.80 1fr8_c01 source 1fr8 BETA 1,4 GALACTOSYLTRANSFERASE : 1 hits 1fr8_c01 naa= 3 ULMN 3 1g8o_c01 N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALuser 1 3 # 1 A 314 TRP A 66 TRP.? 19.31 O1 BME A 300 A 317 GLU A 61 GLU.? 20.99 O1 BME A 300 A 365 ARG A 58 ARG~? 16.62 O1 BME A 300 coo 79.91 26.87 38.77 78.95 23.18 37.81 65.74 40.99 9.25 68.90 38.90 8.16 coo 85.55 26.30 41.25 85.59 24.97 39.65 69.88 39.99 12.89 68.19 39.98 14.15 coo 83.47 25.30 27.10 83.44 27.82 25.29 70.36 39.82 -0.67 72.06 41.99 -2.04 ULMN 3 1g8o_c01 N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALuser 2 3 # 2 A 314 TRP A 127 TRP~? 17.97 O1 BME A 300 A 317 GLU A 130 GLU~? 23.04 O1 BME A 300 A 365 ARG A 58 ARG~? 16.62 O1 BME A 300 coo 79.91 26.87 38.77 78.95 23.18 37.81 83.13 39.72 0.82 80.98 42.71 2.22 coo 85.55 26.30 41.25 85.59 24.97 39.65 84.58 38.87 -3.95 85.40 38.00 -2.18 coo 83.47 25.30 27.10 83.44 27.82 25.29 70.36 39.82 -0.67 72.06 41.99 -2.04 ULMN 3 1g8o_c01 N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALuser 3 3 # 3 A 314 TRP B 66 TRP.? 19.80 S2 BME B 301 A 317 GLU B 61 GLU.? 21.77 S2 BME B 301 A 365 ARG B 58 ARG~? 19.35 S2 BME B 301 coo 79.91 26.87 38.77 78.95 23.18 37.81 76.06 79.86 5.18 73.01 81.54 3.33 coo 85.55 26.30 41.25 85.59 24.97 39.65 72.49 81.24 7.40 73.27 83.04 8.17 coo 83.47 25.30 27.10 83.44 27.82 25.29 73.30 78.23 -5.33 71.23 76.59 -6.88 1g8o_c01 source 1g8o N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALACTOSYLTRA: 3 hits 1g8o_c01 naa= 3 ULMN 3 1grc_c03 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 1 3 # 1 B 106 ASN B 16 ASN~? 33.06 S2 BME B 301 B 108 HIS B 13 HIS~? 34.41 S2 BME B 301 B 144 ASP B 129 ASP.? 27.81 S2 BME B 301 coo 36.64 101.02 13.15 38.55 101.84 12.78 73.64 74.63 -26.43 74.05 74.83 -24.34 coo 41.00 107.18 12.86 42.70 107.82 11.96 67.07 73.58 -27.21 65.85 74.91 -26.15 coo 31.60 110.69 6.14 29.69 109.74 5.94 64.27 77.57 -15.36 64.19 79.64 -15.85 ULMN 3 1grc_c03 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 2 3 # 2 B 106 ASN B 88 ASN.? 14.13 C2 BME A 300 B 108 HIS A 63 HIS.? 17.83 C2 BME A 300 B 144 ASP B 84 ASP^? 10.28 C2 BME B 301 coo 36.64 101.02 13.15 38.55 101.84 12.78 76.46 53.84 16.90 77.36 53.44 18.78 coo 41.00 107.18 12.86 42.70 107.82 11.96 71.61 45.90 17.84 73.56 46.23 18.53 coo 31.60 110.69 6.14 29.69 109.74 5.94 64.49 54.82 11.77 62.58 54.12 11.40 1grc_c03 source 1grc GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMYLASE (E.C: 2 hits 1grc_c03 naa= 3 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 A 189 PHE A 119 PHE~? 14.57 O1 BME A 300 A 298 ASP A 55 ASP~? 17.20 O1 BME A 300 A 329 LYS A 73 LYS~? -2.81 O1 BME A 300s coo 6.56 -4.17 18.88 9.26 -4.62 19.48 80.27 45.41 9.73 77.88 44.61 10.94 coo 2.59 0.29 25.55 4.65 0.18 25.07 76.53 41.69 0.56 76.82 41.16 -1.46 coo 12.42 6.10 23.27 9.95 1.57 20.16 75.23 53.47 4.59 74.97 57.96 1.35 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 A 189 PHE B 119 PHE~? 15.49 S2 BME B 301 A 298 ASP B 55 ASP~? 19.77 S2 BME B 301 A 329 LYS B 73 LYS~? 5.56 C2 BME B 301 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 60.93 76.25 3.98 63.24 76.98 5.43 coo 2.59 0.29 25.55 4.65 0.18 25.07 66.42 77.35 -5.07 66.48 77.29 -7.17 coo 12.42 6.10 23.27 9.95 1.57 20.16 66.37 67.01 1.95 66.56 61.98 -0.01 1gtx_c00 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 2 hits 1gtx_c00 naa= 3 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 B 189 PHE A 119 PHE~? 14.57 O1 BME A 300 B 298 ASP A 55 ASP~? 17.20 O1 BME A 300 B 329 LYS A 73 LYS~? -2.81 O1 BME A 300s coo 20.14 -12.51 41.29 18.81 -10.14 40.57 80.27 45.41 9.73 77.88 44.61 10.94 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 76.53 41.69 0.56 76.82 41.16 -1.46 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 75.23 53.47 4.59 74.97 57.96 1.35 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 B 189 PHE B 119 PHE~? 15.49 S2 BME B 301 B 298 ASP B 55 ASP~? 19.77 S2 BME B 301 B 329 LYS B 73 LYS~? 5.56 C2 BME B 301 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 60.93 76.25 3.98 63.24 76.98 5.43 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 66.42 77.35 -5.07 66.48 77.29 -7.17 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 66.37 67.01 1.95 66.56 61.98 -0.01 1gtx_c01 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 2 hits 1gtx_c01 naa= 3 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 C 189 PHE A 119 PHE~? 14.57 O1 BME A 300 C 298 ASP A 55 ASP~? 17.20 O1 BME A 300 C 329 LYS A 73 LYS~? -2.81 O1 BME A 300s coo 17.41 60.57 64.39 18.40 58.12 65.34 80.27 45.41 9.73 77.88 44.61 10.94 coo 24.10 66.43 63.33 24.18 64.30 63.40 76.53 41.69 0.56 76.82 41.16 -1.46 coo 27.64 56.61 58.17 22.18 57.92 60.36 75.23 53.47 4.59 74.97 57.96 1.35 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 C 189 PHE B 119 PHE~? 15.49 S2 BME B 301 C 298 ASP B 55 ASP~? 19.77 S2 BME B 301 C 329 LYS B 73 LYS~? 5.56 C2 BME B 301 coo 17.41 60.57 64.39 18.40 58.12 65.34 60.93 76.25 3.98 63.24 76.98 5.43 coo 24.10 66.43 63.33 24.18 64.30 63.40 66.42 77.35 -5.07 66.48 77.29 -7.17 coo 27.64 56.61 58.17 22.18 57.92 60.36 66.37 67.01 1.95 66.56 61.98 -0.01 1gtx_c02 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 2 hits 1gtx_c02 naa= 3 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 D 189 PHE A 119 PHE~? 14.57 O1 BME A 300 D 298 ASP A 55 ASP~? 17.20 O1 BME A 300 D 329 LYS A 73 LYS~? -2.81 O1 BME A 300s coo 35.44 53.35 83.81 35.65 54.53 81.28 80.27 45.41 9.73 77.88 44.61 10.94 coo 29.72 46.46 83.60 30.79 47.36 81.99 76.53 41.69 0.56 76.82 41.16 -1.46 coo 36.89 44.91 74.55 37.33 48.94 79.01 75.23 53.47 4.59 74.97 57.96 1.35 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 D 189 PHE B 119 PHE~? 15.49 S2 BME B 301 D 298 ASP B 55 ASP~? 19.77 S2 BME B 301 D 329 LYS B 73 LYS~? 5.56 C2 BME B 301 coo 35.44 53.35 83.81 35.65 54.53 81.28 60.93 76.25 3.98 63.24 76.98 5.43 coo 29.72 46.46 83.60 30.79 47.36 81.99 66.42 77.35 -5.07 66.48 77.29 -7.17 coo 36.89 44.91 74.55 37.33 48.94 79.01 66.37 67.01 1.95 66.56 61.98 -0.01 1gtx_c03 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 2 hits 1gtx_c03 naa= 3 ULMN 3 1i29_c03 CSDB user 1 3 # 1 A 128 VAL B 60 VAL~? 17.79 S2 BME B 301 A 200 ASP B 68 ASP~? 10.36 S2 BME B 301 A 226 LYS B 3 LYS^? 16.28 S2 BME B 301 coo 19.13 38.05 1.41 19.72 38.80 -0.53 68.29 80.07 3.08 66.20 79.59 3.53 coo 24.51 43.28 11.18 25.17 44.50 9.58 74.86 70.68 0.81 74.63 68.81 1.72 coo 34.47 51.09 7.19 28.58 51.18 7.53 73.79 67.72 -12.74 69.00 65.74 -10.30 ULMN 3 1i29_c03 CSDB user 2 3 # 2 A 128 VAL B 75 VAL~? 7.69 S2 BME B 301 A 200 ASP B 68 ASP~? 10.36 S2 BME B 301 A 226 LYS B 3 LYS^? 16.28 S2 BME B 301 coo 19.13 38.05 1.41 19.72 38.80 -0.53 65.26 68.36 7.16 66.01 70.30 7.85 coo 24.51 43.28 11.18 25.17 44.50 9.58 74.86 70.68 0.81 74.63 68.81 1.72 coo 34.47 51.09 7.19 28.58 51.18 7.53 73.79 67.72 -12.74 69.00 65.74 -10.30 ULMN 3 1i29_c03 CSDB user 3 3 # 3 A 128 VAL B 106 VAL~? 18.80 C2 BME B 301 A 200 ASP B 44 ASP~? 23.69 S2 BME B 301 A 226 LYS A 3 LYS.? 20.23 O1 BME A 300 coo 19.13 38.05 1.41 19.72 38.80 -0.53 53.95 59.99 -6.05 53.16 60.05 -8.08 coo 24.51 43.28 11.18 25.17 44.50 9.58 59.88 65.23 -14.80 60.45 65.24 -16.84 coo 34.47 51.09 7.19 28.58 51.18 7.53 68.61 55.34 -21.58 71.21 56.20 -15.92 ULMN 3 1i29_c03 CSDB user 4 3 # 4 A 128 VAL B 106 VAL~? 18.80 C2 BME B 301 A 200 ASP B 44 ASP~? 23.69 S2 BME B 301 A 226 LYS B 3 LYS^? 16.28 S2 BME B 301 coo 19.13 38.05 1.41 19.72 38.80 -0.53 53.95 59.99 -6.05 53.16 60.05 -8.08 coo 24.51 43.28 11.18 25.17 44.50 9.58 59.88 65.23 -14.80 60.45 65.24 -16.84 coo 34.47 51.09 7.19 28.58 51.18 7.53 73.79 67.72 -12.74 69.00 65.74 -10.30 ULMN 3 1i29_c03 CSDB user 5 3 # 5 A 128 VAL B 125 VAL.? 20.89 S2 BME B 301 A 200 ASP B 129 ASP.? 27.81 S2 BME B 301 A 226 LYS B 3 LYS^? 16.28 S2 BME B 301 coo 19.13 38.05 1.41 19.72 38.80 -0.53 63.46 82.20 -2.45 64.18 80.21 -1.98 coo 24.51 43.28 11.18 25.17 44.50 9.58 64.27 77.57 -15.36 64.19 79.64 -15.85 coo 34.47 51.09 7.19 28.58 51.18 7.53 73.79 67.72 -12.74 69.00 65.74 -10.30 1i29_c03 source 1i29 CSDB : 5 hits 1i29_c03 naa= 3 ULMN 3 1ig8_c00 HEXOKINASE PII user 1 3 # 1 A 158 SER A 57 SER~? 13.02 O1 BME A 300 A 173 ARG A 65 ARG.? 12.39 O1 BME B 301 A 211 ASP A 55 ASP~? 17.20 O1 BME A 300 coo 22.72 76.24 0.23 24.60 76.86 -1.25 71.70 44.22 4.13 69.75 45.17 3.03 coo 18.77 77.82 11.69 20.55 80.22 10.73 64.77 47.77 12.73 64.18 50.71 12.02 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 76.53 41.69 0.56 76.82 41.16 -1.46 ULMN 3 1ig8_c00 HEXOKINASE PII user 2 3 # 2 A 158 SER A 57 SER~? 13.02 O1 BME A 300 A 173 ARG A 123 ARG~? 17.98 O1 BME A 300 A 211 ASP A 68 ASP~? 9.92 C1 BME B 301 coo 22.72 76.24 0.23 24.60 76.86 -1.25 71.70 44.22 4.13 69.75 45.17 3.03 coo 18.77 77.82 11.69 20.55 80.22 10.73 79.32 40.68 12.01 79.04 43.03 13.95 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 67.14 48.96 2.96 66.44 50.60 4.08 ULMN 3 1ig8_c00 HEXOKINASE PII user 3 3 # 3 A 158 SER A 57 SER~? 13.02 O1 BME A 300 A 173 ARG B 103 ARG.? 9.89 C2 BME B 301 A 211 ASP A 55 ASP~? 17.20 O1 BME A 300 coo 22.72 76.24 0.23 24.60 76.86 -1.25 71.70 44.22 4.13 69.75 45.17 3.03 coo 18.77 77.82 11.69 20.55 80.22 10.73 63.00 51.98 -1.39 64.93 51.92 1.00 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 76.53 41.69 0.56 76.82 41.16 -1.46 ULMN 3 1ig8_c00 HEXOKINASE PII user 4 3 # 4 A 158 SER B 42 SER~? 17.88 C2 BME B 301 A 173 ARG B 103 ARG.? 9.89 C2 BME B 301 A 211 ASP B 44 ASP~? 23.69 S2 BME B 301 coo 22.72 76.24 0.23 24.60 76.86 -1.25 59.65 59.95 -12.07 60.68 58.03 -11.04 coo 18.77 77.82 11.69 20.55 80.22 10.73 63.00 51.98 -1.39 64.93 51.92 1.00 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 59.88 65.23 -14.80 60.45 65.24 -16.84 ULMN 3 1ig8_c00 HEXOKINASE PII user 5 3 # 5 A 158 SER B 42 SER~? 17.88 C2 BME B 301 A 173 ARG B 105 ARG~? 19.36 C2 BME B 301 A 211 ASP B 44 ASP~? 23.69 S2 BME B 301 coo 22.72 76.24 0.23 24.60 76.86 -1.25 59.65 59.95 -12.07 60.68 58.03 -11.04 coo 18.77 77.82 11.69 20.55 80.22 10.73 52.95 54.23 -2.38 52.26 51.27 -1.82 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 59.88 65.23 -14.80 60.45 65.24 -16.84 ULMN 3 1ig8_c00 HEXOKINASE PII user 6 3 # 6 A 158 SER B 57 SER~? 14.27 S2 BME B 301 A 173 ARG B 65 ARG.? 12.88 S2 BME A 300 A 211 ASP B 55 ASP~? 19.77 S2 BME B 301 coo 22.72 76.24 0.23 24.60 76.86 -1.25 70.33 75.49 -0.10 72.36 74.24 -0.48 coo 18.77 77.82 11.69 20.55 80.22 10.73 75.25 74.20 11.13 75.77 71.55 9.67 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 66.42 77.35 -5.07 66.48 77.29 -7.17 ULMN 3 1ig8_c00 HEXOKINASE PII user 7 3 # 7 A 158 SER B 57 SER~? 14.27 S2 BME B 301 A 173 ARG B 123 ARG~? 19.27 S2 BME B 301 A 211 ASP B 68 ASP~? 10.36 S2 BME B 301 coo 22.72 76.24 0.23 24.60 76.86 -1.25 70.33 75.49 -0.10 72.36 74.24 -0.48 coo 18.77 77.82 11.69 20.55 80.22 10.73 62.37 80.29 5.08 62.68 80.61 8.15 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 74.86 70.68 0.81 74.63 68.81 1.72 1ig8_c00 source 1ig8 HEXOKINASE PII : 7 hits 1ig8_c00 naa= 3 ULMN 3 1iph_c00 CATALASE HPII user 1 3 # 1 A 128 HIS A 13 HIS~? 28.57 O1 BME A 300 A 167 SER A 10 SER~? 30.56 C1 BME A 300 A 201 ASN A 16 ASN~? 32.74 O1 BME A 300 coo 12.95 4.49 19.05 14.87 4.39 19.77 85.22 56.20 -22.53 85.38 54.15 -22.09 coo 10.44 7.96 22.51 12.16 7.57 20.82 88.87 59.13 -21.90 88.60 57.08 -23.12 coo 19.43 6.74 22.83 19.09 5.15 21.60 81.19 57.34 -27.42 83.03 56.27 -27.56 ULMN 3 1iph_c00 CATALASE HPII user 2 3 # 2 A 128 HIS B 13 HIS~? 34.41 S2 BME B 301 A 167 SER B 10 SER~? 37.79 S2 BME B 301 A 201 ASN B 16 ASN~? 33.06 S2 BME B 301 coo 12.95 4.49 19.05 14.87 4.39 19.77 67.07 73.58 -27.21 65.85 74.91 -26.15 coo 10.44 7.96 22.51 12.16 7.57 20.82 65.36 72.56 -31.08 66.40 74.55 -30.17 coo 19.43 6.74 22.83 19.09 5.15 21.60 73.64 74.63 -26.43 74.05 74.83 -24.34 1iph_c00 source 1iph CATALASE HPII : 2 hits 1iph_c00 naa= 3 ULMN 3 1iph_c01 CATALASE HPII user 1 3 # 1 B 128 HIS A 13 HIS~? 28.57 O1 BME A 300 B 167 SER A 10 SER~? 30.56 C1 BME A 300 B 201 ASN A 16 ASN~? 32.74 O1 BME A 300 coo -12.95 -4.49 19.05 -14.87 -4.39 19.77 85.22 56.20 -22.53 85.38 54.15 -22.09 coo -10.44 -7.96 22.51 -12.16 -7.57 20.82 88.87 59.13 -21.90 88.60 57.08 -23.12 coo -19.43 -6.74 22.83 -19.09 -5.15 21.60 81.19 57.34 -27.42 83.03 56.27 -27.56 ULMN 3 1iph_c01 CATALASE HPII user 2 3 # 2 B 128 HIS B 13 HIS~? 34.41 S2 BME B 301 B 167 SER B 10 SER~? 37.79 S2 BME B 301 B 201 ASN B 16 ASN~? 33.06 S2 BME B 301 coo -12.95 -4.49 19.05 -14.87 -4.39 19.77 67.07 73.58 -27.21 65.85 74.91 -26.15 coo -10.44 -7.96 22.51 -12.16 -7.57 20.82 65.36 72.56 -31.08 66.40 74.55 -30.17 coo -19.43 -6.74 22.83 -19.09 -5.15 21.60 73.64 74.63 -26.43 74.05 74.83 -24.34 1iph_c01 source 1iph CATALASE HPII : 2 hits 1iph_c01 naa= 3 ULMN 3 1iph_c02 CATALASE HPII user 1 3 # 1 C 128 HIS A 13 HIS~? 28.57 O1 BME A 300 C 167 SER A 10 SER~? 30.56 C1 BME A 300 C 201 ASN A 16 ASN~? 32.74 O1 BME A 300 coo -12.95 4.49 -19.05 -14.87 4.39 -19.77 85.22 56.20 -22.53 85.38 54.15 -22.09 coo -10.44 7.96 -22.51 -12.16 7.57 -20.82 88.87 59.13 -21.90 88.60 57.08 -23.12 coo -19.43 6.74 -22.83 -19.09 5.15 -21.60 81.19 57.34 -27.42 83.03 56.27 -27.56 ULMN 3 1iph_c02 CATALASE HPII user 2 3 # 2 C 128 HIS B 13 HIS~? 34.41 S2 BME B 301 C 167 SER B 10 SER~? 37.79 S2 BME B 301 C 201 ASN B 16 ASN~? 33.06 S2 BME B 301 coo -12.95 4.49 -19.05 -14.87 4.39 -19.77 67.07 73.58 -27.21 65.85 74.91 -26.15 coo -10.44 7.96 -22.51 -12.16 7.57 -20.82 65.36 72.56 -31.08 66.40 74.55 -30.17 coo -19.43 6.74 -22.83 -19.09 5.15 -21.60 73.64 74.63 -26.43 74.05 74.83 -24.34 1iph_c02 source 1iph CATALASE HPII : 2 hits 1iph_c02 naa= 3 ULMN 3 1iph_c03 CATALASE HPII user 1 3 # 1 D 128 HIS A 13 HIS~? 28.57 O1 BME A 300 D 167 SER A 10 SER~? 30.56 C1 BME A 300 D 201 ASN A 16 ASN~? 32.74 O1 BME A 300 coo 12.95 -4.49 -19.05 14.87 -4.39 -19.77 85.22 56.20 -22.53 85.38 54.15 -22.09 coo 10.44 -7.96 -22.51 12.16 -7.57 -20.82 88.87 59.13 -21.90 88.60 57.08 -23.12 coo 19.43 -6.74 -22.83 19.09 -5.15 -21.60 81.19 57.34 -27.42 83.03 56.27 -27.56 ULMN 3 1iph_c03 CATALASE HPII user 2 3 # 2 D 128 HIS B 13 HIS~? 34.41 S2 BME B 301 D 167 SER B 10 SER~? 37.79 S2 BME B 301 D 201 ASN B 16 ASN~? 33.06 S2 BME B 301 coo 12.95 -4.49 -19.05 14.87 -4.39 -19.77 67.07 73.58 -27.21 65.85 74.91 -26.15 coo 10.44 -7.96 -22.51 12.16 -7.57 -20.82 65.36 72.56 -31.08 66.40 74.55 -30.17 coo 19.43 -6.74 -22.83 19.09 -5.15 -21.60 73.64 74.63 -26.43 74.05 74.83 -24.34 1iph_c03 source 1iph CATALASE HPII : 2 hits 1iph_c03 naa= 3 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 A 2 GLU B 38 GLU^? 31.80 C2 BME B 301 A 56 LYS A 2 LYS.? 28.68 O1 BME A 300 A 258 ARG B 47 ARG~? 23.93 S2 BME B 301 coo 42.33 1.56 26.99 42.38 2.91 28.66 61.52 60.14 -24.13 60.63 59.15 -25.77 coo 38.45 -0.44 19.89 37.36 0.90 25.90 66.36 53.41 -23.99 71.31 50.47 -23.66 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 65.24 66.71 -15.28 63.33 68.13 -17.26 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 A 2 GLU B 108 GLU~? 13.67 C2 BME B 301 A 56 LYS B 81 LYS~? 11.51 C2 BME B 301 A 258 ARG B 103 ARG.? 9.89 C2 BME B 301 coo 42.33 1.56 26.99 42.38 2.91 28.66 54.86 59.36 -0.28 55.08 57.73 1.04 coo 38.45 -0.44 19.89 37.36 0.90 25.90 58.04 61.64 8.69 57.58 55.47 6.95 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 63.00 51.98 -1.39 64.93 51.92 1.00 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 3 3 # 3 A 2 GLU B 111 GLU~? 15.73 S2 BME B 301 A 56 LYS B 81 LYS~? 11.51 C2 BME B 301 A 258 ARG B 105 ARG~? 19.36 C2 BME B 301 coo 42.33 1.56 26.99 42.38 2.91 28.66 52.67 66.26 1.65 52.32 64.94 3.26 coo 38.45 -0.44 19.89 37.36 0.90 25.90 58.04 61.64 8.69 57.58 55.47 6.95 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 52.95 54.23 -2.38 52.26 51.27 -1.82 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 4 3 # 4 A 2 GLU B 130 GLU.? 21.96 S2 BME B 301 A 56 LYS B 3 LYS^? 16.28 S2 BME B 301 A 258 ARG B 39 ARG.? 27.37 S2 BME B 301 coo 42.33 1.56 26.99 42.38 2.91 28.66 65.89 71.50 -12.95 66.09 70.43 -14.77 coo 38.45 -0.44 19.89 37.36 0.90 25.90 73.79 67.72 -12.74 69.00 65.74 -10.30 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 61.31 65.86 -19.69 59.13 67.99 -19.83 1k82_c00 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 4 hits 1k82_c00 naa= 3 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 B 2 GLU B 38 GLU^? 31.80 C2 BME B 301 B 56 LYS A 2 LYS.? 28.68 O1 BME A 300 B 258 ARG B 47 ARG~? 23.93 S2 BME B 301 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 61.52 60.14 -24.13 60.63 59.15 -25.77 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 66.36 53.41 -23.99 71.31 50.47 -23.66 coo 2.64 1.83 34.81 1.56 1.13 32.02 65.24 66.71 -15.28 63.33 68.13 -17.26 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 B 2 GLU B 108 GLU~? 13.67 C2 BME B 301 B 56 LYS B 81 LYS~? 11.51 C2 BME B 301 B 258 ARG B 103 ARG.? 9.89 C2 BME B 301 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 54.86 59.36 -0.28 55.08 57.73 1.04 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 58.04 61.64 8.69 57.58 55.47 6.95 coo 2.64 1.83 34.81 1.56 1.13 32.02 63.00 51.98 -1.39 64.93 51.92 1.00 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 3 3 # 3 B 2 GLU B 111 GLU~? 15.73 S2 BME B 301 B 56 LYS B 81 LYS~? 11.51 C2 BME B 301 B 258 ARG B 105 ARG~? 19.36 C2 BME B 301 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 52.67 66.26 1.65 52.32 64.94 3.26 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 58.04 61.64 8.69 57.58 55.47 6.95 coo 2.64 1.83 34.81 1.56 1.13 32.02 52.95 54.23 -2.38 52.26 51.27 -1.82 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 4 3 # 4 B 2 GLU B 130 GLU.? 21.96 S2 BME B 301 B 56 LYS B 3 LYS^? 16.28 S2 BME B 301 B 258 ARG B 39 ARG.? 27.37 S2 BME B 301 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 65.89 71.50 -12.95 66.09 70.43 -14.77 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 73.79 67.72 -12.74 69.00 65.74 -10.30 coo 2.64 1.83 34.81 1.56 1.13 32.02 61.31 65.86 -19.69 59.13 67.99 -19.83 1k82_c01 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 4 hits 1k82_c01 naa= 3 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 C 2 GLU B 38 GLU^? 31.80 C2 BME B 301 C 56 LYS A 2 LYS.? 28.68 O1 BME A 300 C 258 ARG B 47 ARG~? 23.93 S2 BME B 301 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 61.52 60.14 -24.13 60.63 59.15 -25.77 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 66.36 53.41 -23.99 71.31 50.47 -23.66 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 65.24 66.71 -15.28 63.33 68.13 -17.26 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 C 2 GLU B 108 GLU~? 13.67 C2 BME B 301 C 56 LYS B 81 LYS~? 11.51 C2 BME B 301 C 258 ARG B 103 ARG.? 9.89 C2 BME B 301 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 54.86 59.36 -0.28 55.08 57.73 1.04 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 58.04 61.64 8.69 57.58 55.47 6.95 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 63.00 51.98 -1.39 64.93 51.92 1.00 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 3 3 # 3 C 2 GLU B 111 GLU~? 15.73 S2 BME B 301 C 56 LYS B 81 LYS~? 11.51 C2 BME B 301 C 258 ARG B 105 ARG~? 19.36 C2 BME B 301 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 52.67 66.26 1.65 52.32 64.94 3.26 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 58.04 61.64 8.69 57.58 55.47 6.95 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 52.95 54.23 -2.38 52.26 51.27 -1.82 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 4 3 # 4 C 2 GLU B 130 GLU.? 21.96 S2 BME B 301 C 56 LYS B 3 LYS^? 16.28 S2 BME B 301 C 258 ARG B 39 ARG.? 27.37 S2 BME B 301 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 65.89 71.50 -12.95 66.09 70.43 -14.77 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 73.79 67.72 -12.74 69.00 65.74 -10.30 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 61.31 65.86 -19.69 59.13 67.99 -19.83 1k82_c02 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 4 hits 1k82_c02 naa= 3 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 D 2 GLU B 38 GLU^? 31.80 C2 BME B 301 D 56 LYS A 2 LYS.? 28.68 O1 BME A 300 D 258 ARG B 47 ARG~? 23.93 S2 BME B 301 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 61.52 60.14 -24.13 60.63 59.15 -25.77 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 66.36 53.41 -23.99 71.31 50.47 -23.66 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 65.24 66.71 -15.28 63.33 68.13 -17.26 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 D 2 GLU B 108 GLU~? 13.67 C2 BME B 301 D 56 LYS B 81 LYS~? 11.51 C2 BME B 301 D 258 ARG B 103 ARG.? 9.89 C2 BME B 301 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 54.86 59.36 -0.28 55.08 57.73 1.04 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 58.04 61.64 8.69 57.58 55.47 6.95 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 63.00 51.98 -1.39 64.93 51.92 1.00 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 3 3 # 3 D 2 GLU B 111 GLU~? 15.73 S2 BME B 301 D 56 LYS B 81 LYS~? 11.51 C2 BME B 301 D 258 ARG B 105 ARG~? 19.36 C2 BME B 301 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 52.67 66.26 1.65 52.32 64.94 3.26 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 58.04 61.64 8.69 57.58 55.47 6.95 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 52.95 54.23 -2.38 52.26 51.27 -1.82 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 4 3 # 4 D 2 GLU B 130 GLU.? 21.96 S2 BME B 301 D 56 LYS B 3 LYS^? 16.28 S2 BME B 301 D 258 ARG B 39 ARG.? 27.37 S2 BME B 301 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 65.89 71.50 -12.95 66.09 70.43 -14.77 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 73.79 67.72 -12.74 69.00 65.74 -10.30 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 61.31 65.86 -19.69 59.13 67.99 -19.83 1k82_c03 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 4 hits 1k82_c03 naa= 3 ULMN 3 1kim_c00 THYMIDINE KINASE user 1 3 # 1 A 83 GLU B 7 GLU^? 27.97 S2 BME B 301 A 163 ARG B 9 ARG.? 31.92 S2 BME B 301 A 222 ARG B 39 ARG.? 27.37 S2 BME B 301 coo 51.27 81.34 48.31 51.67 80.79 50.28 64.21 70.19 -21.03 62.19 70.66 -20.57 coo 48.06 78.22 50.94 48.51 78.27 53.98 61.30 71.84 -25.56 62.82 73.83 -23.80 coo 54.85 84.16 52.60 54.26 81.23 53.34 61.31 65.86 -19.69 59.13 67.99 -19.83 ULMN 3 1kim_c00 THYMIDINE KINASE user 2 3 # 2 A 83 GLU B 7 GLU^? 27.97 S2 BME B 301 A 163 ARG B 39 ARG.? 27.37 S2 BME B 301 A 222 ARG B 9 ARG.? 31.92 S2 BME B 301 coo 51.27 81.34 48.31 51.67 80.79 50.28 64.21 70.19 -21.03 62.19 70.66 -20.57 coo 48.06 78.22 50.94 48.51 78.27 53.98 61.31 65.86 -19.69 59.13 67.99 -19.83 coo 54.85 84.16 52.60 54.26 81.23 53.34 61.30 71.84 -25.56 62.82 73.83 -23.80 1kim_c00 source 1kim THYMIDINE KINASE : 2 hits 1kim_c00 naa= 3 ULMN 3 1knp_c00 L-ASPARTATE OXIDASE user 1 3 # 1 A 290 ARG B 65 ARG.? 12.88 S2 BME A 300 A 351 HIS B 63 HIS.? 17.29 S2 BME B 301 A 386 LEU B 67 LEU.? 11.41 S2 BME B 301 coo 57.36 53.34 128.83 58.45 50.56 128.34 75.25 74.20 11.13 75.77 71.55 9.67 coo 60.60 50.64 133.59 60.63 48.82 132.56 68.55 77.48 13.35 66.49 77.49 13.76 coo 63.28 54.23 126.45 63.53 52.07 126.70 71.83 72.73 5.09 71.25 73.05 7.14 1knp_c00 source 1knp L-ASPARTATE OXIDASE : 1 hits 1knp_c00 naa= 3 ULMN 3 1kqf_c03 FORMATE DEHYDROGENASE, NITRATE-INDUCuser 1 3 # 1 A 94 LYS A 2 LYS.? 28.68 O1 BME A 300 A 197 HIS B 13 HIS~? 34.41 S2 BME B 301 A 446 ARG B 9 ARG.? 31.92 S2 BME B 301 coo 3.26 62.02 109.14 4.83 57.73 107.38 66.36 53.41 -23.99 71.31 50.47 -23.66 coo 9.48 43.28 113.60 10.05 44.21 111.80 67.07 73.58 -27.21 65.85 74.91 -26.15 coo 12.14 46.28 115.16 13.57 43.60 115.68 61.30 71.84 -25.56 62.82 73.83 -23.80 ULMN 3 1kqf_c03 FORMATE DEHYDROGENASE, NITRATE-INDUCuser 2 3 # 2 A 94 LYS A 3 LYS.? 20.23 O1 BME A 300 A 197 HIS B 13 HIS~? 34.41 S2 BME B 301 A 446 ARG B 9 ARG.? 31.92 S2 BME B 301 coo 3.26 62.02 109.14 4.83 57.73 107.38 68.61 55.34 -21.58 71.21 56.20 -15.92 coo 9.48 43.28 113.60 10.05 44.21 111.80 67.07 73.58 -27.21 65.85 74.91 -26.15 coo 12.14 46.28 115.16 13.57 43.60 115.68 61.30 71.84 -25.56 62.82 73.83 -23.80 1kqf_c03 source 1kqf FORMATE DEHYDROGENASE, NITRATE-INDUCIBLE, CYTO: 2 hits 1kqf_c03 naa= 3 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 1 3 # 1 255 ASP B 44 ASP~? 23.69 S2 BME B 301 262 LYS B 48 LYS~? 21.20 S2 BME B 301 336 ARG B 9 ARG.? 31.92 S2 BME B 301 coo 61.88 50.78 12.96 63.84 50.60 13.71 59.88 65.23 -14.80 60.45 65.24 -16.84 coo 63.59 44.40 18.32 63.20 49.74 17.95 62.47 69.43 -9.84 56.65 72.06 -9.69 coo 72.60 57.42 15.86 71.61 56.68 18.70 61.30 71.84 -25.56 62.82 73.83 -23.80 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 2 3 # 2 255 ASP B 68 ASP~? 10.36 S2 BME B 301 262 LYS B 73 LYS~? 5.56 C2 BME B 301 336 ARG B 65 ARG.? 12.88 S2 BME A 300 coo 61.88 50.78 12.96 63.84 50.60 13.71 74.86 70.68 0.81 74.63 68.81 1.72 coo 63.59 44.40 18.32 63.20 49.74 17.95 66.37 67.01 1.95 66.56 61.98 -0.01 coo 72.60 57.42 15.86 71.61 56.68 18.70 75.25 74.20 11.13 75.77 71.55 9.67 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 3 3 # 3 255 ASP B 84 ASP^? 10.28 C2 BME B 301 262 LYS B 81 LYS~? 11.51 C2 BME B 301 336 ARG B 103 ARG.? 9.89 C2 BME B 301 coo 61.88 50.78 12.96 63.84 50.60 13.71 64.49 54.82 11.77 62.58 54.12 11.40 coo 63.59 44.40 18.32 63.20 49.74 17.95 58.04 61.64 8.69 57.58 55.47 6.95 coo 72.60 57.42 15.86 71.61 56.68 18.70 63.00 51.98 -1.39 64.93 51.92 1.00 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 4 3 # 4 255 ASP B 129 ASP.? 27.81 S2 BME B 301 262 LYS B 48 LYS~? 21.20 S2 BME B 301 336 ARG B 9 ARG.? 31.92 S2 BME B 301 coo 61.88 50.78 12.96 63.84 50.60 13.71 64.27 77.57 -15.36 64.19 79.64 -15.85 coo 63.59 44.40 18.32 63.20 49.74 17.95 62.47 69.43 -9.84 56.65 72.06 -9.69 coo 72.60 57.42 15.86 71.61 56.68 18.70 61.30 71.84 -25.56 62.82 73.83 -23.80 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 5 3 # 5 255 ASP B 129 ASP.? 27.81 S2 BME B 301 262 LYS B 48 LYS~? 21.20 S2 BME B 301 336 ARG B 58 ARG~? 19.35 S2 BME B 301 coo 61.88 50.78 12.96 63.84 50.60 13.71 64.27 77.57 -15.36 64.19 79.64 -15.85 coo 63.59 44.40 18.32 63.20 49.74 17.95 62.47 69.43 -9.84 56.65 72.06 -9.69 coo 72.60 57.42 15.86 71.61 56.68 18.70 73.30 78.23 -5.33 71.23 76.59 -6.88 1lam_c00 source 1lam LEUCINE AMINOPEPTIDASE : 5 hits 1lam_c00 naa= 3 ULMN 3 1lij_c01 ADENOSINE KINASE user 1 3 # 1 A 316 ALA A 51 ALA~? 15.38 O1 BME A 300 A 317 GLY A 54 GLY~? 12.91 O1 BME A 300 A 318 ASP A 55 ASP~? 17.20 O1 BME A 300 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 76.81 45.65 -3.69 77.80 45.08 -4.70 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 73.25 45.16 -0.27 73.90 44.96 0.21 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 76.53 41.69 0.56 76.82 41.16 -1.46 ULMN 3 1lij_c01 ADENOSINE KINASE user 2 3 # 2 A 316 ALA B 51 ALA~? 18.20 S2 BME B 301 A 317 GLY B 54 GLY~? 15.43 S2 BME B 301 A 318 ASP B 55 ASP~? 19.77 S2 BME B 301 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 66.36 72.04 -8.23 65.50 72.30 -9.45 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 69.56 73.71 -4.55 68.86 74.06 -4.25 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 66.42 77.35 -5.07 66.48 77.29 -7.17 1lij_c01 source 1lij ADENOSINE KINASE : 2 hits 1lij_c01 naa= 3 ULMN 3 1lio_c01 ADENOSINE KINASE user 1 3 # 1 A 316 ALA A 51 ALA~? 15.38 O1 BME A 300 A 317 GLY A 54 GLY~? 12.91 O1 BME A 300 A 318 ASP A 55 ASP~? 17.20 O1 BME A 300 coo 27.04 23.54 41.85 25.72 24.19 42.18 76.81 45.65 -3.69 77.80 45.08 -4.70 coo 27.87 23.16 38.17 28.43 22.97 38.87 73.25 45.16 -0.27 73.90 44.96 0.21 coo 32.11 22.71 40.58 33.42 24.22 39.78 76.53 41.69 0.56 76.82 41.16 -1.46 ULMN 3 1lio_c01 ADENOSINE KINASE user 2 3 # 2 A 316 ALA B 51 ALA~? 18.20 S2 BME B 301 A 317 GLY B 54 GLY~? 15.43 S2 BME B 301 A 318 ASP B 55 ASP~? 19.77 S2 BME B 301 coo 27.04 23.54 41.85 25.72 24.19 42.18 66.36 72.04 -8.23 65.50 72.30 -9.45 coo 27.87 23.16 38.17 28.43 22.97 38.87 69.56 73.71 -4.55 68.86 74.06 -4.25 coo 32.11 22.71 40.58 33.42 24.22 39.78 66.42 77.35 -5.07 66.48 77.29 -7.17 1lio_c01 source 1lio ADENOSINE KINASE : 2 hits 1lio_c01 naa= 3 ULMN 3 1m21_c00 PEPTIDE AMIDASE user 1 3 # 1 A 123 LYS A 73 LYS~? -2.81 O1 BME A 300s A 202 SER A 100 SER.? 7.07 C1 BME A 300 A 226 SER A 102 SER.? 8.36 C1 BME A 300 coo 1.62 6.10 69.30 3.81 1.25 65.91 75.23 53.47 4.59 74.97 57.96 1.35 coo 4.43 1.89 61.79 4.31 0.09 63.40 76.98 62.85 2.47 76.76 63.82 0.26 coo 8.52 -0.27 63.61 6.46 -1.15 62.94 78.79 62.05 -2.37 76.46 61.88 -3.05 ULMN 3 1m21_c00 PEPTIDE AMIDASE user 2 3 # 2 A 123 LYS B 73 LYS~? 5.56 C2 BME B 301 A 202 SER B 100 SER.? 7.38 C2 BME B 301 A 226 SER B 102 SER.? 9.52 C2 BME B 301 coo 1.62 6.10 69.30 3.81 1.25 65.91 66.37 67.01 1.95 66.56 61.98 -0.01 coo 4.43 1.89 61.79 4.31 0.09 63.40 64.33 57.82 1.68 64.28 55.45 1.01 coo 8.52 -0.27 63.61 6.46 -1.15 62.94 63.38 56.52 -3.17 65.79 56.15 -3.09 1m21_c00 source 1m21 PEPTIDE AMIDASE : 2 hits 1m21_c00 naa= 3 ULMN 3 1m21_c01 PEPTIDE AMIDASE user 1 3 # 1 B 123 LYS A 73 LYS~? -2.81 O1 BME A 300s B 202 SER A 100 SER.? 7.07 C1 BME A 300 B 226 SER A 102 SER.? 8.36 C1 BME A 300 coo 35.67 -0.01 18.11 33.47 4.84 14.73 75.23 53.47 4.59 74.97 57.96 1.35 coo 32.81 4.27 10.70 32.87 6.07 12.31 76.98 62.85 2.47 76.76 63.82 0.26 coo 28.77 6.36 12.44 30.83 7.25 11.75 78.79 62.05 -2.37 76.46 61.88 -3.05 ULMN 3 1m21_c01 PEPTIDE AMIDASE user 2 3 # 2 B 123 LYS B 73 LYS~? 5.56 C2 BME B 301 B 202 SER B 100 SER.? 7.38 C2 BME B 301 B 226 SER B 102 SER.? 9.52 C2 BME B 301 coo 35.67 -0.01 18.11 33.47 4.84 14.73 66.37 67.01 1.95 66.56 61.98 -0.01 coo 32.81 4.27 10.70 32.87 6.07 12.31 64.33 57.82 1.68 64.28 55.45 1.01 coo 28.77 6.36 12.44 30.83 7.25 11.75 63.38 56.52 -3.17 65.79 56.15 -3.09 1m21_c01 source 1m21 PEPTIDE AMIDASE : 2 hits 1m21_c01 naa= 3 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 1 3 # 1 A 241 ASP B 129 ASP.? 27.81 S2 BME B 301 A 295 GLU B 130 GLU.? 21.96 S2 BME B 301 A 369 ASP B 55 ASP~? 19.77 S2 BME B 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 64.27 77.57 -15.36 64.19 79.64 -15.85 coo 16.11 33.72 80.99 14.10 33.54 81.63 65.89 71.50 -12.95 66.09 70.43 -14.77 coo 12.19 31.08 87.29 11.13 32.66 86.38 66.42 77.35 -5.07 66.48 77.29 -7.17 1m53_c03 source 1m53 ISOMALTULOSE SYNTHASE : 1 hits 1m53_c03 naa= 3 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 1 3 # 1 A 241 ASP A 44 ASP~? 20.39 O1 BME A 300 A 265 GLU A 70 GLU~? 7.34 C1 BME B 301 A 369 ASP A 129 ASP~? 19.06 O1 BME A 300 coo 11.74 38.14 80.19 10.63 36.40 80.65 83.66 51.21 -11.72 83.67 49.16 -12.23 coo 17.36 23.57 72.04 18.68 21.92 71.98 68.92 53.57 0.58 67.76 55.17 -0.17 coo 12.19 31.08 87.29 11.13 32.66 86.38 80.80 42.21 -6.02 80.73 43.57 -7.63 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 2 3 # 2 A 241 ASP A 68 ASP~? 9.92 C1 BME B 301 A 265 GLU B 70 GLU~? 7.75 C1 BME A 300 A 369 ASP B 84 ASP^? 10.28 C2 BME B 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 67.14 48.96 2.96 66.44 50.60 4.08 coo 17.36 23.57 72.04 18.68 21.92 71.98 72.71 65.28 -0.66 74.40 64.00 -0.70 coo 12.19 31.08 87.29 11.13 32.66 86.38 64.49 54.82 11.77 62.58 54.12 11.40 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 3 3 # 3 A 241 ASP A 68 ASP~? 9.92 C1 BME B 301 A 265 GLU B 108 GLU~? 13.67 C2 BME B 301 A 369 ASP B 84 ASP^? 10.28 C2 BME B 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 67.14 48.96 2.96 66.44 50.60 4.08 coo 17.36 23.57 72.04 18.68 21.92 71.98 54.86 59.36 -0.28 55.08 57.73 1.04 coo 12.19 31.08 87.29 11.13 32.66 86.38 64.49 54.82 11.77 62.58 54.12 11.40 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 4 3 # 4 A 241 ASP A 84 ASP^? 10.85 S2 BME A 300 A 265 GLU A 70 GLU~? 7.34 C1 BME B 301 A 369 ASP B 68 ASP~? 10.36 S2 BME B 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 75.39 67.64 11.32 77.43 68.14 11.09 coo 17.36 23.57 72.04 18.68 21.92 71.98 68.92 53.57 0.58 67.76 55.17 -0.17 coo 12.19 31.08 87.29 11.13 32.66 86.38 74.86 70.68 0.81 74.63 68.81 1.72 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 5 3 # 5 A 241 ASP A 129 ASP~? 19.06 O1 BME A 300 A 265 GLU A 70 GLU~? 7.34 C1 BME B 301 A 369 ASP A 44 ASP~? 20.39 O1 BME A 300 coo 11.74 38.14 80.19 10.63 36.40 80.65 80.80 42.21 -6.02 80.73 43.57 -7.63 coo 17.36 23.57 72.04 18.68 21.92 71.98 68.92 53.57 0.58 67.76 55.17 -0.17 coo 12.19 31.08 87.29 11.13 32.66 86.38 83.66 51.21 -11.72 83.67 49.16 -12.23 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 6 3 # 6 A 241 ASP B 55 ASP~? 19.77 S2 BME B 301 A 265 GLU A 38 GLU^? 20.48 C1 BME A 300 A 369 ASP B 129 ASP.? 27.81 S2 BME B 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 66.42 77.35 -5.07 66.48 77.29 -7.17 coo 17.36 23.57 72.04 18.68 21.92 71.98 80.67 68.42 -11.46 82.73 68.27 -11.88 coo 12.19 31.08 87.29 11.13 32.66 86.38 64.27 77.57 -15.36 64.19 79.64 -15.85 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 7 3 # 7 A 241 ASP B 68 ASP~? 10.36 S2 BME B 301 A 265 GLU A 70 GLU~? 7.34 C1 BME B 301 A 369 ASP A 84 ASP^? 10.85 S2 BME A 300 coo 11.74 38.14 80.19 10.63 36.40 80.65 74.86 70.68 0.81 74.63 68.81 1.72 coo 17.36 23.57 72.04 18.68 21.92 71.98 68.92 53.57 0.58 67.76 55.17 -0.17 coo 12.19 31.08 87.29 11.13 32.66 86.38 75.39 67.64 11.32 77.43 68.14 11.09 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 8 3 # 8 A 241 ASP B 84 ASP^? 10.28 C2 BME B 301 A 265 GLU B 70 GLU~? 7.75 C1 BME A 300 A 369 ASP A 68 ASP~? 9.92 C1 BME B 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 64.49 54.82 11.77 62.58 54.12 11.40 coo 17.36 23.57 72.04 18.68 21.92 71.98 72.71 65.28 -0.66 74.40 64.00 -0.70 coo 12.19 31.08 87.29 11.13 32.66 86.38 67.14 48.96 2.96 66.44 50.60 4.08 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 9 3 # 9 A 241 ASP B 84 ASP^? 10.28 C2 BME B 301 A 265 GLU B 108 GLU~? 13.67 C2 BME B 301 A 369 ASP A 68 ASP~? 9.92 C1 BME B 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 64.49 54.82 11.77 62.58 54.12 11.40 coo 17.36 23.57 72.04 18.68 21.92 71.98 54.86 59.36 -0.28 55.08 57.73 1.04 coo 12.19 31.08 87.29 11.13 32.66 86.38 67.14 48.96 2.96 66.44 50.60 4.08 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 10 3 # 10 A 241 ASP B 129 ASP.? 27.81 S2 BME B 301 A 265 GLU A 38 GLU^? 20.48 C1 BME A 300 A 369 ASP B 55 ASP~? 19.77 S2 BME B 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 64.27 77.57 -15.36 64.19 79.64 -15.85 coo 17.36 23.57 72.04 18.68 21.92 71.98 80.67 68.42 -11.46 82.73 68.27 -11.88 coo 12.19 31.08 87.29 11.13 32.66 86.38 66.42 77.35 -5.07 66.48 77.29 -7.17 1m53_c05 source 1m53 ISOMALTULOSE SYNTHASE : 10 hits 1m53_c05 naa= 3 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 1 3 # 1 A 241 ASP A 44 ASP~? 20.39 O1 BME A 300 A 279 GLU A 38 GLU^? 20.48 C1 BME A 300 A 369 ASP A 129 ASP~? 19.06 O1 BME A 300 coo 11.74 38.14 80.19 10.63 36.40 80.65 83.66 51.21 -11.72 83.67 49.16 -12.23 coo 16.54 46.37 63.94 14.77 45.79 62.95 80.67 68.42 -11.46 82.73 68.27 -11.88 coo 12.19 31.08 87.29 11.13 32.66 86.38 80.80 42.21 -6.02 80.73 43.57 -7.63 1m53_c06 source 1m53 ISOMALTULOSE SYNTHASE : 1 hits 1m53_c06 naa= 3 ULMN 3 1mt5_c00 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 A 142 LYS A 73 LYS~? -2.81 O1 BME A 300s A 217 SER A 100 SER.? 7.07 C1 BME A 300 A 241 SER A 102 SER.? 8.36 C1 BME A 300 coo 12.59 -31.89 29.79 15.18 -27.54 26.08 75.23 53.47 4.59 74.97 57.96 1.35 coo 19.52 -27.28 27.04 17.55 -25.93 26.56 76.98 62.85 2.47 76.76 63.82 0.26 coo 18.91 -27.35 22.36 18.66 -25.43 23.90 78.79 62.05 -2.37 76.46 61.88 -3.05 ULMN 3 1mt5_c00 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 A 142 LYS B 73 LYS~? 5.56 C2 BME B 301 A 217 SER B 100 SER.? 7.38 C2 BME B 301 A 241 SER B 102 SER.? 9.52 C2 BME B 301 coo 12.59 -31.89 29.79 15.18 -27.54 26.08 66.37 67.01 1.95 66.56 61.98 -0.01 coo 19.52 -27.28 27.04 17.55 -25.93 26.56 64.33 57.82 1.68 64.28 55.45 1.01 coo 18.91 -27.35 22.36 18.66 -25.43 23.90 63.38 56.52 -3.17 65.79 56.15 -3.09 1mt5_c00 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 2 hits 1mt5_c00 naa= 3 ULMN 3 1mt5_c01 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 B 142 LYS A 73 LYS~? -2.81 O1 BME A 300s B 217 SER A 100 SER.? 7.07 C1 BME A 300 B 241 SER A 102 SER.? 8.36 C1 BME A 300 coo -7.04 -5.02 -4.87 -7.61 -4.05 1.23 75.23 53.47 4.59 74.97 57.96 1.35 coo -9.93 -0.90 2.43 -7.82 -1.91 3.00 76.98 62.85 2.47 76.76 63.82 0.26 coo -11.06 -4.56 5.15 -9.38 -2.84 5.46 78.79 62.05 -2.37 76.46 61.88 -3.05 ULMN 3 1mt5_c01 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 B 142 LYS B 73 LYS~? 5.56 C2 BME B 301 B 217 SER B 100 SER.? 7.38 C2 BME B 301 B 241 SER B 102 SER.? 9.52 C2 BME B 301 coo -7.04 -5.02 -4.87 -7.61 -4.05 1.23 66.37 67.01 1.95 66.56 61.98 -0.01 coo -9.93 -0.90 2.43 -7.82 -1.91 3.00 64.33 57.82 1.68 64.28 55.45 1.01 coo -11.06 -4.56 5.15 -9.38 -2.84 5.46 63.38 56.52 -3.17 65.79 56.15 -3.09 1mt5_c01 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 2 hits 1mt5_c01 naa= 3 ULMN 3 1mt5_c02 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 C 142 LYS A 73 LYS~? -2.81 O1 BME A 300s C 217 SER A 100 SER.? 7.07 C1 BME A 300 C 241 SER A 102 SER.? 8.36 C1 BME A 300 coo -12.07 2.83 63.52 -8.95 7.56 61.01 75.23 53.47 4.59 74.97 57.96 1.35 coo -11.64 10.12 58.62 -9.34 9.31 58.79 76.98 62.85 2.47 76.76 63.82 0.26 coo -9.31 12.91 61.58 -8.56 11.90 59.50 78.79 62.05 -2.37 76.46 61.88 -3.05 ULMN 3 1mt5_c02 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 C 142 LYS B 73 LYS~? 5.56 C2 BME B 301 C 217 SER B 100 SER.? 7.38 C2 BME B 301 C 241 SER B 102 SER.? 9.52 C2 BME B 301 coo -12.07 2.83 63.52 -8.95 7.56 61.01 66.37 67.01 1.95 66.56 61.98 -0.01 coo -11.64 10.12 58.62 -9.34 9.31 58.79 64.33 57.82 1.68 64.28 55.45 1.01 coo -9.31 12.91 61.58 -8.56 11.90 59.50 63.38 56.52 -3.17 65.79 56.15 -3.09 1mt5_c02 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 2 hits 1mt5_c02 naa= 3 ULMN 3 1mt5_c03 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 D 142 LYS A 73 LYS~? -2.81 O1 BME A 300s D 217 SER A 100 SER.? 7.07 C1 BME A 300 D 241 SER A 102 SER.? 8.36 C1 BME A 300 coo 32.93 17.78 71.88 30.89 13.50 67.83 75.23 53.47 4.59 74.97 57.96 1.35 coo 34.38 11.17 66.10 32.18 12.14 65.65 76.98 62.85 2.47 76.76 63.82 0.26 coo 31.34 7.96 67.74 31.44 9.08 65.62 78.79 62.05 -2.37 76.46 61.88 -3.05 ULMN 3 1mt5_c03 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 D 142 LYS B 73 LYS~? 5.56 C2 BME B 301 D 217 SER B 100 SER.? 7.38 C2 BME B 301 D 241 SER B 102 SER.? 9.52 C2 BME B 301 coo 32.93 17.78 71.88 30.89 13.50 67.83 66.37 67.01 1.95 66.56 61.98 -0.01 coo 34.38 11.17 66.10 32.18 12.14 65.65 64.33 57.82 1.68 64.28 55.45 1.01 coo 31.34 7.96 67.74 31.44 9.08 65.62 63.38 56.52 -3.17 65.79 56.15 -3.09 1mt5_c03 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 2 hits 1mt5_c03 naa= 3 ULMN 3 1mt5_c04 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 E 142 LYS A 73 LYS~? -2.81 O1 BME A 300s E 217 SER A 100 SER.? 7.07 C1 BME A 300 E 241 SER A 102 SER.? 8.36 C1 BME A 300 coo 75.33 -22.06 34.43 71.44 -18.39 37.56 75.23 53.47 4.59 74.97 57.96 1.35 coo 67.33 -19.20 36.79 68.69 -17.23 37.19 76.98 62.85 2.47 76.76 63.82 0.26 coo 67.84 -18.40 41.49 67.44 -16.90 39.59 78.79 62.05 -2.37 76.46 61.88 -3.05 ULMN 3 1mt5_c04 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 E 142 LYS B 73 LYS~? 5.56 C2 BME B 301 E 217 SER B 100 SER.? 7.38 C2 BME B 301 E 241 SER B 102 SER.? 9.52 C2 BME B 301 coo 75.33 -22.06 34.43 71.44 -18.39 37.56 66.37 67.01 1.95 66.56 61.98 -0.01 coo 67.33 -19.20 36.79 68.69 -17.23 37.19 64.33 57.82 1.68 64.28 55.45 1.01 coo 67.84 -18.40 41.49 67.44 -16.90 39.59 63.38 56.52 -3.17 65.79 56.15 -3.09 1mt5_c04 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 2 hits 1mt5_c04 naa= 3 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 F 142 LYS A 73 LYS~? -2.81 O1 BME A 300s F 217 SER A 100 SER.? 7.07 C1 BME A 300 F 241 SER A 102 SER.? 8.36 C1 BME A 300 coo 85.78 13.19 64.96 85.47 13.47 58.63 75.23 53.47 4.59 74.97 57.96 1.35 coo 87.43 17.13 57.15 85.84 15.39 56.76 76.98 62.85 2.47 76.76 63.82 0.26 coo 89.69 13.60 54.86 87.60 14.67 54.46 78.79 62.05 -2.37 76.46 61.88 -3.05 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 F 142 LYS B 73 LYS~? 5.56 C2 BME B 301 F 217 SER B 100 SER.? 7.38 C2 BME B 301 F 241 SER B 102 SER.? 9.52 C2 BME B 301 coo 85.78 13.19 64.96 85.47 13.47 58.63 66.37 67.01 1.95 66.56 61.98 -0.01 coo 87.43 17.13 57.15 85.84 15.39 56.76 64.33 57.82 1.68 64.28 55.45 1.01 coo 89.69 13.60 54.86 87.60 14.67 54.46 63.38 56.52 -3.17 65.79 56.15 -3.09 1mt5_c05 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 2 hits 1mt5_c05 naa= 3 ULMN 3 1mt5_c06 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 G 142 LYS A 73 LYS~? -2.81 O1 BME A 300s G 217 SER A 100 SER.? 7.07 C1 BME A 300 G 241 SER A 102 SER.? 8.36 C1 BME A 300 coo 89.44 13.59 -3.79 85.15 17.81 -2.15 75.23 53.47 4.59 74.97 57.96 1.35 coo 86.84 21.07 -0.09 84.89 19.68 -0.05 76.98 62.85 2.47 76.76 63.82 0.26 coo 83.77 22.72 -3.25 83.41 21.94 -0.96 78.79 62.05 -2.37 76.46 61.88 -3.05 ULMN 3 1mt5_c06 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 G 142 LYS B 73 LYS~? 5.56 C2 BME B 301 G 217 SER B 100 SER.? 7.38 C2 BME B 301 G 241 SER B 102 SER.? 9.52 C2 BME B 301 coo 89.44 13.59 -3.79 85.15 17.81 -2.15 66.37 67.01 1.95 66.56 61.98 -0.01 coo 86.84 21.07 -0.09 84.89 19.68 -0.05 64.33 57.82 1.68 64.28 55.45 1.01 coo 83.77 22.72 -3.25 83.41 21.94 -0.96 63.38 56.52 -3.17 65.79 56.15 -3.09 1mt5_c06 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 2 hits 1mt5_c06 naa= 3 ULMN 3 1mt5_c07 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 H 142 LYS A 73 LYS~? -2.81 O1 BME A 300s H 217 SER A 100 SER.? 7.07 C1 BME A 300 H 241 SER A 102 SER.? 8.36 C1 BME A 300 coo 42.27 12.37 -13.24 45.60 9.85 -8.67 75.23 53.47 4.59 74.97 57.96 1.35 coo 42.97 6.75 -6.56 44.94 8.04 -6.19 76.98 62.85 2.47 76.76 63.82 0.26 coo 46.96 4.33 -7.53 46.37 5.62 -5.61 78.79 62.05 -2.37 76.46 61.88 -3.05 ULMN 3 1mt5_c07 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 H 142 LYS B 73 LYS~? 5.56 C2 BME B 301 H 217 SER B 100 SER.? 7.38 C2 BME B 301 H 241 SER B 102 SER.? 9.52 C2 BME B 301 coo 42.27 12.37 -13.24 45.60 9.85 -8.67 66.37 67.01 1.95 66.56 61.98 -0.01 coo 42.97 6.75 -6.56 44.94 8.04 -6.19 64.33 57.82 1.68 64.28 55.45 1.01 coo 46.96 4.33 -7.53 46.37 5.62 -5.61 63.38 56.52 -3.17 65.79 56.15 -3.09 1mt5_c07 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 2 hits 1mt5_c07 naa= 3 ULMN 3 1mt5_c08 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 I 142 LYS A 73 LYS~? -2.81 O1 BME A 300s I 217 SER A 100 SER.? 7.07 C1 BME A 300 I 241 SER A 102 SER.? 8.36 C1 BME A 300 coo -5.05 91.11 27.04 -1.24 87.39 30.21 75.23 53.47 4.59 74.97 57.96 1.35 coo 2.83 88.63 29.54 1.30 86.82 30.03 76.98 62.85 2.47 76.76 63.82 0.26 coo 2.37 88.32 34.25 2.82 86.58 32.61 78.79 62.05 -2.37 76.46 61.88 -3.05 ULMN 3 1mt5_c08 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 I 142 LYS B 73 LYS~? 5.56 C2 BME B 301 I 217 SER B 100 SER.? 7.38 C2 BME B 301 I 241 SER B 102 SER.? 9.52 C2 BME B 301 coo -5.05 91.11 27.04 -1.24 87.39 30.21 66.37 67.01 1.95 66.56 61.98 -0.01 coo 2.83 88.63 29.54 1.30 86.82 30.03 64.33 57.82 1.68 64.28 55.45 1.01 coo 2.37 88.32 34.25 2.82 86.58 32.61 63.38 56.52 -3.17 65.79 56.15 -3.09 1mt5_c08 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 2 hits 1mt5_c08 naa= 3 ULMN 3 1mt5_c09 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 J 142 LYS A 73 LYS~? -2.81 O1 BME A 300s J 217 SER A 100 SER.? 7.07 C1 BME A 300 J 241 SER A 102 SER.? 8.36 C1 BME A 300 coo -16.11 59.78 61.53 -15.92 58.68 55.43 75.23 53.47 4.59 74.97 57.96 1.35 coo -17.65 54.92 54.17 -15.81 56.46 53.79 76.98 62.85 2.47 76.76 63.82 0.26 coo -19.92 58.10 51.57 -17.75 57.08 51.34 78.79 62.05 -2.37 76.46 61.88 -3.05 ULMN 3 1mt5_c09 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 J 142 LYS B 73 LYS~? 5.56 C2 BME B 301 J 217 SER B 100 SER.? 7.38 C2 BME B 301 J 241 SER B 102 SER.? 9.52 C2 BME B 301 coo -16.11 59.78 61.53 -15.92 58.68 55.43 66.37 67.01 1.95 66.56 61.98 -0.01 coo -17.65 54.92 54.17 -15.81 56.46 53.79 64.33 57.82 1.68 64.28 55.45 1.01 coo -19.92 58.10 51.57 -17.75 57.08 51.34 63.38 56.52 -3.17 65.79 56.15 -3.09 1mt5_c09 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 2 hits 1mt5_c09 naa= 3 ULMN 3 1mt5_c10 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 K 142 LYS A 73 LYS~? -2.81 O1 BME A 300s K 217 SER A 100 SER.? 7.07 C1 BME A 300 K 241 SER A 102 SER.? 8.36 C1 BME A 300 coo -19.03 51.36 -6.94 -15.20 46.99 -4.75 75.23 53.47 4.59 74.97 57.96 1.35 coo -16.83 44.30 -2.14 -14.73 45.44 -2.29 76.98 62.85 2.47 76.76 63.82 0.26 coo -13.82 42.19 -5.17 -13.38 43.30 -3.07 78.79 62.05 -2.37 76.46 61.88 -3.05 ULMN 3 1mt5_c10 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 K 142 LYS B 73 LYS~? 5.56 C2 BME B 301 K 217 SER B 100 SER.? 7.38 C2 BME B 301 K 241 SER B 102 SER.? 9.52 C2 BME B 301 coo -19.03 51.36 -6.94 -15.20 46.99 -4.75 66.37 67.01 1.95 66.56 61.98 -0.01 coo -16.83 44.30 -2.14 -14.73 45.44 -2.29 64.33 57.82 1.68 64.28 55.45 1.01 coo -13.82 42.19 -5.17 -13.38 43.30 -3.07 63.38 56.52 -3.17 65.79 56.15 -3.09 1mt5_c10 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 2 hits 1mt5_c10 naa= 3 ULMN 3 1mt5_c11 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 L 142 LYS A 73 LYS~? -2.81 O1 BME A 300s L 217 SER A 100 SER.? 7.07 C1 BME A 300 L 241 SER A 102 SER.? 8.36 C1 BME A 300 coo 28.16 48.07 -15.34 25.35 51.49 -11.15 75.23 53.47 4.59 74.97 57.96 1.35 coo 28.02 54.76 -9.49 26.01 53.53 -9.27 76.98 62.85 2.47 76.76 63.82 0.26 coo 24.20 57.36 -11.16 24.62 56.31 -9.00 78.79 62.05 -2.37 76.46 61.88 -3.05 ULMN 3 1mt5_c11 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 L 142 LYS B 73 LYS~? 5.56 C2 BME B 301 L 217 SER B 100 SER.? 7.38 C2 BME B 301 L 241 SER B 102 SER.? 9.52 C2 BME B 301 coo 28.16 48.07 -15.34 25.35 51.49 -11.15 66.37 67.01 1.95 66.56 61.98 -0.01 coo 28.02 54.76 -9.49 26.01 53.53 -9.27 64.33 57.82 1.68 64.28 55.45 1.01 coo 24.20 57.36 -11.16 24.62 56.31 -9.00 63.38 56.52 -3.17 65.79 56.15 -3.09 1mt5_c11 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 2 hits 1mt5_c11 naa= 3 ULMN 3 1mt5_c12 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 M 142 LYS A 73 LYS~? -2.81 O1 BME A 300s M 217 SER A 100 SER.? 7.07 C1 BME A 300 M 241 SER A 102 SER.? 8.36 C1 BME A 300 coo 57.83 99.61 24.25 54.90 95.14 20.60 75.23 53.47 4.59 74.97 57.96 1.35 coo 51.07 94.66 21.52 53.18 93.49 22.20 76.98 62.85 2.47 76.76 63.82 0.26 coo 51.67 94.23 16.93 51.60 92.47 18.57 78.79 62.05 -2.37 76.46 61.88 -3.05 ULMN 3 1mt5_c12 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 M 142 LYS B 73 LYS~? 5.56 C2 BME B 301 M 217 SER B 100 SER.? 7.38 C2 BME B 301 M 241 SER B 102 SER.? 9.52 C2 BME B 301 coo 57.83 99.61 24.25 54.90 95.14 20.60 66.37 67.01 1.95 66.56 61.98 -0.01 coo 51.07 94.66 21.52 53.18 93.49 22.20 64.33 57.82 1.68 64.28 55.45 1.01 coo 51.67 94.23 16.93 51.60 92.47 18.57 63.38 56.52 -3.17 65.79 56.15 -3.09 1mt5_c12 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 2 hits 1mt5_c12 naa= 3 ULMN 3 1mt5_c13 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 N 142 LYS A 73 LYS~? -2.81 O1 BME A 300s N 217 SER A 100 SER.? 7.07 C1 BME A 300 N 241 SER A 102 SER.? 8.36 C1 BME A 300 coo 79.06 71.19 -8.17 79.37 70.55 -1.89 75.23 53.47 4.59 74.97 57.96 1.35 coo 81.67 67.31 -0.58 79.53 68.28 0.00 76.98 62.85 2.47 76.76 63.82 0.26 coo 82.47 71.15 2.07 80.82 69.44 2.28 78.79 62.05 -2.37 76.46 61.88 -3.05 ULMN 3 1mt5_c13 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 N 142 LYS B 73 LYS~? 5.56 C2 BME B 301 N 217 SER B 100 SER.? 7.38 C2 BME B 301 N 241 SER B 102 SER.? 9.52 C2 BME B 301 coo 79.06 71.19 -8.17 79.37 70.55 -1.89 66.37 67.01 1.95 66.56 61.98 -0.01 coo 81.67 67.31 -0.58 79.53 68.28 0.00 64.33 57.82 1.68 64.28 55.45 1.01 coo 82.47 71.15 2.07 80.82 69.44 2.28 63.38 56.52 -3.17 65.79 56.15 -3.09 1mt5_c13 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 2 hits 1mt5_c13 naa= 3 ULMN 3 1mt5_c14 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 O 142 LYS A 73 LYS~? -2.81 O1 BME A 300s O 217 SER A 100 SER.? 7.07 C1 BME A 300 O 241 SER A 102 SER.? 8.36 C1 BME A 300 coo 81.67 70.12 58.71 78.82 64.87 57.22 75.23 53.47 4.59 74.97 57.96 1.35 coo 81.62 62.23 55.05 79.32 62.93 55.20 76.98 62.85 2.47 76.76 63.82 0.26 coo 79.39 59.54 58.42 78.72 60.00 56.11 78.79 62.05 -2.37 76.46 61.88 -3.05 ULMN 3 1mt5_c14 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 O 142 LYS B 73 LYS~? 5.56 C2 BME B 301 O 217 SER B 100 SER.? 7.38 C2 BME B 301 O 241 SER B 102 SER.? 9.52 C2 BME B 301 coo 81.67 70.12 58.71 78.82 64.87 57.22 66.37 67.01 1.95 66.56 61.98 -0.01 coo 81.62 62.23 55.05 79.32 62.93 55.20 64.33 57.82 1.68 64.28 55.45 1.01 coo 79.39 59.54 58.42 78.72 60.00 56.11 63.38 56.52 -3.17 65.79 56.15 -3.09 1mt5_c14 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 2 hits 1mt5_c14 naa= 3 ULMN 3 1mt5_c15 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 P 142 LYS A 73 LYS~? -2.81 O1 BME A 300s P 217 SER A 100 SER.? 7.07 C1 BME A 300 P 241 SER A 102 SER.? 8.36 C1 BME A 300 coo 37.29 55.72 69.54 38.73 59.85 65.07 75.23 53.47 4.59 74.97 57.96 1.35 coo 35.55 61.40 62.96 37.72 60.41 62.66 76.98 62.85 2.47 76.76 63.82 0.26 coo 38.60 64.77 64.10 38.63 63.28 62.26 78.79 62.05 -2.37 76.46 61.88 -3.05 ULMN 3 1mt5_c15 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 P 142 LYS B 73 LYS~? 5.56 C2 BME B 301 P 217 SER B 100 SER.? 7.38 C2 BME B 301 P 241 SER B 102 SER.? 9.52 C2 BME B 301 coo 37.29 55.72 69.54 38.73 59.85 65.07 66.37 67.01 1.95 66.56 61.98 -0.01 coo 35.55 61.40 62.96 37.72 60.41 62.66 64.33 57.82 1.68 64.28 55.45 1.01 coo 38.60 64.77 64.10 38.63 63.28 62.26 63.38 56.52 -3.17 65.79 56.15 -3.09 1mt5_c15 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 2 hits 1mt5_c15 naa= 3 ULMN 3 1ohh_c06 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 1 3 # 1 A 175 LYS B 3 LYS^? 16.28 S2 BME B 301 A 208 GLN B 37 GLN^? 22.79 C1 BME B 301 A 209 LYS A 3 LYS.? 20.23 O1 BME A 300 coo 98.39 14.31 -19.34 101.13 12.36 -14.91 73.79 67.72 -12.74 69.00 65.74 -10.30 coo 107.44 7.66 -20.60 106.37 8.45 -22.25 67.31 60.31 -19.68 67.74 59.93 -17.63 coo 109.03 2.06 -20.49 104.00 -1.36 -18.88 68.61 55.34 -21.58 71.21 56.20 -15.92 1ohh_c06 source 1ohh ATP SYNTHASE ALPHA CHAIN HEART ISOFORM, MITOCH: 1 hits 1ohh_c06 naa= 3 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 1 3 # 1 B 175 LYS B 3 LYS^? 16.28 S2 BME B 301 B 208 GLN B 37 GLN^? 22.79 C1 BME B 301 B 209 LYS A 3 LYS.? 20.23 O1 BME A 300 coo 105.03 46.01 19.55 106.59 42.35 15.55 73.79 67.72 -12.74 69.00 65.74 -10.30 coo 113.93 46.99 13.56 113.37 48.52 14.95 67.31 60.31 -19.68 67.74 59.93 -17.63 coo 115.66 49.12 8.60 111.19 49.52 4.73 68.61 55.34 -21.58 71.21 56.20 -15.92 1ohh_c07 source 1ohh ATP SYNTHASE ALPHA CHAIN HEART ISOFORM, MITOCH: 1 hits 1ohh_c07 naa= 3 ULMN 3 1ohh_c08 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 1 3 # 1 C 175 LYS B 3 LYS^? 16.28 S2 BME B 301 C 208 GLN B 37 GLN^? 22.79 C1 BME B 301 C 209 LYS A 3 LYS.? 20.23 O1 BME A 300 coo 100.54 -2.78 25.52 103.29 2.02 24.05 73.79 67.72 -12.74 69.00 65.74 -10.30 coo 111.02 -1.31 30.92 109.87 -2.78 29.89 67.31 60.31 -19.68 67.74 59.93 -17.63 coo 113.62 1.19 33.65 109.52 3.92 36.47 68.61 55.34 -21.58 71.21 56.20 -15.92 1ohh_c08 source 1ohh ATP SYNTHASE ALPHA CHAIN HEART ISOFORM, MITOCH: 1 hits 1ohh_c08 naa= 3 ULMN 3 1oyg_c00 LEVANSUCRASE user 1 3 # 1 A 86 ASP A 55 ASP~? 17.20 O1 BME A 300 A 247 ASP A 129 ASP~? 19.06 O1 BME A 300 A 342 GLU A 130 GLU~? 23.04 O1 BME A 300 coo 44.36 35.68 9.71 43.29 36.20 11.51 76.53 41.69 0.56 76.82 41.16 -1.46 coo 41.40 28.81 12.91 40.82 30.90 12.97 80.80 42.21 -6.02 80.73 43.57 -7.63 coo 40.37 33.11 18.06 39.99 34.93 17.06 84.58 38.87 -3.95 85.40 38.00 -2.18 1oyg_c00 source 1oyg LEVANSUCRASE : 1 hits 1oyg_c00 naa= 3 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 A 70 ALA A 79 ALA~? 9.98 C2 BME A 300 A 126 LEU A 80 LEU~? 9.60 C2 BME A 300 A 158 GLU A 111 GLU~? 14.81 C1 BME A 300 coo -2.29 37.66 144.73 -1.46 37.12 145.87 81.00 55.28 12.41 81.18 53.79 12.09 coo -4.62 32.83 147.14 -5.50 32.85 149.12 83.70 57.43 9.09 84.12 55.31 8.78 coo -0.83 29.57 149.77 -0.39 31.47 148.95 89.56 55.57 5.81 89.83 56.98 7.35 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 A 70 ALA A 79 ALA~? 9.98 C2 BME A 300 A 126 LEU A 115 LEU~? 11.91 C1 BME A 300 A 158 GLU A 111 GLU~? 14.81 C1 BME A 300 coo -2.29 37.66 144.73 -1.46 37.12 145.87 81.00 55.28 12.41 81.18 53.79 12.09 coo -4.62 32.83 147.14 -5.50 32.85 149.12 84.23 50.98 7.58 83.58 51.18 9.62 coo -0.83 29.57 149.77 -0.39 31.47 148.95 89.56 55.57 5.81 89.83 56.98 7.35 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 3 3 # 3 A 70 ALA A 118 ALA~? 17.31 C1 BME A 300 A 126 LEU A 115 LEU~? 11.91 C1 BME A 300 A 158 GLU A 111 GLU~? 14.81 C1 BME A 300 coo -2.29 37.66 144.73 -1.46 37.12 145.87 86.00 44.74 7.42 86.79 45.80 8.18 coo -4.62 32.83 147.14 -5.50 32.85 149.12 84.23 50.98 7.58 83.58 51.18 9.62 coo -0.83 29.57 149.77 -0.39 31.47 148.95 89.56 55.57 5.81 89.83 56.98 7.35 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 4 3 # 4 A 70 ALA A 131 ALA~? 24.49 O1 BME A 300 A 126 LEU A 133 LEU~? 25.43 O1 BME A 300 A 158 GLU A 136 GLU~? 27.28 O1 BME A 300 coo -2.29 37.66 144.73 -1.46 37.12 145.87 80.49 35.59 -6.71 79.16 35.44 -5.99 coo -4.62 32.83 147.14 -5.50 32.85 149.12 84.15 38.63 -10.06 85.81 39.80 -10.78 coo -0.83 29.57 149.77 -0.39 31.47 148.95 81.55 37.42 -15.14 81.99 39.46 -15.20 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 5 3 # 5 A 70 ALA A 131 ALA~? 24.49 O1 BME A 300 A 126 LEU A 135 LEU~? 29.60 O1 BME A 300 A 158 GLU A 136 GLU~? 27.28 O1 BME A 300 coo -2.29 37.66 144.73 -1.46 37.12 145.87 80.49 35.59 -6.71 79.16 35.44 -5.99 coo -4.62 32.83 147.14 -5.50 32.85 149.12 79.71 33.17 -12.14 78.55 31.88 -10.85 coo -0.83 29.57 149.77 -0.39 31.47 148.95 81.55 37.42 -15.14 81.99 39.46 -15.20 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 6 3 # 6 A 70 ALA A 134 ALA~? 28.72 O1 BME A 300 A 126 LEU A 133 LEU~? 25.43 O1 BME A 300 A 158 GLU A 130 GLU~? 23.04 O1 BME A 300 coo -2.29 37.66 144.73 -1.46 37.12 145.87 84.07 34.12 -10.27 83.99 33.48 -8.89 coo -4.62 32.83 147.14 -5.50 32.85 149.12 84.15 38.63 -10.06 85.81 39.80 -10.78 coo -0.83 29.57 149.77 -0.39 31.47 148.95 84.58 38.87 -3.95 85.40 38.00 -2.18 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 7 3 # 7 A 70 ALA B 78 ALA~? 6.66 S2 BME B 301 A 126 LEU B 80 LEU~? 11.70 S2 BME B 301 A 158 GLU B 111 GLU~? 15.73 S2 BME B 301 coo -2.29 37.66 144.73 -1.46 37.12 145.87 61.66 64.81 8.40 62.93 65.17 9.16 coo -4.62 32.83 147.14 -5.50 32.85 149.12 56.76 64.71 5.48 56.13 66.38 4.27 coo -0.83 29.57 149.77 -0.39 31.47 148.95 52.67 66.26 1.65 52.32 64.94 3.26 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 8 3 # 8 A 70 ALA B 79 ALA~? 11.20 S2 BME B 301 A 126 LEU B 80 LEU~? 11.70 S2 BME B 301 A 158 GLU B 111 GLU~? 15.73 S2 BME B 301 coo -2.29 37.66 144.73 -1.46 37.12 145.87 58.94 67.45 8.63 58.89 68.77 7.88 coo -4.62 32.83 147.14 -5.50 32.85 149.12 56.76 64.71 5.48 56.13 66.38 4.27 coo -0.83 29.57 149.77 -0.39 31.47 148.95 52.67 66.26 1.65 52.32 64.94 3.26 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 9 3 # 9 A 70 ALA B 79 ALA~? 11.20 S2 BME B 301 A 126 LEU B 115 LEU~? 13.88 S2 BME B 301 A 158 GLU B 111 GLU~? 15.73 S2 BME B 301 coo -2.29 37.66 144.73 -1.46 37.12 145.87 58.94 67.45 8.63 58.89 68.77 7.88 coo -4.62 32.83 147.14 -5.50 32.85 149.12 56.84 70.68 2.42 56.94 70.79 4.57 coo -0.83 29.57 149.77 -0.39 31.47 148.95 52.67 66.26 1.65 52.32 64.94 3.26 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 10 3 # 10 A 70 ALA B 118 ALA~? 18.89 S2 BME B 301 A 126 LEU B 115 LEU~? 13.88 S2 BME B 301 A 158 GLU B 111 GLU~? 15.73 S2 BME B 301 coo -2.29 37.66 144.73 -1.46 37.12 145.87 55.85 76.49 0.36 55.00 75.55 1.22 coo -4.62 32.83 147.14 -5.50 32.85 149.12 56.84 70.68 2.42 56.94 70.79 4.57 coo -0.83 29.57 149.77 -0.39 31.47 148.95 52.67 66.26 1.65 52.32 64.94 3.26 1pjh_c00 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 10 hits 1pjh_c00 naa= 3 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 B 70 ALA A 79 ALA~? 9.98 C2 BME A 300 B 126 LEU A 80 LEU~? 9.60 C2 BME A 300 B 158 GLU A 111 GLU~? 14.81 C1 BME A 300 coo -39.79 4.61 147.27 -39.61 5.56 148.47 81.00 55.28 12.41 81.18 53.79 12.09 coo -34.22 5.06 149.25 -33.65 4.24 151.15 83.70 57.43 9.09 84.12 55.31 8.78 coo -33.03 9.93 151.71 -34.98 9.38 151.11 89.56 55.57 5.81 89.83 56.98 7.35 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 B 70 ALA A 79 ALA~? 9.98 C2 BME A 300 B 126 LEU A 115 LEU~? 11.91 C1 BME A 300 B 158 GLU A 111 GLU~? 14.81 C1 BME A 300 coo -39.79 4.61 147.27 -39.61 5.56 148.47 81.00 55.28 12.41 81.18 53.79 12.09 coo -34.22 5.06 149.25 -33.65 4.24 151.15 84.23 50.98 7.58 83.58 51.18 9.62 coo -33.03 9.93 151.71 -34.98 9.38 151.11 89.56 55.57 5.81 89.83 56.98 7.35 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 3 3 # 3 B 70 ALA A 118 ALA~? 17.31 C1 BME A 300 B 126 LEU A 115 LEU~? 11.91 C1 BME A 300 B 158 GLU A 111 GLU~? 14.81 C1 BME A 300 coo -39.79 4.61 147.27 -39.61 5.56 148.47 86.00 44.74 7.42 86.79 45.80 8.18 coo -34.22 5.06 149.25 -33.65 4.24 151.15 84.23 50.98 7.58 83.58 51.18 9.62 coo -33.03 9.93 151.71 -34.98 9.38 151.11 89.56 55.57 5.81 89.83 56.98 7.35 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 4 3 # 4 B 70 ALA A 131 ALA~? 24.49 O1 BME A 300 B 126 LEU A 133 LEU~? 25.43 O1 BME A 300 B 158 GLU A 136 GLU~? 27.28 O1 BME A 300 coo -39.79 4.61 147.27 -39.61 5.56 148.47 80.49 35.59 -6.71 79.16 35.44 -5.99 coo -34.22 5.06 149.25 -33.65 4.24 151.15 84.15 38.63 -10.06 85.81 39.80 -10.78 coo -33.03 9.93 151.71 -34.98 9.38 151.11 81.55 37.42 -15.14 81.99 39.46 -15.20 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 5 3 # 5 B 70 ALA A 131 ALA~? 24.49 O1 BME A 300 B 126 LEU A 135 LEU~? 29.60 O1 BME A 300 B 158 GLU A 136 GLU~? 27.28 O1 BME A 300 coo -39.79 4.61 147.27 -39.61 5.56 148.47 80.49 35.59 -6.71 79.16 35.44 -5.99 coo -34.22 5.06 149.25 -33.65 4.24 151.15 79.71 33.17 -12.14 78.55 31.88 -10.85 coo -33.03 9.93 151.71 -34.98 9.38 151.11 81.55 37.42 -15.14 81.99 39.46 -15.20 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 6 3 # 6 B 70 ALA A 134 ALA~? 28.72 O1 BME A 300 B 126 LEU A 133 LEU~? 25.43 O1 BME A 300 B 158 GLU A 130 GLU~? 23.04 O1 BME A 300 coo -39.79 4.61 147.27 -39.61 5.56 148.47 84.07 34.12 -10.27 83.99 33.48 -8.89 coo -34.22 5.06 149.25 -33.65 4.24 151.15 84.15 38.63 -10.06 85.81 39.80 -10.78 coo -33.03 9.93 151.71 -34.98 9.38 151.11 84.58 38.87 -3.95 85.40 38.00 -2.18 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 7 3 # 7 B 70 ALA B 78 ALA~? 6.66 S2 BME B 301 B 126 LEU B 80 LEU~? 11.70 S2 BME B 301 B 158 GLU B 111 GLU~? 15.73 S2 BME B 301 coo -39.79 4.61 147.27 -39.61 5.56 148.47 61.66 64.81 8.40 62.93 65.17 9.16 coo -34.22 5.06 149.25 -33.65 4.24 151.15 56.76 64.71 5.48 56.13 66.38 4.27 coo -33.03 9.93 151.71 -34.98 9.38 151.11 52.67 66.26 1.65 52.32 64.94 3.26 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 8 3 # 8 B 70 ALA B 79 ALA~? 11.20 S2 BME B 301 B 126 LEU B 80 LEU~? 11.70 S2 BME B 301 B 158 GLU B 111 GLU~? 15.73 S2 BME B 301 coo -39.79 4.61 147.27 -39.61 5.56 148.47 58.94 67.45 8.63 58.89 68.77 7.88 coo -34.22 5.06 149.25 -33.65 4.24 151.15 56.76 64.71 5.48 56.13 66.38 4.27 coo -33.03 9.93 151.71 -34.98 9.38 151.11 52.67 66.26 1.65 52.32 64.94 3.26 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 9 3 # 9 B 70 ALA B 79 ALA~? 11.20 S2 BME B 301 B 126 LEU B 115 LEU~? 13.88 S2 BME B 301 B 158 GLU B 111 GLU~? 15.73 S2 BME B 301 coo -39.79 4.61 147.27 -39.61 5.56 148.47 58.94 67.45 8.63 58.89 68.77 7.88 coo -34.22 5.06 149.25 -33.65 4.24 151.15 56.84 70.68 2.42 56.94 70.79 4.57 coo -33.03 9.93 151.71 -34.98 9.38 151.11 52.67 66.26 1.65 52.32 64.94 3.26 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 10 3 # 10 B 70 ALA B 118 ALA~? 18.89 S2 BME B 301 B 126 LEU B 115 LEU~? 13.88 S2 BME B 301 B 158 GLU B 111 GLU~? 15.73 S2 BME B 301 coo -39.79 4.61 147.27 -39.61 5.56 148.47 55.85 76.49 0.36 55.00 75.55 1.22 coo -34.22 5.06 149.25 -33.65 4.24 151.15 56.84 70.68 2.42 56.94 70.79 4.57 coo -33.03 9.93 151.71 -34.98 9.38 151.11 52.67 66.26 1.65 52.32 64.94 3.26 1pjh_c01 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 10 hits 1pjh_c01 naa= 3 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 C 70 ALA A 79 ALA~? 9.98 C2 BME A 300 C 126 LEU A 80 LEU~? 9.60 C2 BME A 300 C 158 GLU A 111 GLU~? 14.81 C1 BME A 300 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 81.00 55.28 12.41 81.18 53.79 12.09 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 83.70 57.43 9.09 84.12 55.31 8.78 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 89.56 55.57 5.81 89.83 56.98 7.35 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 C 70 ALA A 79 ALA~? 9.98 C2 BME A 300 C 126 LEU A 115 LEU~? 11.91 C1 BME A 300 C 158 GLU A 111 GLU~? 14.81 C1 BME A 300 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 81.00 55.28 12.41 81.18 53.79 12.09 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 84.23 50.98 7.58 83.58 51.18 9.62 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 89.56 55.57 5.81 89.83 56.98 7.35 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 3 3 # 3 C 70 ALA A 118 ALA~? 17.31 C1 BME A 300 C 126 LEU A 115 LEU~? 11.91 C1 BME A 300 C 158 GLU A 111 GLU~? 14.81 C1 BME A 300 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 86.00 44.74 7.42 86.79 45.80 8.18 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 84.23 50.98 7.58 83.58 51.18 9.62 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 89.56 55.57 5.81 89.83 56.98 7.35 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 4 3 # 4 C 70 ALA A 131 ALA~? 24.49 O1 BME A 300 C 126 LEU A 133 LEU~? 25.43 O1 BME A 300 C 158 GLU A 136 GLU~? 27.28 O1 BME A 300 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 80.49 35.59 -6.71 79.16 35.44 -5.99 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 84.15 38.63 -10.06 85.81 39.80 -10.78 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 81.55 37.42 -15.14 81.99 39.46 -15.20 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 5 3 # 5 C 70 ALA A 131 ALA~? 24.49 O1 BME A 300 C 126 LEU A 135 LEU~? 29.60 O1 BME A 300 C 158 GLU A 136 GLU~? 27.28 O1 BME A 300 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 80.49 35.59 -6.71 79.16 35.44 -5.99 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 79.71 33.17 -12.14 78.55 31.88 -10.85 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 81.55 37.42 -15.14 81.99 39.46 -15.20 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 6 3 # 6 C 70 ALA A 134 ALA~? 28.72 O1 BME A 300 C 126 LEU A 133 LEU~? 25.43 O1 BME A 300 C 158 GLU A 130 GLU~? 23.04 O1 BME A 300 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 84.07 34.12 -10.27 83.99 33.48 -8.89 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 84.15 38.63 -10.06 85.81 39.80 -10.78 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 84.58 38.87 -3.95 85.40 38.00 -2.18 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 7 3 # 7 C 70 ALA B 78 ALA~? 6.66 S2 BME B 301 C 126 LEU B 80 LEU~? 11.70 S2 BME B 301 C 158 GLU B 111 GLU~? 15.73 S2 BME B 301 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 61.66 64.81 8.40 62.93 65.17 9.16 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 56.76 64.71 5.48 56.13 66.38 4.27 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 52.67 66.26 1.65 52.32 64.94 3.26 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 8 3 # 8 C 70 ALA B 79 ALA~? 11.20 S2 BME B 301 C 126 LEU B 80 LEU~? 11.70 S2 BME B 301 C 158 GLU B 111 GLU~? 15.73 S2 BME B 301 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 58.94 67.45 8.63 58.89 68.77 7.88 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 56.76 64.71 5.48 56.13 66.38 4.27 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 52.67 66.26 1.65 52.32 64.94 3.26 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 9 3 # 9 C 70 ALA B 79 ALA~? 11.20 S2 BME B 301 C 126 LEU B 115 LEU~? 13.88 S2 BME B 301 C 158 GLU B 111 GLU~? 15.73 S2 BME B 301 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 58.94 67.45 8.63 58.89 68.77 7.88 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 56.84 70.68 2.42 56.94 70.79 4.57 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 52.67 66.26 1.65 52.32 64.94 3.26 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 10 3 # 10 C 70 ALA B 118 ALA~? 18.89 S2 BME B 301 C 126 LEU B 115 LEU~? 13.88 S2 BME B 301 C 158 GLU B 111 GLU~? 15.73 S2 BME B 301 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 55.85 76.49 0.36 55.00 75.55 1.22 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 56.84 70.68 2.42 56.94 70.79 4.57 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 52.67 66.26 1.65 52.32 64.94 3.26 1pjh_c02 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 10 hits 1pjh_c02 naa= 3 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 1 3 # 1 A 248 ASP A 68 ASP~? 9.92 C1 BME B 301 A 270 LYS A 73 LYS~? -2.81 O1 BME A 300s A 382 MET B 104 MET.? 10.25 C2 BME B 301 coo -27.63 121.99 45.48 -26.66 123.86 45.68 67.14 48.96 2.96 66.44 50.60 4.08 coo -32.20 115.91 49.56 -31.37 121.03 53.12 75.23 53.47 4.59 74.97 57.96 1.35 coo -23.75 127.89 58.42 -26.02 128.79 55.12 58.35 57.26 -1.73 59.27 61.13 -0.41 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 2 3 # 2 A 248 ASP B 44 ASP~? 23.69 S2 BME B 301 A 270 LYS B 48 LYS~? 21.20 S2 BME B 301 A 382 MET B 104 MET.? 10.25 C2 BME B 301 coo -27.63 121.99 45.48 -26.66 123.86 45.68 59.88 65.23 -14.80 60.45 65.24 -16.84 coo -32.20 115.91 49.56 -31.37 121.03 53.12 62.47 69.43 -9.84 56.65 72.06 -9.69 coo -23.75 127.89 58.42 -26.02 128.79 55.12 58.35 57.26 -1.73 59.27 61.13 -0.41 1pjq_c02 source 1pjq SIROHEME SYNTHASE : 2 hits 1pjq_c02 naa= 3 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 1 3 # 1 B 248 ASP B 44 ASP~? 23.69 S2 BME B 301 B 270 LYS B 48 LYS~? 21.20 S2 BME B 301 B 382 MET B 104 MET.? 10.25 C2 BME B 301 coo -11.82 154.51 43.38 -12.86 152.74 43.79 59.88 65.23 -14.80 60.45 65.24 -16.84 coo -5.09 158.39 43.41 -0.74 158.80 47.15 62.47 69.43 -9.84 56.65 72.06 -9.69 coo -2.79 145.52 50.38 -5.75 148.14 51.66 58.35 57.26 -1.73 59.27 61.13 -0.41 1pjq_c03 source 1pjq SIROHEME SYNTHASE : 1 hits 1pjq_c03 naa= 3 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 1 3 # 1 111 GLN A 37 GLN^? 16.20 O1 BME A 300 294 GLU B 130 GLU.? 21.96 S2 BME B 301 304 ARG A 39 ARG.? 14.17 O1 BME A 300 coo 15.89 18.45 46.53 15.82 16.91 48.02 75.99 64.37 -11.97 74.53 63.06 -11.11 coo 22.84 13.44 52.91 20.84 13.18 52.38 65.89 71.50 -12.95 66.09 70.43 -14.77 coo 8.71 17.11 46.51 7.23 17.64 49.20 79.32 60.12 -11.34 77.45 58.25 -9.78 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 2 3 # 2 111 GLN A 59 GLN~? 20.02 O1 BME A 300 294 GLU A 130 GLU~? 23.04 O1 BME A 300 304 ARG A 58 ARG~? 16.62 O1 BME A 300 coo 15.89 18.45 46.53 15.82 16.91 48.02 74.35 37.89 3.46 76.23 37.40 2.62 coo 22.84 13.44 52.91 20.84 13.18 52.38 84.58 38.87 -3.95 85.40 38.00 -2.18 coo 8.71 17.11 46.51 7.23 17.64 49.20 70.36 39.82 -0.67 72.06 41.99 -2.04 1pmi_c00 source 1pmi PHOSPHOMANNOSE ISOMERASE : 2 hits 1pmi_c00 naa= 3 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 1 3 # 1 A 264 ARG A 123 ARG~? 17.98 O1 BME A 300 A 479 PHE A 119 PHE~? 14.57 O1 BME A 300 A 483 GLU A 122 GLU~? 20.27 C2 BME A 300 coo 17.33 52.29 2.24 18.71 54.03 0.18 79.32 40.68 12.01 79.04 43.03 13.95 coo 20.06 57.44 1.28 18.39 56.19 3.12 80.27 45.41 9.73 77.88 44.61 10.94 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 83.94 41.43 11.78 84.52 42.47 13.54 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 2 3 # 2 A 264 ARG B 123 ARG~? 19.27 S2 BME B 301 A 479 PHE B 119 PHE~? 15.49 S2 BME B 301 A 483 GLU B 122 GLU~? 20.09 S2 BME B 301 coo 17.33 52.29 2.24 18.71 54.03 0.18 62.37 80.29 5.08 62.68 80.61 8.15 coo 20.06 57.44 1.28 18.39 56.19 3.12 60.93 76.25 3.98 63.24 76.98 5.43 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 58.24 80.53 4.30 58.07 79.83 6.28 1pow_c02 source 1pow PYRUVATE OXIDASE (E.C.1.2.3.3) (WILD TYPE) : 2 hits 1pow_c02 naa= 3 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 1 3 # 1 B 264 ARG A 123 ARG~? 17.98 O1 BME A 300 B 479 PHE A 119 PHE~? 14.57 O1 BME A 300 B 483 GLU A 122 GLU~? 20.27 C2 BME A 300 coo -26.72 93.28 20.13 -28.02 93.55 17.39 79.32 40.68 12.01 79.04 43.03 13.95 coo -29.34 90.48 15.69 -27.62 89.95 17.80 80.27 45.41 9.73 77.88 44.61 10.94 coo -26.63 95.49 14.65 -25.77 93.77 13.77 83.94 41.43 11.78 84.52 42.47 13.54 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 2 3 # 2 B 264 ARG B 123 ARG~? 19.27 S2 BME B 301 B 479 PHE B 119 PHE~? 15.49 S2 BME B 301 B 483 GLU B 122 GLU~? 20.09 S2 BME B 301 coo -26.72 93.28 20.13 -28.02 93.55 17.39 62.37 80.29 5.08 62.68 80.61 8.15 coo -29.34 90.48 15.69 -27.62 89.95 17.80 60.93 76.25 3.98 63.24 76.98 5.43 coo -26.63 95.49 14.65 -25.77 93.77 13.77 58.24 80.53 4.30 58.07 79.83 6.28 1pow_c03 source 1pow PYRUVATE OXIDASE (E.C.1.2.3.3) (WILD TYPE) : 2 hits 1pow_c03 naa= 3 ULMN 3 1pyl_c00 RIBONUCLEASE user 1 3 # 1 A 56 GLU A 61 GLU.? 20.99 O1 BME A 300 A 67 ARG A 65 ARG.? 12.39 O1 BME B 301 A 86 HIS A 63 HIS.? 17.83 C2 BME A 300 coo 18.15 3.28 18.56 20.10 2.92 19.20 69.88 39.99 12.89 68.19 39.98 14.15 coo 21.52 6.83 26.64 21.22 5.53 23.85 64.77 47.77 12.73 64.18 50.71 12.02 coo 22.36 -1.88 25.52 23.57 -0.73 24.25 71.61 45.90 17.84 73.56 46.23 18.53 ULMN 3 1pyl_c00 RIBONUCLEASE user 2 3 # 2 A 56 GLU B 61 GLU.? 21.77 S2 BME B 301 A 67 ARG B 65 ARG.? 12.88 S2 BME A 300 A 86 HIS B 63 HIS.? 17.29 S2 BME B 301 coo 18.15 3.28 18.56 20.10 2.92 19.20 72.49 81.24 7.40 73.27 83.04 8.17 coo 21.52 6.83 26.64 21.22 5.53 23.85 75.25 74.20 11.13 75.77 71.55 9.67 coo 22.36 -1.88 25.52 23.57 -0.73 24.25 68.55 77.48 13.35 66.49 77.49 13.76 ULMN 3 1pyl_c00 RIBONUCLEASE user 3 3 # 3 A 56 GLU B 61 GLU.? 21.77 S2 BME B 301 A 67 ARG B 123 ARG~? 19.27 S2 BME B 301 A 86 HIS B 63 HIS.? 17.29 S2 BME B 301 coo 18.15 3.28 18.56 20.10 2.92 19.20 72.49 81.24 7.40 73.27 83.04 8.17 coo 21.52 6.83 26.64 21.22 5.53 23.85 62.37 80.29 5.08 62.68 80.61 8.15 coo 22.36 -1.88 25.52 23.57 -0.73 24.25 68.55 77.48 13.35 66.49 77.49 13.76 1pyl_c00 source 1pyl RIBONUCLEASE : 3 hits 1pyl_c00 naa= 3 ULMN 3 1pyl_c01 RIBONUCLEASE user 1 3 # 1 B 56 GLU A 61 GLU.? 20.99 O1 BME A 300 B 67 ARG A 65 ARG.? 12.39 O1 BME B 301 B 86 HIS A 63 HIS.? 17.83 C2 BME A 300 coo 33.14 -5.53 11.32 32.45 -5.14 9.39 69.88 39.99 12.89 68.19 39.98 14.15 coo 31.86 -4.62 2.25 31.08 -4.78 5.21 64.77 47.77 12.73 64.18 50.71 12.02 coo 25.42 -9.42 7.20 25.63 -7.36 7.52 71.61 45.90 17.84 73.56 46.23 18.53 ULMN 3 1pyl_c01 RIBONUCLEASE user 2 3 # 2 B 56 GLU A 61 GLU.? 20.99 O1 BME A 300 B 67 ARG A 123 ARG~? 17.98 O1 BME A 300 B 86 HIS A 63 HIS.? 17.83 C2 BME A 300 coo 33.14 -5.53 11.32 32.45 -5.14 9.39 69.88 39.99 12.89 68.19 39.98 14.15 coo 31.86 -4.62 2.25 31.08 -4.78 5.21 79.32 40.68 12.01 79.04 43.03 13.95 coo 25.42 -9.42 7.20 25.63 -7.36 7.52 71.61 45.90 17.84 73.56 46.23 18.53 ULMN 3 1pyl_c01 RIBONUCLEASE user 3 3 # 3 B 56 GLU B 61 GLU.? 21.77 S2 BME B 301 B 67 ARG B 65 ARG.? 12.88 S2 BME A 300 B 86 HIS B 63 HIS.? 17.29 S2 BME B 301 coo 33.14 -5.53 11.32 32.45 -5.14 9.39 72.49 81.24 7.40 73.27 83.04 8.17 coo 31.86 -4.62 2.25 31.08 -4.78 5.21 75.25 74.20 11.13 75.77 71.55 9.67 coo 25.42 -9.42 7.20 25.63 -7.36 7.52 68.55 77.48 13.35 66.49 77.49 13.76 ULMN 3 1pyl_c01 RIBONUCLEASE user 4 3 # 4 B 56 GLU B 61 GLU.? 21.77 S2 BME B 301 B 67 ARG B 123 ARG~? 19.27 S2 BME B 301 B 86 HIS B 63 HIS.? 17.29 S2 BME B 301 coo 33.14 -5.53 11.32 32.45 -5.14 9.39 72.49 81.24 7.40 73.27 83.04 8.17 coo 31.86 -4.62 2.25 31.08 -4.78 5.21 62.37 80.29 5.08 62.68 80.61 8.15 coo 25.42 -9.42 7.20 25.63 -7.36 7.52 68.55 77.48 13.35 66.49 77.49 13.76 1pyl_c01 source 1pyl RIBONUCLEASE : 4 hits 1pyl_c01 naa= 3 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 1 3 # 1 A 48 LEU A 133 LEU~? 25.43 O1 BME A 300 A 58 ASP A 129 ASP~? 19.06 O1 BME A 300 A 120 LYS A 126 LYS.? 26.12 O1 BME A 300 coo 34.02 69.29 75.26 34.82 67.82 76.74 84.15 38.63 -10.06 85.81 39.80 -10.78 coo 34.46 72.45 78.57 32.82 72.75 77.28 80.80 42.21 -6.02 80.73 43.57 -7.63 coo 28.96 77.64 81.19 29.05 74.53 77.51 79.50 36.17 1.43 79.74 32.57 -2.57 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 2 3 # 2 A 48 LEU B 43 LEU~? 21.14 C2 BME B 301 A 58 ASP B 44 ASP~? 23.69 S2 BME B 301 A 120 LYS B 48 LYS~? 21.20 S2 BME B 301 coo 34.02 69.29 75.26 34.82 67.82 76.74 63.43 61.24 -14.88 64.66 62.40 -16.26 coo 34.46 72.45 78.57 32.82 72.75 77.28 59.88 65.23 -14.80 60.45 65.24 -16.84 coo 28.96 77.64 81.19 29.05 74.53 77.51 62.47 69.43 -9.84 56.65 72.06 -9.69 1pym_c00 source 1pym PHOSPHOENOLPYRUVATE MUTASE : 2 hits 1pym_c00 naa= 3 ULMN 3 1pym_c01 PHOSPHOENOLPYRUVATE MUTASE user 1 3 # 1 B 48 LEU A 133 LEU~? 25.43 O1 BME A 300 B 58 ASP A 129 ASP~? 19.06 O1 BME A 300 B 120 LYS A 126 LYS.? 26.12 O1 BME A 300 coo 54.50 104.32 58.69 55.83 105.69 59.81 84.15 38.63 -10.06 85.81 39.80 -10.78 coo 57.63 101.19 59.83 56.60 100.89 57.99 80.80 42.21 -6.02 80.73 43.57 -7.63 coo 61.58 95.88 55.22 58.18 99.30 54.71 79.50 36.17 1.43 79.74 32.57 -2.57 ULMN 3 1pym_c01 PHOSPHOENOLPYRUVATE MUTASE user 2 3 # 2 B 48 LEU B 43 LEU~? 21.14 C2 BME B 301 B 58 ASP B 44 ASP~? 23.69 S2 BME B 301 B 120 LYS B 48 LYS~? 21.20 S2 BME B 301 coo 54.50 104.32 58.69 55.83 105.69 59.81 63.43 61.24 -14.88 64.66 62.40 -16.26 coo 57.63 101.19 59.83 56.60 100.89 57.99 59.88 65.23 -14.80 60.45 65.24 -16.84 coo 61.58 95.88 55.22 58.18 99.30 54.71 62.47 69.43 -9.84 56.65 72.06 -9.69 1pym_c01 source 1pym PHOSPHOENOLPYRUVATE MUTASE : 2 hits 1pym_c01 naa= 3 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 1 3 # 1 A 67 ASP A 55 ASP~? 17.20 O1 BME A 300 A 68 ALA A 51 ALA~? 15.38 O1 BME A 300 A 72 LEU A 53 LEU~? 8.08 O1 BME A 300 coo 46.76 7.59 18.65 45.27 6.01 18.52 76.53 41.69 0.56 76.82 41.16 -1.46 coo 48.88 4.35 16.59 48.73 5.09 15.20 76.81 45.65 -3.69 77.80 45.08 -4.70 coo 53.89 6.25 15.09 52.88 7.92 14.14 75.26 48.89 1.11 76.35 50.61 1.83 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 2 3 # 2 A 67 ASP A 68 ASP~? 9.92 C1 BME B 301 A 68 ALA A 69 ALA~? 9.22 O1 BME A 300 A 72 LEU A 53 LEU~? 8.08 O1 BME A 300 coo 46.76 7.59 18.65 45.27 6.01 18.52 67.14 48.96 2.96 66.44 50.60 4.08 coo 48.88 4.35 16.59 48.73 5.09 15.20 71.41 49.37 1.91 71.70 49.24 0.42 coo 53.89 6.25 15.09 52.88 7.92 14.14 75.26 48.89 1.11 76.35 50.61 1.83 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 3 3 # 3 A 67 ASP B 55 ASP~? 19.77 S2 BME B 301 A 68 ALA B 51 ALA~? 18.20 S2 BME B 301 A 72 LEU B 53 LEU~? 10.80 S2 BME B 301 coo 46.76 7.59 18.65 45.27 6.01 18.52 66.42 77.35 -5.07 66.48 77.29 -7.17 coo 48.88 4.35 16.59 48.73 5.09 15.20 66.36 72.04 -8.23 65.50 72.30 -9.45 coo 53.89 6.25 15.09 52.88 7.92 14.14 67.02 70.54 -2.60 65.88 69.08 -1.46 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 4 3 # 4 A 67 ASP B 68 ASP~? 10.36 S2 BME B 301 A 68 ALA B 69 ALA~? 11.48 S2 BME B 301 A 72 LEU B 53 LEU~? 10.80 S2 BME B 301 coo 46.76 7.59 18.65 45.27 6.01 18.52 74.86 70.68 0.81 74.63 68.81 1.72 coo 48.88 4.35 16.59 48.73 5.09 15.20 70.83 70.14 -0.86 70.81 69.91 -2.35 coo 53.89 6.25 15.09 52.88 7.92 14.14 67.02 70.54 -2.60 65.88 69.08 -1.46 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 5 3 # 5 A 67 ASP B 129 ASP.? 27.81 S2 BME B 301 A 68 ALA B 131 ALA.? 20.07 S2 BME B 301 A 72 LEU B 133 LEU.? 22.91 S2 BME B 301 coo 46.76 7.59 18.65 45.27 6.01 18.52 64.27 77.57 -15.36 64.19 79.64 -15.85 coo 48.88 4.35 16.59 48.73 5.09 15.20 62.65 74.33 -10.13 63.22 75.25 -9.05 coo 53.89 6.25 15.09 52.88 7.92 14.14 60.20 71.60 -13.70 60.57 70.00 -15.16 1q6l_c05 source 1q6l 3-KETO-L-GULONATE 6-PHOSPHATE DECARBOXYLASE : 5 hits 1q6l_c05 naa= 3 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 1 3 # 1 A 396 ARG B 39 ARG.? 27.37 S2 BME B 301 A 581 ARG B 47 ARG~? 23.93 S2 BME B 301 A 713 ARG B 9 ARG.? 31.92 S2 BME B 301 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 61.31 65.86 -19.69 59.13 67.99 -19.83 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 65.24 66.71 -15.28 63.33 68.13 -17.26 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 61.30 71.84 -25.56 62.82 73.83 -23.80 1qb4_c01 source 1qb4 PHOSPHOENOLPYRUVATE CARBOXYLASE : 1 hits 1qb4_c01 naa= 3 ULMN 3 1qe3_c00 PARA-NITROBENZYL ESTERASE user 1 3 # 1 A 189 SER A 10 SER~? 30.56 C1 BME A 300 A 310 GLU A 7 GLU^? 21.08 O1 BME A 300 A 399 HIS A 13 HIS~? 28.57 O1 BME A 300 coo 2.67 37.96 55.23 1.78 40.01 56.16 88.87 59.13 -21.90 88.60 57.08 -23.12 coo 6.61 38.44 63.61 6.69 38.31 61.50 82.55 57.05 -16.50 82.95 55.46 -15.17 coo 4.95 41.82 59.53 3.85 40.70 58.14 85.22 56.20 -22.53 85.38 54.15 -22.09 1qe3_c00 source 1qe3 PARA-NITROBENZYL ESTERASE : 1 hits 1qe3_c00 naa= 3 ULMN 3 1qho_c07 ALPHA-AMYLASE user 1 3 # 1 A 228 ASP B 55 ASP~? 19.77 S2 BME B 301 A 260 ASP B 44 ASP~? 23.69 S2 BME B 301 A 329 ASP B 129 ASP.? 27.81 S2 BME B 301 coo 28.46 69.88 26.74 30.40 70.70 26.53 66.42 77.35 -5.07 66.48 77.29 -7.17 coo 30.73 81.29 37.61 31.23 82.07 35.69 59.88 65.23 -14.80 60.45 65.24 -16.84 coo 37.87 70.12 31.80 36.61 69.74 30.15 64.27 77.57 -15.36 64.19 79.64 -15.85 1qho_c07 source 1qho ALPHA-AMYLASE : 1 hits 1qho_c07 naa= 3 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 1 3 # 1 A 10 ASP A 44 ASP~? 20.39 O1 BME A 300 A 186 ASN A 46 ASN~? 11.04 O1 BME A 300 A 260 ALA A 51 ALA~? 15.38 O1 BME A 300 coo 11.81 33.10 11.71 13.07 31.45 11.40 83.66 51.21 -11.72 83.67 49.16 -12.23 coo 11.43 26.53 7.41 13.01 27.56 8.43 78.74 53.91 -7.24 78.48 55.71 -6.12 coo 21.53 26.33 6.96 20.26 25.69 7.52 76.81 45.65 -3.69 77.80 45.08 -4.70 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 2 3 # 2 A 10 ASP B 44 ASP~? 23.69 S2 BME B 301 A 186 ASN B 46 ASN~? 13.59 C2 BME B 301 A 260 ALA B 51 ALA~? 18.20 S2 BME B 301 coo 11.81 33.10 11.71 13.07 31.45 11.40 59.88 65.23 -14.80 60.45 65.24 -16.84 coo 11.43 26.53 7.41 13.01 27.56 8.43 64.66 62.99 -9.32 64.25 61.47 -7.89 coo 21.53 26.33 6.96 20.26 25.69 7.52 66.36 72.04 -8.23 65.50 72.30 -9.45 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 3 3 # 3 A 10 ASP B 44 ASP~? 23.69 S2 BME B 301 A 186 ASN B 46 ASN~? 13.59 C2 BME B 301 A 260 ALA B 110 ALA~? 18.51 S2 BME B 301 coo 11.81 33.10 11.71 13.07 31.45 11.40 59.88 65.23 -14.80 60.45 65.24 -16.84 coo 11.43 26.53 7.41 13.01 27.56 8.43 64.66 62.99 -9.32 64.25 61.47 -7.89 coo 21.53 26.33 6.96 20.26 25.69 7.52 54.15 65.71 -4.34 52.84 65.57 -5.07 1r4f_c00 source 1r4f IAG-NUCLEOSIDE HYDROLASE : 3 hits 1r4f_c00 naa= 3 ULMN 3 1rhc_c00 F420-DEPENDENT ALCOHOL DEHYDROGENASEuser 1 3 # 1 A 39 HIS B 63 HIS.? 17.29 S2 BME B 301 A 43 TRP B 62 TRP.? 13.85 S2 BME B 301 A 108 GLU B 61 GLU.? 21.77 S2 BME B 301 coo 33.67 25.97 25.39 31.70 26.60 25.75 68.55 77.48 13.35 66.49 77.49 13.76 coo 29.43 26.12 28.46 27.08 29.25 29.01 68.29 74.36 9.74 64.89 76.31 9.74 coo 29.13 31.14 24.26 29.28 29.08 24.66 72.49 81.24 7.40 73.27 83.04 8.17 1rhc_c00 source 1rhc F420-DEPENDENT ALCOHOL DEHYDROGENASE : 1 hits 1rhc_c00 naa= 3 ULMN 3 1stc_c02 CAMP-DEPENDENT PROTEIN KINASE user 1 3 # 1 E 166 ASP A 55 ASP~? 17.20 O1 BME A 300 E 168 LYS A 126 LYS.? 26.12 O1 BME A 300 E 201 THR A 121 THR~? 20.71 O1 BME A 300 coo 5.36 16.20 22.10 3.88 17.00 23.31 76.53 41.69 0.56 76.82 41.16 -1.46 coo 5.06 22.32 18.11 1.02 22.08 22.74 79.50 36.17 1.43 79.74 32.57 -2.57 coo -1.79 18.29 19.05 -1.19 20.28 19.71 84.25 40.08 6.83 86.21 40.39 6.13 ULMN 3 1stc_c02 CAMP-DEPENDENT PROTEIN KINASE user 2 3 # 2 E 166 ASP B 55 ASP~? 19.77 S2 BME B 301 E 168 LYS B 126 LYS.? 28.14 S2 BME B 301 E 201 THR B 121 THR~? 23.09 S2 BME B 301 coo 5.36 16.20 22.10 3.88 17.00 23.31 66.42 77.35 -5.07 66.48 77.29 -7.17 coo 5.06 22.32 18.11 1.02 22.08 22.74 64.27 82.78 -6.16 67.59 84.99 -10.95 coo -1.79 18.29 19.05 -1.19 20.28 19.71 58.24 81.00 -0.76 56.42 80.96 -1.87 1stc_c02 source 1stc CAMP-DEPENDENT PROTEIN KINASE : 2 hits 1stc_c02 naa= 3 ULMN 3 1t7d_c00 SIGNAL PEPTIDASE I user 1 3 # 1 A 88 SER A 102 SER.? 8.36 C1 BME A 300 A 90 SER A 100 SER.? 7.07 C1 BME A 300 A 145 LYS A 73 LYS~? -2.81 O1 BME A 300s coo -3.31 40.95 15.56 -0.94 40.79 14.97 78.79 62.05 -2.37 76.46 61.88 -3.05 coo 1.47 40.03 18.48 2.45 41.37 16.68 76.98 62.85 2.47 76.76 63.82 0.26 coo 7.35 44.71 16.29 4.71 40.98 14.52 75.23 53.47 4.59 74.97 57.96 1.35 ULMN 3 1t7d_c00 SIGNAL PEPTIDASE I user 2 3 # 2 A 88 SER B 102 SER.? 9.52 C2 BME B 301 A 90 SER B 100 SER.? 7.38 C2 BME B 301 A 145 LYS B 73 LYS~? 5.56 C2 BME B 301 coo -3.31 40.95 15.56 -0.94 40.79 14.97 63.38 56.52 -3.17 65.79 56.15 -3.09 coo 1.47 40.03 18.48 2.45 41.37 16.68 64.33 57.82 1.68 64.28 55.45 1.01 coo 7.35 44.71 16.29 4.71 40.98 14.52 66.37 67.01 1.95 66.56 61.98 -0.01 1t7d_c00 source 1t7d SIGNAL PEPTIDASE I : 2 hits 1t7d_c00 naa= 3 ULMN 3 1t7d_c01 SIGNAL PEPTIDASE I user 1 3 # 1 B 88 SER B 102 SER.? 9.52 C2 BME B 301 B 90 SER B 100 SER.? 7.38 C2 BME B 301 B 145 LYS B 73 LYS~? 5.56 C2 BME B 301 coo 61.01 10.03 12.97 58.78 10.97 12.69 63.38 56.52 -3.17 65.79 56.15 -3.09 coo 56.85 12.22 16.37 55.62 11.34 14.45 64.33 57.82 1.68 64.28 55.45 1.01 coo 49.80 9.51 14.88 53.14 11.99 12.77 66.37 67.01 1.95 66.56 61.98 -0.01 1t7d_c01 source 1t7d SIGNAL PEPTIDASE I : 1 hits 1t7d_c01 naa= 3 ULMN 3 1thg_c00 LIPASE (E.C.3.1.1.3) TRIACYLGLYCEROLuser 1 3 # 1 217 SER A 10 SER~? 30.56 C1 BME A 300 354 GLU A 7 GLU^? 21.08 O1 BME A 300 463 HIS A 13 HIS~? 28.57 O1 BME A 300 coo 48.87 13.74 2.81 48.49 11.54 3.93 88.87 59.13 -21.90 88.60 57.08 -23.12 coo 39.95 14.43 3.01 41.55 14.10 1.63 82.55 57.05 -16.50 82.95 55.46 -15.17 coo 43.90 10.50 2.81 45.63 11.48 3.27 85.22 56.20 -22.53 85.38 54.15 -22.09 1thg_c00 source 1thg LIPASE (E.C.3.1.1.3) TRIACYLGLYCEROL HYDROLASE: 1 hits 1thg_c00 naa= 3 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 1 3 # 1 A 250 ALA A 51 ALA~? 15.38 O1 BME A 300 A 251 GLY A 54 GLY~? 12.91 O1 BME A 300 A 252 ASP A 55 ASP~? 17.20 O1 BME A 300 coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 76.81 45.65 -3.69 77.80 45.08 -4.70 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 73.25 45.16 -0.27 73.90 44.96 0.21 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 76.53 41.69 0.56 76.82 41.16 -1.46 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 2 3 # 2 A 250 ALA B 51 ALA~? 18.20 S2 BME B 301 A 251 GLY B 54 GLY~? 15.43 S2 BME B 301 A 252 ASP B 55 ASP~? 19.77 S2 BME B 301 coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 66.36 72.04 -8.23 65.50 72.30 -9.45 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 69.56 73.71 -4.55 68.86 74.06 -4.25 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 66.42 77.35 -5.07 66.48 77.29 -7.17 1tz3_c02 source 1tz3 PUTATIVE SUGAR KINASE : 2 hits 1tz3_c02 naa= 3 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 1 3 # 1 B 250 ALA A 51 ALA~? 15.38 O1 BME A 300 B 251 GLY A 54 GLY~? 12.91 O1 BME A 300 B 252 ASP A 55 ASP~? 17.20 O1 BME A 300 coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 76.81 45.65 -3.69 77.80 45.08 -4.70 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 73.25 45.16 -0.27 73.90 44.96 0.21 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 76.53 41.69 0.56 76.82 41.16 -1.46 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 2 3 # 2 B 250 ALA B 51 ALA~? 18.20 S2 BME B 301 B 251 GLY B 54 GLY~? 15.43 S2 BME B 301 B 252 ASP B 55 ASP~? 19.77 S2 BME B 301 coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 66.36 72.04 -8.23 65.50 72.30 -9.45 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 69.56 73.71 -4.55 68.86 74.06 -4.25 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 66.42 77.35 -5.07 66.48 77.29 -7.17 1tz3_c03 source 1tz3 PUTATIVE SUGAR KINASE : 2 hits 1tz3_c03 naa= 3 ULMN 3 1uaq_c00 CYTOSINE DEAMINASE user 1 3 # 1 A 64 GLU A 70 GLU~? 7.34 C1 BME B 301 A 89 SER A 71 SER~? 8.26 C1 BME B 301 A 91 CYH A 74 CYH~? 2.95 S2 BME A 300s coo -18.27 -3.12 10.92 -16.30 -3.26 10.07 68.92 53.57 0.58 67.76 55.17 -0.17 coo -16.83 -3.83 3.62 -17.28 -5.61 2.05 70.10 52.54 6.16 67.71 52.03 6.39 coo -13.84 -8.33 7.58 -13.00 -8.13 10.24 74.14 55.73 7.46 71.82 57.29 7.21 ULMN 3 1uaq_c00 CYTOSINE DEAMINASE user 2 3 # 2 A 64 GLU B 70 GLU~? 7.75 C1 BME A 300 A 89 SER B 71 SER~? 8.60 S2 BME B 301 A 91 CYH B 74 CYH~? -2.15 S2 BME B 301s coo -18.27 -3.12 10.92 -16.30 -3.26 10.07 72.71 65.28 -0.66 74.40 64.00 -0.70 coo -16.83 -3.83 3.62 -17.28 -5.61 2.05 71.04 68.14 4.29 73.26 68.66 5.07 coo -13.84 -8.33 7.58 -13.00 -8.13 10.24 66.79 65.33 5.35 68.26 63.59 7.03 ULMN 3 1uaq_c00 CYTOSINE DEAMINASE user 3 3 # 3 A 64 GLU B 130 GLU.? 21.96 S2 BME B 301 A 89 SER B 128 SER.? 21.18 S2 BME B 301 A 91 CYH B 52 CYH~? 17.21 S2 BME B 301 coo -18.27 -3.12 10.92 -16.30 -3.26 10.07 65.89 71.50 -12.95 66.09 70.43 -14.77 coo -16.83 -3.83 3.62 -17.28 -5.61 2.05 65.44 78.54 -10.74 66.24 76.31 -10.20 coo -13.84 -8.33 7.58 -13.00 -8.13 10.24 64.37 73.52 -5.35 61.67 73.37 -6.12 1uaq_c00 source 1uaq CYTOSINE DEAMINASE : 3 hits 1uaq_c00 naa= 3 ULMN 3 1uaq_c01 CYTOSINE DEAMINASE user 1 3 # 1 B 64 GLU A 70 GLU~? 7.34 C1 BME B 301 B 89 SER A 71 SER~? 8.26 C1 BME B 301 B 91 CYH A 74 CYH~? 2.95 S2 BME A 300s coo -13.67 -17.67 21.70 -15.74 -17.78 22.24 68.92 53.57 0.58 67.76 55.17 -0.17 coo -17.71 -23.81 20.93 -18.57 -24.92 18.94 70.10 52.54 6.16 67.71 52.03 6.39 coo -20.38 -18.31 18.13 -20.06 -15.64 18.96 74.14 55.73 7.46 71.82 57.29 7.21 ULMN 3 1uaq_c01 CYTOSINE DEAMINASE user 2 3 # 2 B 64 GLU B 70 GLU~? 7.75 C1 BME A 300 B 89 SER B 71 SER~? 8.60 S2 BME B 301 B 91 CYH B 74 CYH~? -2.15 S2 BME B 301s coo -13.67 -17.67 21.70 -15.74 -17.78 22.24 72.71 65.28 -0.66 74.40 64.00 -0.70 coo -17.71 -23.81 20.93 -18.57 -24.92 18.94 71.04 68.14 4.29 73.26 68.66 5.07 coo -20.38 -18.31 18.13 -20.06 -15.64 18.96 66.79 65.33 5.35 68.26 63.59 7.03 ULMN 3 1uaq_c01 CYTOSINE DEAMINASE user 3 3 # 3 B 64 GLU B 130 GLU.? 21.96 S2 BME B 301 B 89 SER B 128 SER.? 21.18 S2 BME B 301 B 91 CYH B 52 CYH~? 17.21 S2 BME B 301 coo -13.67 -17.67 21.70 -15.74 -17.78 22.24 65.89 71.50 -12.95 66.09 70.43 -14.77 coo -17.71 -23.81 20.93 -18.57 -24.92 18.94 65.44 78.54 -10.74 66.24 76.31 -10.20 coo -20.38 -18.31 18.13 -20.06 -15.64 18.96 64.37 73.52 -5.35 61.67 73.37 -6.12 1uaq_c01 source 1uaq CYTOSINE DEAMINASE : 3 hits 1uaq_c01 naa= 3 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 1 3 # 1 A 46 GLU A 70 GLU~? 7.34 C1 BME B 301 A 126 LYS A 73 LYS~? -2.81 O1 BME A 300s A 171 ALA A 69 ALA~? 9.22 O1 BME A 300 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 68.92 53.57 0.58 67.76 55.17 -0.17 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 75.23 53.47 4.59 74.97 57.96 1.35 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 71.41 49.37 1.91 71.70 49.24 0.42 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 2 3 # 2 A 46 GLU A 130 GLU~? 23.04 O1 BME A 300 A 126 LYS A 126 LYS.? 26.12 O1 BME A 300 A 171 ALA A 131 ALA~? 24.49 O1 BME A 300 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 84.58 38.87 -3.95 85.40 38.00 -2.18 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 79.50 36.17 1.43 79.74 32.57 -2.57 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 80.49 35.59 -6.71 79.16 35.44 -5.99 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 3 3 # 3 A 46 GLU B 130 GLU.? 21.96 S2 BME B 301 A 126 LYS B 3 LYS^? 16.28 S2 BME B 301 A 171 ALA B 51 ALA~? 18.20 S2 BME B 301 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 65.89 71.50 -12.95 66.09 70.43 -14.77 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 73.79 67.72 -12.74 69.00 65.74 -10.30 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 66.36 72.04 -8.23 65.50 72.30 -9.45 1uf7_c00 source 1uf7 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLASE : 3 hits 1uf7_c00 naa= 3 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 1 3 # 1 B 46 GLU A 130 GLU~? 23.04 O1 BME A 300 B 126 LYS A 126 LYS.? 26.12 O1 BME A 300 B 171 ALA A 131 ALA~? 24.49 O1 BME A 300 coo 20.47 87.42 16.54 20.16 87.17 14.45 84.58 38.87 -3.95 85.40 38.00 -2.18 coo 24.73 94.37 14.59 21.08 89.84 11.98 79.50 36.17 1.43 79.74 32.57 -2.57 coo 24.38 86.32 12.71 22.88 86.54 12.71 80.49 35.59 -6.71 79.16 35.44 -5.99 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 2 3 # 2 B 46 GLU B 130 GLU.? 21.96 S2 BME B 301 B 126 LYS B 3 LYS^? 16.28 S2 BME B 301 B 171 ALA B 51 ALA~? 18.20 S2 BME B 301 coo 20.47 87.42 16.54 20.16 87.17 14.45 65.89 71.50 -12.95 66.09 70.43 -14.77 coo 24.73 94.37 14.59 21.08 89.84 11.98 73.79 67.72 -12.74 69.00 65.74 -10.30 coo 24.38 86.32 12.71 22.88 86.54 12.71 66.36 72.04 -8.23 65.50 72.30 -9.45 1uf7_c01 source 1uf7 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLASE : 2 hits 1uf7_c01 naa= 3 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 1 3 # 1 199 ASP A 68 ASP~? 9.92 C1 BME B 301 218 GLU B 61 GLU.? 21.77 S2 BME B 301 329 ASP B 84 ASP^? 10.28 C2 BME B 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 67.14 48.96 2.96 66.44 50.60 4.08 coo 70.09 11.71 8.46 70.56 12.89 6.77 72.49 81.24 7.40 73.27 83.04 8.17 coo 59.16 37.82 13.95 57.63 37.03 15.12 64.49 54.82 11.77 62.58 54.12 11.40 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 2 3 # 2 199 ASP A 68 ASP~? 9.92 C1 BME B 301 218 GLU B 122 GLU~? 20.09 S2 BME B 301 329 ASP B 84 ASP^? 10.28 C2 BME B 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 67.14 48.96 2.96 66.44 50.60 4.08 coo 70.09 11.71 8.46 70.56 12.89 6.77 58.24 80.53 4.30 58.07 79.83 6.28 coo 59.16 37.82 13.95 57.63 37.03 15.12 64.49 54.82 11.77 62.58 54.12 11.40 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 3 3 # 3 199 ASP A 129 ASP~? 19.06 O1 BME A 300 218 GLU B 38 GLU^? 31.80 C2 BME B 301 329 ASP A 44 ASP~? 20.39 O1 BME A 300 coo 49.16 35.16 15.19 51.08 34.43 15.65 80.80 42.21 -6.02 80.73 43.57 -7.63 coo 70.09 11.71 8.46 70.56 12.89 6.77 61.52 60.14 -24.13 60.63 59.15 -25.77 coo 59.16 37.82 13.95 57.63 37.03 15.12 83.66 51.21 -11.72 83.67 49.16 -12.23 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 4 3 # 4 199 ASP A 129 ASP~? 19.06 O1 BME A 300 218 GLU B 130 GLU.? 21.96 S2 BME B 301 329 ASP A 44 ASP~? 20.39 O1 BME A 300 coo 49.16 35.16 15.19 51.08 34.43 15.65 80.80 42.21 -6.02 80.73 43.57 -7.63 coo 70.09 11.71 8.46 70.56 12.89 6.77 65.89 71.50 -12.95 66.09 70.43 -14.77 coo 59.16 37.82 13.95 57.63 37.03 15.12 83.66 51.21 -11.72 83.67 49.16 -12.23 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 5 3 # 5 199 ASP B 68 ASP~? 10.36 S2 BME B 301 218 GLU A 61 GLU.? 20.99 O1 BME A 300 329 ASP A 84 ASP^? 10.85 S2 BME A 300 coo 49.16 35.16 15.19 51.08 34.43 15.65 74.86 70.68 0.81 74.63 68.81 1.72 coo 70.09 11.71 8.46 70.56 12.89 6.77 69.88 39.99 12.89 68.19 39.98 14.15 coo 59.16 37.82 13.95 57.63 37.03 15.12 75.39 67.64 11.32 77.43 68.14 11.09 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 6 3 # 6 199 ASP B 68 ASP~? 10.36 S2 BME B 301 218 GLU A 122 GLU~? 20.27 C2 BME A 300 329 ASP A 84 ASP^? 10.85 S2 BME A 300 coo 49.16 35.16 15.19 51.08 34.43 15.65 74.86 70.68 0.81 74.63 68.81 1.72 coo 70.09 11.71 8.46 70.56 12.89 6.77 83.94 41.43 11.78 84.52 42.47 13.54 coo 59.16 37.82 13.95 57.63 37.03 15.12 75.39 67.64 11.32 77.43 68.14 11.09 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 7 3 # 7 199 ASP B 84 ASP^? 10.28 C2 BME B 301 218 GLU A 38 GLU^? 20.48 C1 BME A 300 329 ASP A 68 ASP~? 9.92 C1 BME B 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 64.49 54.82 11.77 62.58 54.12 11.40 coo 70.09 11.71 8.46 70.56 12.89 6.77 80.67 68.42 -11.46 82.73 68.27 -11.88 coo 59.16 37.82 13.95 57.63 37.03 15.12 67.14 48.96 2.96 66.44 50.60 4.08 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 8 3 # 8 199 ASP B 129 ASP.? 27.81 S2 BME B 301 218 GLU A 108 GLU~? 11.49 C1 BME A 300 329 ASP B 55 ASP~? 19.77 S2 BME B 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 64.27 77.57 -15.36 64.19 79.64 -15.85 coo 70.09 11.71 8.46 70.56 12.89 6.77 87.15 61.55 3.86 85.80 63.08 4.38 coo 59.16 37.82 13.95 57.63 37.03 15.12 66.42 77.35 -5.07 66.48 77.29 -7.17 1uok_c04 source 1uok OLIGO-1,6-GLUCOSIDASE : 8 hits 1uok_c04 naa= 3 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 1 3 # 1 199 ASP A 68 ASP~? 9.92 C1 BME B 301 242 GLU A 130 GLU~? 23.04 O1 BME A 300 329 ASP B 84 ASP^? 10.28 C2 BME B 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 67.14 48.96 2.96 66.44 50.60 4.08 coo 30.42 34.74 5.00 29.09 35.09 3.38 84.58 38.87 -3.95 85.40 38.00 -2.18 coo 59.16 37.82 13.95 57.63 37.03 15.12 64.49 54.82 11.77 62.58 54.12 11.40 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 2 3 # 2 199 ASP A 129 ASP~? 19.06 O1 BME A 300 242 GLU A 61 GLU.? 20.99 O1 BME A 300 329 ASP A 44 ASP~? 20.39 O1 BME A 300 coo 49.16 35.16 15.19 51.08 34.43 15.65 80.80 42.21 -6.02 80.73 43.57 -7.63 coo 30.42 34.74 5.00 29.09 35.09 3.38 69.88 39.99 12.89 68.19 39.98 14.15 coo 59.16 37.82 13.95 57.63 37.03 15.12 83.66 51.21 -11.72 83.67 49.16 -12.23 1uok_c05 source 1uok OLIGO-1,6-GLUCOSIDASE : 2 hits 1uok_c05 naa= 3 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 1 3 # 1 A 581 GLU B 38 GLU^? 31.80 C2 BME B 301 A 596 ARG B 39 ARG.? 27.37 S2 BME B 301 A 647 ARG B 9 ARG.? 31.92 S2 BME B 301 coo 69.13 32.20 28.58 68.39 32.96 30.44 61.52 60.14 -24.13 60.63 59.15 -25.77 coo 70.89 37.31 29.70 69.54 36.29 32.39 61.31 65.86 -19.69 59.13 67.99 -19.83 coo 66.09 40.54 34.70 66.92 37.69 35.49 61.30 71.84 -25.56 62.82 73.83 -23.80 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 2 3 # 2 A 581 GLU B 38 GLU^? 31.80 C2 BME B 301 A 596 ARG B 39 ARG.? 27.37 S2 BME B 301 A 647 ARG B 47 ARG~? 23.93 S2 BME B 301 coo 69.13 32.20 28.58 68.39 32.96 30.44 61.52 60.14 -24.13 60.63 59.15 -25.77 coo 70.89 37.31 29.70 69.54 36.29 32.39 61.31 65.86 -19.69 59.13 67.99 -19.83 coo 66.09 40.54 34.70 66.92 37.69 35.49 65.24 66.71 -15.28 63.33 68.13 -17.26 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 3 3 # 3 A 581 GLU B 130 GLU.? 21.96 S2 BME B 301 A 596 ARG B 47 ARG~? 23.93 S2 BME B 301 A 647 ARG B 39 ARG.? 27.37 S2 BME B 301 coo 69.13 32.20 28.58 68.39 32.96 30.44 65.89 71.50 -12.95 66.09 70.43 -14.77 coo 70.89 37.31 29.70 69.54 36.29 32.39 65.24 66.71 -15.28 63.33 68.13 -17.26 coo 66.09 40.54 34.70 66.92 37.69 35.49 61.31 65.86 -19.69 59.13 67.99 -19.83 1v0e_c00 source 1v0e ENDO-ALPHA-SIALIDASE : 3 hits 1v0e_c00 naa= 3 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 1 3 # 1 B 581 GLU B 38 GLU^? 31.80 C2 BME B 301 B 596 ARG B 39 ARG.? 27.37 S2 BME B 301 B 647 ARG B 9 ARG.? 31.92 S2 BME B 301 coo 38.22 57.83 70.36 36.82 56.74 69.18 61.52 60.14 -24.13 60.63 59.15 -25.77 coo 34.24 60.89 68.08 33.31 57.93 67.63 61.31 65.86 -19.69 59.13 67.99 -19.83 coo 31.43 57.38 61.97 31.90 55.58 64.41 61.30 71.84 -25.56 62.82 73.83 -23.80 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 2 3 # 2 B 581 GLU B 38 GLU^? 31.80 C2 BME B 301 B 596 ARG B 39 ARG.? 27.37 S2 BME B 301 B 647 ARG B 47 ARG~? 23.93 S2 BME B 301 coo 38.22 57.83 70.36 36.82 56.74 69.18 61.52 60.14 -24.13 60.63 59.15 -25.77 coo 34.24 60.89 68.08 33.31 57.93 67.63 61.31 65.86 -19.69 59.13 67.99 -19.83 coo 31.43 57.38 61.97 31.90 55.58 64.41 65.24 66.71 -15.28 63.33 68.13 -17.26 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 3 3 # 3 B 581 GLU B 130 GLU.? 21.96 S2 BME B 301 B 596 ARG B 47 ARG~? 23.93 S2 BME B 301 B 647 ARG B 39 ARG.? 27.37 S2 BME B 301 coo 38.22 57.83 70.36 36.82 56.74 69.18 65.89 71.50 -12.95 66.09 70.43 -14.77 coo 34.24 60.89 68.08 33.31 57.93 67.63 65.24 66.71 -15.28 63.33 68.13 -17.26 coo 31.43 57.38 61.97 31.90 55.58 64.41 61.31 65.86 -19.69 59.13 67.99 -19.83 1v0e_c01 source 1v0e ENDO-ALPHA-SIALIDASE : 3 hits 1v0e_c01 naa= 3 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 1 3 # 1 C 581 GLU B 38 GLU^? 31.80 C2 BME B 301 C 596 ARG B 39 ARG.? 27.37 S2 BME B 301 C 647 ARG B 9 ARG.? 31.92 S2 BME B 301 coo 11.31 31.26 27.00 13.31 30.71 26.58 61.52 60.14 -24.13 60.63 59.15 -25.77 coo 13.44 32.78 22.07 15.56 30.91 23.37 61.31 65.86 -19.69 59.13 67.99 -19.83 coo 21.00 33.35 22.82 19.83 30.82 24.09 61.30 71.84 -25.56 62.82 73.83 -23.80 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 2 3 # 2 C 581 GLU B 38 GLU^? 31.80 C2 BME B 301 C 596 ARG B 39 ARG.? 27.37 S2 BME B 301 C 647 ARG B 47 ARG~? 23.93 S2 BME B 301 coo 11.31 31.26 27.00 13.31 30.71 26.58 61.52 60.14 -24.13 60.63 59.15 -25.77 coo 13.44 32.78 22.07 15.56 30.91 23.37 61.31 65.86 -19.69 59.13 67.99 -19.83 coo 21.00 33.35 22.82 19.83 30.82 24.09 65.24 66.71 -15.28 63.33 68.13 -17.26 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 3 3 # 3 C 581 GLU B 130 GLU.? 21.96 S2 BME B 301 C 596 ARG B 47 ARG~? 23.93 S2 BME B 301 C 647 ARG B 39 ARG.? 27.37 S2 BME B 301 coo 11.31 31.26 27.00 13.31 30.71 26.58 65.89 71.50 -12.95 66.09 70.43 -14.77 coo 13.44 32.78 22.07 15.56 30.91 23.37 65.24 66.71 -15.28 63.33 68.13 -17.26 coo 21.00 33.35 22.82 19.83 30.82 24.09 61.31 65.86 -19.69 59.13 67.99 -19.83 1v0e_c02 source 1v0e ENDO-ALPHA-SIALIDASE : 3 hits 1v0e_c02 naa= 3 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 1 3 # 1 D 581 GLU B 38 GLU^? 31.80 C2 BME B 301 D 596 ARG B 39 ARG.? 27.37 S2 BME B 301 D 647 ARG B 9 ARG.? 31.92 S2 BME B 301 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 61.52 60.14 -24.13 60.63 59.15 -25.77 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 61.31 65.86 -19.69 59.13 67.99 -19.83 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 61.30 71.84 -25.56 62.82 73.83 -23.80 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 2 3 # 2 D 581 GLU B 38 GLU^? 31.80 C2 BME B 301 D 596 ARG B 39 ARG.? 27.37 S2 BME B 301 D 647 ARG B 47 ARG~? 23.93 S2 BME B 301 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 61.52 60.14 -24.13 60.63 59.15 -25.77 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 61.31 65.86 -19.69 59.13 67.99 -19.83 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 65.24 66.71 -15.28 63.33 68.13 -17.26 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 3 3 # 3 D 581 GLU B 130 GLU.? 21.96 S2 BME B 301 D 596 ARG B 47 ARG~? 23.93 S2 BME B 301 D 647 ARG B 39 ARG.? 27.37 S2 BME B 301 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 65.89 71.50 -12.95 66.09 70.43 -14.77 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 65.24 66.71 -15.28 63.33 68.13 -17.26 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 61.31 65.86 -19.69 59.13 67.99 -19.83 1v0e_c03 source 1v0e ENDO-ALPHA-SIALIDASE : 3 hits 1v0e_c03 naa= 3 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 1 3 # 1 E 581 GLU B 38 GLU^? 31.80 C2 BME B 301 E 596 ARG B 39 ARG.? 27.37 S2 BME B 301 E 647 ARG B 9 ARG.? 31.92 S2 BME B 301 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 61.52 60.14 -24.13 60.63 59.15 -25.77 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 61.31 65.86 -19.69 59.13 67.99 -19.83 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 61.30 71.84 -25.56 62.82 73.83 -23.80 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 2 3 # 2 E 581 GLU B 38 GLU^? 31.80 C2 BME B 301 E 596 ARG B 39 ARG.? 27.37 S2 BME B 301 E 647 ARG B 47 ARG~? 23.93 S2 BME B 301 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 61.52 60.14 -24.13 60.63 59.15 -25.77 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 61.31 65.86 -19.69 59.13 67.99 -19.83 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 65.24 66.71 -15.28 63.33 68.13 -17.26 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 3 3 # 3 E 581 GLU B 130 GLU.? 21.96 S2 BME B 301 E 596 ARG B 47 ARG~? 23.93 S2 BME B 301 E 647 ARG B 39 ARG.? 27.37 S2 BME B 301 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 65.89 71.50 -12.95 66.09 70.43 -14.77 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 65.24 66.71 -15.28 63.33 68.13 -17.26 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 61.31 65.86 -19.69 59.13 67.99 -19.83 1v0e_c04 source 1v0e ENDO-ALPHA-SIALIDASE : 3 hits 1v0e_c04 naa= 3 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 1 3 # 1 F 581 GLU B 38 GLU^? 31.80 C2 BME B 301 F 596 ARG B 39 ARG.? 27.37 S2 BME B 301 F 647 ARG B 9 ARG.? 31.92 S2 BME B 301 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 61.52 60.14 -24.13 60.63 59.15 -25.77 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 61.31 65.86 -19.69 59.13 67.99 -19.83 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 61.30 71.84 -25.56 62.82 73.83 -23.80 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 2 3 # 2 F 581 GLU B 38 GLU^? 31.80 C2 BME B 301 F 596 ARG B 39 ARG.? 27.37 S2 BME B 301 F 647 ARG B 47 ARG~? 23.93 S2 BME B 301 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 61.52 60.14 -24.13 60.63 59.15 -25.77 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 61.31 65.86 -19.69 59.13 67.99 -19.83 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 65.24 66.71 -15.28 63.33 68.13 -17.26 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 3 3 # 3 F 581 GLU B 130 GLU.? 21.96 S2 BME B 301 F 596 ARG B 47 ARG~? 23.93 S2 BME B 301 F 647 ARG B 39 ARG.? 27.37 S2 BME B 301 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 65.89 71.50 -12.95 66.09 70.43 -14.77 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 65.24 66.71 -15.28 63.33 68.13 -17.26 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 61.31 65.86 -19.69 59.13 67.99 -19.83 1v0e_c05 source 1v0e ENDO-ALPHA-SIALIDASE : 3 hits 1v0e_c05 naa= 3 ULMN 3 1vom_c00 MYOSIN user 1 3 # 1 233 ASN A 40 ASN.? 14.17 C1 BME A 300 457 GLY A 107 GLY~? 15.59 C1 BME A 300 459 GLU A 108 GLU~? 11.49 C1 BME A 300 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 83.12 63.00 -5.61 82.62 65.08 -5.69 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 90.64 59.31 1.39 89.81 59.35 1.31 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 87.15 61.55 3.86 85.80 63.08 4.38 1vom_c00 source 1vom MYOSIN : 1 hits 1vom_c00 naa= 3 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 1 3 # 1 A 183 GLY A 93 GLY.? 15.31 S2 BME B 301 B 419 GLY A 91 GLY.? 17.38 S2 BME B 301 B 420 ALA A 90 ALA.? 16.34 S2 BME B 301 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 62.45 69.60 17.87 62.71 70.25 17.36 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 60.88 74.75 15.45 60.38 74.14 15.64 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 58.27 73.33 13.07 57.55 72.13 13.66 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 2 3 # 2 A 183 GLY B 93 GLY.? 15.48 C2 BME A 300 B 419 GLY B 91 GLY.? 17.31 C2 BME A 300 B 420 ALA B 90 ALA.? 15.84 C2 BME A 300 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 75.52 55.36 20.96 75.34 54.55 20.70 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 77.25 49.87 20.59 77.72 50.53 20.70 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 80.35 50.63 18.53 80.97 51.96 18.93 1xny_c00 source 1xny PROPIONYL-COA CARBOXYLASE COMPLEX B SUBUNIT : 2 hits 1xny_c00 naa= 3 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 1 3 # 1 142 TRP A 50 TRP~? 8.27 O1 BME A 300 223 ASP A 44 ASP~? 20.39 O1 BME A 300 258 ALA A 110 ALA~? 15.12 C1 BME A 300 coo 128.40 33.01 26.67 128.12 36.28 28.81 75.65 52.45 -4.37 73.11 53.11 -1.46 coo 127.91 41.73 23.55 129.18 40.35 24.44 83.66 51.21 -11.72 83.67 49.16 -12.23 coo 141.00 37.49 25.74 139.80 37.53 24.78 88.15 54.80 0.60 89.61 55.18 0.35 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 2 3 # 2 142 TRP A 62 TRP.? 13.96 C2 BME A 300 223 ASP B 84 ASP^? 10.28 C2 BME B 301 258 ALA A 69 ALA~? 9.22 O1 BME A 300 coo 128.40 33.01 26.67 128.12 36.28 28.81 72.00 48.24 13.73 75.57 46.89 14.64 coo 127.91 41.73 23.55 129.18 40.35 24.44 64.49 54.82 11.77 62.58 54.12 11.40 coo 141.00 37.49 25.74 139.80 37.53 24.78 71.41 49.37 1.91 71.70 49.24 0.42 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 3 3 # 3 142 TRP A 72 TRP~? 11.16 O1 BME A 300 223 ASP A 55 ASP~? 17.20 O1 BME A 300 258 ALA A 118 ALA~? 17.31 C1 BME A 300 coo 128.40 33.01 26.67 128.12 36.28 28.81 72.29 47.21 6.20 74.37 46.50 9.46 coo 127.91 41.73 23.55 129.18 40.35 24.44 76.53 41.69 0.56 76.82 41.16 -1.46 coo 141.00 37.49 25.74 139.80 37.53 24.78 86.00 44.74 7.42 86.79 45.80 8.18 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 4 3 # 4 142 TRP A 127 TRP~? 17.97 O1 BME A 300 223 ASP A 129 ASP~? 19.06 O1 BME A 300 258 ALA A 69 ALA~? 9.22 O1 BME A 300 coo 128.40 33.01 26.67 128.12 36.28 28.81 83.13 39.72 0.82 80.98 42.71 2.22 coo 127.91 41.73 23.55 129.18 40.35 24.44 80.80 42.21 -6.02 80.73 43.57 -7.63 coo 141.00 37.49 25.74 139.80 37.53 24.78 71.41 49.37 1.91 71.70 49.24 0.42 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 5 3 # 5 142 TRP B 50 TRP~? 11.26 S2 BME B 301 223 ASP B 44 ASP~? 23.69 S2 BME B 301 258 ALA B 110 ALA~? 18.51 S2 BME B 301 coo 128.40 33.01 26.67 128.12 36.28 28.81 67.49 65.30 -7.05 69.14 65.31 -3.49 coo 127.91 41.73 23.55 129.18 40.35 24.44 59.88 65.23 -14.80 60.45 65.24 -16.84 coo 141.00 37.49 25.74 139.80 37.53 24.78 54.15 65.71 -4.34 52.84 65.57 -5.07 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 6 3 # 6 142 TRP B 62 TRP.? 13.85 S2 BME B 301 223 ASP A 84 ASP^? 10.85 S2 BME A 300 258 ALA B 69 ALA~? 11.48 S2 BME B 301 coo 128.40 33.01 26.67 128.12 36.28 28.81 68.29 74.36 9.74 64.89 76.31 9.74 coo 127.91 41.73 23.55 129.18 40.35 24.44 75.39 67.64 11.32 77.43 68.14 11.09 coo 141.00 37.49 25.74 139.80 37.53 24.78 70.83 70.14 -0.86 70.81 69.91 -2.35 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 7 3 # 7 142 TRP B 62 TRP.? 13.85 S2 BME B 301 223 ASP A 84 ASP^? 10.85 S2 BME A 300 258 ALA B 78 ALA~? 6.66 S2 BME B 301 coo 128.40 33.01 26.67 128.12 36.28 28.81 68.29 74.36 9.74 64.89 76.31 9.74 coo 127.91 41.73 23.55 129.18 40.35 24.44 75.39 67.64 11.32 77.43 68.14 11.09 coo 141.00 37.49 25.74 139.80 37.53 24.78 61.66 64.81 8.40 62.93 65.17 9.16 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 8 3 # 8 142 TRP B 72 TRP~? 12.10 S2 BME B 301 223 ASP B 55 ASP~? 19.77 S2 BME B 301 258 ALA B 118 ALA~? 18.89 S2 BME B 301 coo 128.40 33.01 26.67 128.12 36.28 28.81 69.24 73.45 2.61 66.61 74.89 5.18 coo 127.91 41.73 23.55 129.18 40.35 24.44 66.42 77.35 -5.07 66.48 77.29 -7.17 coo 141.00 37.49 25.74 139.80 37.53 24.78 55.85 76.49 0.36 55.00 75.55 1.22 2aat_c01 source 2aat ASPARTATE AMINOTRANSFERASE (E.C.2.6.1.1) MUTAN: 8 hits 2aat_c01 naa= 3 ULMN 3 2ace_c00 ACETYLCHOLINESTERASE user 1 3 # 1 200 SER A 10 SER~? 30.56 C1 BME A 300 327 GLU A 7 GLU^? 21.08 O1 BME A 300 440 HIS A 13 HIS~? 28.57 O1 BME A 300 coo 6.96 64.04 57.84 6.74 63.69 60.26 88.87 59.13 -21.90 88.60 57.08 -23.12 coo 14.82 64.63 62.37 13.47 65.72 61.17 82.55 57.05 -16.50 82.95 55.46 -15.17 coo 9.52 66.51 63.07 8.75 65.02 61.81 85.22 56.20 -22.53 85.38 54.15 -22.09 ULMN 3 2ace_c00 ACETYLCHOLINESTERASE user 2 3 # 2 200 SER B 10 SER~? 37.79 S2 BME B 301 327 GLU B 7 GLU^? 27.97 S2 BME B 301 440 HIS B 13 HIS~? 34.41 S2 BME B 301 coo 6.96 64.04 57.84 6.74 63.69 60.26 65.36 72.56 -31.08 66.40 74.55 -30.17 coo 14.82 64.63 62.37 13.47 65.72 61.17 64.21 70.19 -21.03 62.19 70.66 -20.57 coo 9.52 66.51 63.07 8.75 65.02 61.81 67.07 73.58 -27.21 65.85 74.91 -26.15 2ace_c00 source 2ace ACETYLCHOLINESTERASE : 2 hits 2ace_c00 naa= 3 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 1 3 # 1 193 ASP A 84 ASP^? 10.85 S2 BME A 300 231 ASP A 68 ASP~? 9.92 C1 BME B 301 294 ASP B 68 ASP~? 10.36 S2 BME B 301 coo 27.89 102.52 14.98 29.35 101.92 13.57 75.39 67.64 11.32 77.43 68.14 11.09 coo 14.74 93.05 -1.00 14.30 94.22 0.73 67.14 48.96 2.96 66.44 50.60 4.08 coo 33.16 106.80 7.72 33.34 104.87 6.92 74.86 70.68 0.81 74.63 68.81 1.72 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 2 3 # 2 193 ASP B 84 ASP^? 10.28 C2 BME B 301 231 ASP B 68 ASP~? 10.36 S2 BME B 301 294 ASP A 68 ASP~? 9.92 C1 BME B 301 coo 27.89 102.52 14.98 29.35 101.92 13.57 64.49 54.82 11.77 62.58 54.12 11.40 coo 14.74 93.05 -1.00 14.30 94.22 0.73 74.86 70.68 0.81 74.63 68.81 1.72 coo 33.16 106.80 7.72 33.34 104.87 6.92 67.14 48.96 2.96 66.44 50.60 4.08 2amg_c06 source 2amg 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLASE : 2 hits 2amg_c06 naa= 3 ULMN 3 2dbt_c00 CHITINASE C user 1 3 # 1 A 147 GLU A 70 GLU~? 7.34 C1 BME B 301 A 156 GLU B 70 GLU~? 7.75 C1 BME A 300 A 194 ASN A 46 ASN~? 11.04 O1 BME A 300 coo 74.14 15.91 8.55 72.08 15.36 8.63 68.92 53.57 0.58 67.76 55.17 -0.17 coo 67.47 20.07 1.34 65.99 20.06 2.88 72.71 65.28 -0.66 74.40 64.00 -0.70 coo 67.44 25.26 13.91 67.54 23.65 15.28 78.74 53.91 -7.24 78.48 55.71 -6.12 ULMN 3 2dbt_c00 CHITINASE C user 2 3 # 2 A 147 GLU A 70 GLU~? 7.34 C1 BME B 301 A 156 GLU B 70 GLU~? 7.75 C1 BME A 300 A 194 ASN B 46 ASN~? 13.59 C2 BME B 301 coo 74.14 15.91 8.55 72.08 15.36 8.63 68.92 53.57 0.58 67.76 55.17 -0.17 coo 67.47 20.07 1.34 65.99 20.06 2.88 72.71 65.28 -0.66 74.40 64.00 -0.70 coo 67.44 25.26 13.91 67.54 23.65 15.28 64.66 62.99 -9.32 64.25 61.47 -7.89 ULMN 3 2dbt_c00 CHITINASE C user 3 3 # 3 A 147 GLU B 7 GLU^? 27.97 S2 BME B 301 A 156 GLU B 38 GLU^? 31.80 C2 BME B 301 A 194 ASN B 46 ASN~? 13.59 C2 BME B 301 coo 74.14 15.91 8.55 72.08 15.36 8.63 64.21 70.19 -21.03 62.19 70.66 -20.57 coo 67.47 20.07 1.34 65.99 20.06 2.88 61.52 60.14 -24.13 60.63 59.15 -25.77 coo 67.44 25.26 13.91 67.54 23.65 15.28 64.66 62.99 -9.32 64.25 61.47 -7.89 ULMN 3 2dbt_c00 CHITINASE C user 4 3 # 4 A 147 GLU B 70 GLU~? 7.75 C1 BME A 300 A 156 GLU A 70 GLU~? 7.34 C1 BME B 301 A 194 ASN A 46 ASN~? 11.04 O1 BME A 300 coo 74.14 15.91 8.55 72.08 15.36 8.63 72.71 65.28 -0.66 74.40 64.00 -0.70 coo 67.47 20.07 1.34 65.99 20.06 2.88 68.92 53.57 0.58 67.76 55.17 -0.17 coo 67.44 25.26 13.91 67.54 23.65 15.28 78.74 53.91 -7.24 78.48 55.71 -6.12 ULMN 3 2dbt_c00 CHITINASE C user 5 3 # 5 A 147 GLU B 70 GLU~? 7.75 C1 BME A 300 A 156 GLU A 70 GLU~? 7.34 C1 BME B 301 A 194 ASN B 46 ASN~? 13.59 C2 BME B 301 coo 74.14 15.91 8.55 72.08 15.36 8.63 72.71 65.28 -0.66 74.40 64.00 -0.70 coo 67.47 20.07 1.34 65.99 20.06 2.88 68.92 53.57 0.58 67.76 55.17 -0.17 coo 67.44 25.26 13.91 67.54 23.65 15.28 64.66 62.99 -9.32 64.25 61.47 -7.89 2dbt_c00 source 2dbt CHITINASE C : 5 hits 2dbt_c00 naa= 3 ULMN 3 2dbt_c01 CHITINASE C user 1 3 # 1 B 147 GLU B 7 GLU^? 27.97 S2 BME B 301 B 156 GLU B 130 GLU.? 21.96 S2 BME B 301 B 194 ASN B 40 ASN~? 22.06 C2 BME B 301 coo 45.64 63.11 17.20 47.48 62.43 16.45 64.21 70.19 -21.03 62.19 70.66 -20.57 coo 54.43 67.89 19.82 55.62 67.90 18.07 65.89 71.50 -12.95 66.09 70.43 -14.77 coo 49.79 70.75 7.78 50.10 68.90 6.86 59.67 59.12 -17.42 60.89 58.88 -15.71 ULMN 3 2dbt_c01 CHITINASE C user 2 3 # 2 B 147 GLU B 130 GLU.? 21.96 S2 BME B 301 B 156 GLU B 7 GLU^? 27.97 S2 BME B 301 B 194 ASN B 40 ASN~? 22.06 C2 BME B 301 coo 45.64 63.11 17.20 47.48 62.43 16.45 65.89 71.50 -12.95 66.09 70.43 -14.77 coo 54.43 67.89 19.82 55.62 67.90 18.07 64.21 70.19 -21.03 62.19 70.66 -20.57 coo 49.79 70.75 7.78 50.10 68.90 6.86 59.67 59.12 -17.42 60.89 58.88 -15.71 2dbt_c01 source 2dbt CHITINASE C : 2 hits 2dbt_c01 naa= 3 ULMN 3 2dbt_c02 CHITINASE C user 1 3 # 1 C 147 GLU A 70 GLU~? 7.34 C1 BME B 301 C 156 GLU B 70 GLU~? 7.75 C1 BME A 300 C 194 ASN A 46 ASN~? 11.04 O1 BME A 300 coo 41.23 29.31 13.28 43.03 29.85 12.29 68.92 53.57 0.58 67.76 55.17 -0.17 coo 44.75 23.09 5.51 46.77 22.91 6.12 72.71 65.28 -0.66 74.40 64.00 -0.70 coo 49.75 21.00 18.12 50.45 23.02 18.26 78.74 53.91 -7.24 78.48 55.71 -6.12 ULMN 3 2dbt_c02 CHITINASE C user 2 3 # 2 C 147 GLU A 70 GLU~? 7.34 C1 BME B 301 C 156 GLU B 70 GLU~? 7.75 C1 BME A 300 C 194 ASN B 46 ASN~? 13.59 C2 BME B 301 coo 41.23 29.31 13.28 43.03 29.85 12.29 68.92 53.57 0.58 67.76 55.17 -0.17 coo 44.75 23.09 5.51 46.77 22.91 6.12 72.71 65.28 -0.66 74.40 64.00 -0.70 coo 49.75 21.00 18.12 50.45 23.02 18.26 64.66 62.99 -9.32 64.25 61.47 -7.89 ULMN 3 2dbt_c02 CHITINASE C user 3 3 # 3 C 147 GLU B 7 GLU^? 27.97 S2 BME B 301 C 156 GLU B 38 GLU^? 31.80 C2 BME B 301 C 194 ASN B 46 ASN~? 13.59 C2 BME B 301 coo 41.23 29.31 13.28 43.03 29.85 12.29 64.21 70.19 -21.03 62.19 70.66 -20.57 coo 44.75 23.09 5.51 46.77 22.91 6.12 61.52 60.14 -24.13 60.63 59.15 -25.77 coo 49.75 21.00 18.12 50.45 23.02 18.26 64.66 62.99 -9.32 64.25 61.47 -7.89 ULMN 3 2dbt_c02 CHITINASE C user 4 3 # 4 C 147 GLU B 70 GLU~? 7.75 C1 BME A 300 C 156 GLU A 70 GLU~? 7.34 C1 BME B 301 C 194 ASN A 46 ASN~? 11.04 O1 BME A 300 coo 41.23 29.31 13.28 43.03 29.85 12.29 72.71 65.28 -0.66 74.40 64.00 -0.70 coo 44.75 23.09 5.51 46.77 22.91 6.12 68.92 53.57 0.58 67.76 55.17 -0.17 coo 49.75 21.00 18.12 50.45 23.02 18.26 78.74 53.91 -7.24 78.48 55.71 -6.12 ULMN 3 2dbt_c02 CHITINASE C user 5 3 # 5 C 147 GLU B 70 GLU~? 7.75 C1 BME A 300 C 156 GLU A 70 GLU~? 7.34 C1 BME B 301 C 194 ASN B 46 ASN~? 13.59 C2 BME B 301 coo 41.23 29.31 13.28 43.03 29.85 12.29 72.71 65.28 -0.66 74.40 64.00 -0.70 coo 44.75 23.09 5.51 46.77 22.91 6.12 68.92 53.57 0.58 67.76 55.17 -0.17 coo 49.75 21.00 18.12 50.45 23.02 18.26 64.66 62.99 -9.32 64.25 61.47 -7.89 2dbt_c02 source 2dbt CHITINASE C : 5 hits 2dbt_c02 naa= 3 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 1 3 # 1 A 157 PHE B 94 PHE^? 12.77 O1 BME B 301 A 245 ASP B 84 ASP^? 10.28 C2 BME B 301 A 273 LYS A 73 LYS~? -2.81 O1 BME A 300s coo 9.49 9.24 -34.27 7.12 7.86 -33.75 71.58 57.30 18.86 71.41 60.08 19.10 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 64.49 54.82 11.77 62.58 54.12 11.40 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 75.23 53.47 4.59 74.97 57.96 1.35 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 2 3 # 2 A 157 PHE B 119 PHE~? 15.49 S2 BME B 301 A 245 ASP B 55 ASP~? 19.77 S2 BME B 301 A 273 LYS B 48 LYS~? 21.20 S2 BME B 301 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 60.93 76.25 3.98 63.24 76.98 5.43 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 66.42 77.35 -5.07 66.48 77.29 -7.17 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 62.47 69.43 -9.84 56.65 72.06 -9.69 2gsa_c04 source 2gsa GLUTAMATE SEMIALDEHYDE AMINOTRANSFERASE : 2 hits 2gsa_c04 naa= 3 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 A 177 PHE B 76 PHE~? 11.05 S2 BME B 301 A 263 ASP B 55 ASP~? 19.77 S2 BME B 301 A 292 LYS B 48 LYS~? 21.20 S2 BME B 301 coo 51.51 50.32 16.39 52.13 49.68 13.75 62.48 70.31 3.16 62.78 73.09 2.84 coo 54.43 44.82 23.74 55.21 45.06 21.80 66.42 77.35 -5.07 66.48 77.29 -7.17 coo 63.95 45.30 16.71 59.11 49.15 16.05 62.47 69.43 -9.84 56.65 72.06 -9.69 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 A 177 PHE B 94 PHE^? 12.77 O1 BME B 301 A 263 ASP B 84 ASP^? 10.28 C2 BME B 301 A 292 LYS A 73 LYS~? -2.81 O1 BME A 300s coo 51.51 50.32 16.39 52.13 49.68 13.75 71.58 57.30 18.86 71.41 60.08 19.10 coo 54.43 44.82 23.74 55.21 45.06 21.80 64.49 54.82 11.77 62.58 54.12 11.40 coo 63.95 45.30 16.71 59.11 49.15 16.05 75.23 53.47 4.59 74.97 57.96 1.35 2oat_c03 source 2oat ORNITHINE AMINOTRANSFERASE : 2 hits 2oat_c03 naa= 3 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 C 177 PHE B 76 PHE~? 11.05 S2 BME B 301 C 263 ASP B 55 ASP~? 19.77 S2 BME B 301 C 292 LYS B 48 LYS~? 21.20 S2 BME B 301 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 62.48 70.31 3.16 62.78 73.09 2.84 coo 19.84 12.02 9.33 18.68 11.23 7.75 66.42 77.35 -5.07 66.48 77.29 -7.17 coo 12.82 3.49 4.98 17.80 5.59 1.90 62.47 69.43 -9.84 56.65 72.06 -9.69 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 C 177 PHE B 94 PHE^? 12.77 O1 BME B 301 C 263 ASP B 84 ASP^? 10.28 C2 BME B 301 C 292 LYS A 73 LYS~? -2.81 O1 BME A 300s coo 21.96 11.84 -0.03 20.04 11.74 -2.01 71.58 57.30 18.86 71.41 60.08 19.10 coo 19.84 12.02 9.33 18.68 11.23 7.75 64.49 54.82 11.77 62.58 54.12 11.40 coo 12.82 3.49 4.98 17.80 5.59 1.90 75.23 53.47 4.59 74.97 57.96 1.35 2oat_c05 source 2oat ORNITHINE AMINOTRANSFERASE : 2 hits 2oat_c05 naa= 3 ULMN 3 2oat_c06 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 A 178 TRP A 127 TRP~? 17.97 O1 BME A 300 A 263 ASP A 55 ASP~? 17.20 O1 BME A 300 A 292 LYS A 73 LYS~? -2.81 O1 BME A 300s coo 48.96 45.07 19.49 48.62 41.39 18.16 83.13 39.72 0.82 80.98 42.71 2.22 coo 54.43 44.82 23.74 55.21 45.06 21.80 76.53 41.69 0.56 76.82 41.16 -1.46 coo 63.95 45.30 16.71 59.11 49.15 16.05 75.23 53.47 4.59 74.97 57.96 1.35 ULMN 3 2oat_c06 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 A 178 TRP B 72 TRP~? 12.10 S2 BME B 301 A 263 ASP B 68 ASP~? 10.36 S2 BME B 301 A 292 LYS B 2 LYS.? 15.81 C1 BME A 300 coo 48.96 45.07 19.49 48.62 41.39 18.16 69.24 73.45 2.61 66.61 74.89 5.18 coo 54.43 44.82 23.74 55.21 45.06 21.80 74.86 70.68 0.81 74.63 68.81 1.72 coo 63.95 45.30 16.71 59.11 49.15 16.05 75.93 68.83 -9.78 80.88 67.42 -7.25 ULMN 3 2oat_c06 ORNITHINE AMINOTRANSFERASE user 3 3 # 3 A 178 TRP B 127 TRP.? 20.56 S2 BME B 301 A 263 ASP B 55 ASP~? 19.77 S2 BME B 301 A 292 LYS B 73 LYS~? 5.56 C2 BME B 301 coo 48.96 45.07 19.49 48.62 41.39 18.16 60.13 79.81 -6.22 61.23 77.20 -3.48 coo 54.43 44.82 23.74 55.21 45.06 21.80 66.42 77.35 -5.07 66.48 77.29 -7.17 coo 63.95 45.30 16.71 59.11 49.15 16.05 66.37 67.01 1.95 66.56 61.98 -0.01 2oat_c06 source 2oat ORNITHINE AMINOTRANSFERASE : 3 hits 2oat_c06 naa= 3 ULMN 3 2oat_c07 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 B 178 TRP A 127 TRP~? 17.97 O1 BME A 300 B 263 ASP A 55 ASP~? 17.20 O1 BME A 300 B 292 LYS A 73 LYS~? -2.81 O1 BME A 300s coo 45.83 31.15 4.65 45.88 34.74 6.24 83.13 39.72 0.82 80.98 42.71 2.22 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 76.53 41.69 0.56 76.82 41.16 -1.46 coo 60.53 31.67 0.97 57.79 27.51 3.63 75.23 53.47 4.59 74.97 57.96 1.35 ULMN 3 2oat_c07 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 B 178 TRP B 72 TRP~? 12.10 S2 BME B 301 B 263 ASP B 68 ASP~? 10.36 S2 BME B 301 B 292 LYS B 2 LYS.? 15.81 C1 BME A 300 coo 45.83 31.15 4.65 45.88 34.74 6.24 69.24 73.45 2.61 66.61 74.89 5.18 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 74.86 70.68 0.81 74.63 68.81 1.72 coo 60.53 31.67 0.97 57.79 27.51 3.63 75.93 68.83 -9.78 80.88 67.42 -7.25 ULMN 3 2oat_c07 ORNITHINE AMINOTRANSFERASE user 3 3 # 3 B 178 TRP B 127 TRP.? 20.56 S2 BME B 301 B 263 ASP B 55 ASP~? 19.77 S2 BME B 301 B 292 LYS B 73 LYS~? 5.56 C2 BME B 301 coo 45.83 31.15 4.65 45.88 34.74 6.24 60.13 79.81 -6.22 61.23 77.20 -3.48 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 66.42 77.35 -5.07 66.48 77.29 -7.17 coo 60.53 31.67 0.97 57.79 27.51 3.63 66.37 67.01 1.95 66.56 61.98 -0.01 2oat_c07 source 2oat ORNITHINE AMINOTRANSFERASE : 3 hits 2oat_c07 naa= 3 ULMN 3 2oat_c08 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 C 178 TRP A 127 TRP~? 17.97 O1 BME A 300 C 263 ASP A 55 ASP~? 17.20 O1 BME A 300 C 292 LYS A 73 LYS~? -2.81 O1 BME A 300s coo 20.52 16.65 4.15 17.32 18.91 4.39 83.13 39.72 0.82 80.98 42.71 2.22 coo 19.84 12.02 9.33 18.68 11.23 7.75 76.53 41.69 0.56 76.82 41.16 -1.46 coo 12.82 3.49 4.98 17.80 5.59 1.90 75.23 53.47 4.59 74.97 57.96 1.35 ULMN 3 2oat_c08 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 C 178 TRP B 72 TRP~? 12.10 S2 BME B 301 C 263 ASP B 68 ASP~? 10.36 S2 BME B 301 C 292 LYS B 2 LYS.? 15.81 C1 BME A 300 coo 20.52 16.65 4.15 17.32 18.91 4.39 69.24 73.45 2.61 66.61 74.89 5.18 coo 19.84 12.02 9.33 18.68 11.23 7.75 74.86 70.68 0.81 74.63 68.81 1.72 coo 12.82 3.49 4.98 17.80 5.59 1.90 75.93 68.83 -9.78 80.88 67.42 -7.25 ULMN 3 2oat_c08 ORNITHINE AMINOTRANSFERASE user 3 3 # 3 C 178 TRP B 127 TRP.? 20.56 S2 BME B 301 C 263 ASP B 55 ASP~? 19.77 S2 BME B 301 C 292 LYS B 73 LYS~? 5.56 C2 BME B 301 coo 20.52 16.65 4.15 17.32 18.91 4.39 60.13 79.81 -6.22 61.23 77.20 -3.48 coo 19.84 12.02 9.33 18.68 11.23 7.75 66.42 77.35 -5.07 66.48 77.29 -7.17 coo 12.82 3.49 4.98 17.80 5.59 1.90 66.37 67.01 1.95 66.56 61.98 -0.01 2oat_c08 source 2oat ORNITHINE AMINOTRANSFERASE : 3 hits 2oat_c08 naa= 3 ULMN 3 2phk_c03 MC-PEPTIDE user 1 3 # 1 A 149 ASP B 44 ASP~? 23.69 S2 BME B 301 A 151 LYS B 48 LYS~? 21.20 S2 BME B 301 A 154 ASN B 46 ASN~? 13.59 C2 BME B 301 coo 41.42 17.90 44.98 43.39 18.36 45.61 59.88 65.23 -14.80 60.45 65.24 -16.84 coo 45.75 16.58 39.61 47.43 18.26 45.54 62.47 69.43 -9.84 56.65 72.06 -9.69 coo 44.77 13.10 43.25 45.01 14.21 45.03 64.66 62.99 -9.32 64.25 61.47 -7.89 2phk_c03 source 2phk MC-PEPTIDE : 1 hits 2phk_c03 naa= 3 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 1 3 # 1 141 ASP A 84 ASP^? 10.85 S2 BME A 300 166 GLY B 54 GLY~? 15.43 S2 BME B 301 169 GLU B 130 GLU.? 21.96 S2 BME B 301 coo 8.28 6.87 1.62 10.08 5.77 1.34 75.39 67.64 11.32 77.43 68.14 11.09 coo -8.58 13.22 3.21 -8.90 13.15 4.05 69.56 73.71 -4.55 68.86 74.06 -4.25 coo -16.67 7.89 2.78 -17.65 6.56 1.49 65.89 71.50 -12.95 66.09 70.43 -14.77 2tdt_c00 source 2tdt TETRAHYDRODIPICOLINATE N-SUCCINYLTRANSFERASE : 1 hits 2tdt_c00 naa= 3 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 1 3 # 1 A 59 ARG B 47 ARG~? 23.93 S2 BME B 301 A 130 SER B 128 SER.? 21.18 S2 BME B 301 A 159 LYS B 3 LYS^? 16.28 S2 BME B 301 coo 18.35 45.84 20.99 16.20 47.83 21.89 65.24 66.71 -15.28 63.33 68.13 -17.26 coo 15.14 43.67 10.77 15.61 44.43 13.04 65.44 78.54 -10.74 66.24 76.31 -10.20 coo 11.57 48.49 22.18 13.51 49.99 17.21 73.79 67.72 -12.74 69.00 65.74 -10.30 2tps_c00 source 2tps THIAMIN PHOSPHATE SYNTHASE : 1 hits 2tps_c00 naa= 3 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 1 3 # 1 B 59 ARG B 47 ARG~? 23.93 S2 BME B 301 B 130 SER B 128 SER.? 21.18 S2 BME B 301 B 159 LYS B 3 LYS^? 16.28 S2 BME B 301 coo 58.72 31.58 20.45 60.80 29.39 20.94 65.24 66.71 -15.28 63.33 68.13 -17.26 coo 61.66 35.17 10.39 61.29 34.14 12.56 65.44 78.54 -10.74 66.24 76.31 -10.20 coo 65.38 28.77 21.17 63.49 28.03 16.12 73.79 67.72 -12.74 69.00 65.74 -10.30 2tps_c01 source 2tps THIAMIN PHOSPHATE SYNTHASE : 1 hits 2tps_c01 naa= 3 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 1 1 # 1 A 461 ASN A 16 ASN~? 32.74 O1 BME A 300 coo 5.80 63.03 55.85 5.52 65.03 56.45 81.19 57.34 -27.42 83.03 56.27 -27.56 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 2 1 # 2 A 461 ASN A 40 ASN.? 14.17 C1 BME A 300 coo 5.80 63.03 55.85 5.52 65.03 56.45 83.12 63.00 -5.61 82.62 65.08 -5.69 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 3 1 # 3 A 461 ASN A 46 ASN~? 11.04 O1 BME A 300 coo 5.80 63.03 55.85 5.52 65.03 56.45 78.74 53.91 -7.24 78.48 55.71 -6.12 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 4 1 # 4 A 461 ASN A 88 ASN.? 14.08 S2 BME B 301 coo 5.80 63.03 55.85 5.52 65.03 56.45 62.51 69.97 13.22 61.16 70.64 14.74 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 5 1 # 5 A 461 ASN A 92 ASN.? 17.57 S2 BME B 301 coo 5.80 63.03 55.85 5.52 65.03 56.45 58.62 72.30 18.50 57.75 71.24 16.88 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 6 1 # 6 A 461 ASN B 16 ASN~? 33.06 S2 BME B 301 coo 5.80 63.03 55.85 5.52 65.03 56.45 73.64 74.63 -26.43 74.05 74.83 -24.34 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 7 1 # 7 A 461 ASN B 40 ASN~? 22.06 C2 BME B 301 coo 5.80 63.03 55.85 5.52 65.03 56.45 59.67 59.12 -17.42 60.89 58.88 -15.71 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 8 1 # 8 A 461 ASN B 46 ASN~? 13.59 C2 BME B 301 coo 5.80 63.03 55.85 5.52 65.03 56.45 64.66 62.99 -9.32 64.25 61.47 -7.89 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 9 1 # 9 A 461 ASN B 88 ASN.? 14.13 C2 BME A 300 coo 5.80 63.03 55.85 5.52 65.03 56.45 76.46 53.84 16.90 77.36 53.44 18.78 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 10 1 # 10 A 461 ASN B 92 ASN.? 17.15 C2 BME A 300 coo 5.80 63.03 55.85 5.52 65.03 56.45 79.23 53.21 23.13 80.31 54.07 21.53 1kbk_p00 source 1kbk ALPHA-AMYLASE, PANCREATIC : 10 hits 1kbk_p00 naa= 1 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 1 3 # 1 A 459 ASN A 88 ASN.? 14.08 S2 BME B 301 A 460 GLY A 91 GLY.? 17.38 S2 BME B 301 A 461 ASN A 92 ASN.? 17.57 S2 BME B 301 coo 15.00 94.38 6.97 13.00 93.59 6.99 62.51 69.97 13.22 61.16 70.64 14.74 coo 19.48 94.04 5.03 19.26 94.00 5.78 60.88 74.75 15.45 60.38 74.14 15.64 coo 20.23 95.69 9.16 21.55 97.37 9.20 58.62 72.30 18.50 57.75 71.24 16.88 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 2 3 # 2 A 459 ASN A 88 ASN.? 14.08 S2 BME B 301 A 460 GLY A 93 GLY.? 15.31 S2 BME B 301 A 461 ASN A 92 ASN.? 17.57 S2 BME B 301 coo 15.00 94.38 6.97 13.00 93.59 6.99 62.51 69.97 13.22 61.16 70.64 14.74 coo 19.48 94.04 5.03 19.26 94.00 5.78 62.45 69.60 17.87 62.71 70.25 17.36 coo 20.23 95.69 9.16 21.55 97.37 9.20 58.62 72.30 18.50 57.75 71.24 16.88 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 3 3 # 3 A 459 ASN A 92 ASN.? 17.57 S2 BME B 301 A 460 GLY A 91 GLY.? 17.38 S2 BME B 301 A 461 ASN A 88 ASN.? 14.08 S2 BME B 301 coo 15.00 94.38 6.97 13.00 93.59 6.99 58.62 72.30 18.50 57.75 71.24 16.88 coo 19.48 94.04 5.03 19.26 94.00 5.78 60.88 74.75 15.45 60.38 74.14 15.64 coo 20.23 95.69 9.16 21.55 97.37 9.20 62.51 69.97 13.22 61.16 70.64 14.74 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 4 3 # 4 A 459 ASN A 92 ASN.? 17.57 S2 BME B 301 A 460 GLY A 93 GLY.? 15.31 S2 BME B 301 A 461 ASN A 88 ASN.? 14.08 S2 BME B 301 coo 15.00 94.38 6.97 13.00 93.59 6.99 58.62 72.30 18.50 57.75 71.24 16.88 coo 19.48 94.04 5.03 19.26 94.00 5.78 62.45 69.60 17.87 62.71 70.25 17.36 coo 20.23 95.69 9.16 21.55 97.37 9.20 62.51 69.97 13.22 61.16 70.64 14.74 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 5 3 # 5 A 459 ASN B 88 ASN.? 14.13 C2 BME A 300 A 460 GLY B 91 GLY.? 17.31 C2 BME A 300 A 461 ASN B 92 ASN.? 17.15 C2 BME A 300 coo 15.00 94.38 6.97 13.00 93.59 6.99 76.46 53.84 16.90 77.36 53.44 18.78 coo 19.48 94.04 5.03 19.26 94.00 5.78 77.25 49.87 20.59 77.72 50.53 20.70 coo 20.23 95.69 9.16 21.55 97.37 9.20 79.23 53.21 23.13 80.31 54.07 21.53 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 6 3 # 6 A 459 ASN B 88 ASN.? 14.13 C2 BME A 300 A 460 GLY B 93 GLY.? 15.48 C2 BME A 300 A 461 ASN B 92 ASN.? 17.15 C2 BME A 300 coo 15.00 94.38 6.97 13.00 93.59 6.99 76.46 53.84 16.90 77.36 53.44 18.78 coo 19.48 94.04 5.03 19.26 94.00 5.78 75.52 55.36 20.96 75.34 54.55 20.70 coo 20.23 95.69 9.16 21.55 97.37 9.20 79.23 53.21 23.13 80.31 54.07 21.53 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 7 3 # 7 A 459 ASN B 92 ASN.? 17.15 C2 BME A 300 A 460 GLY B 91 GLY.? 17.31 C2 BME A 300 A 461 ASN B 88 ASN.? 14.13 C2 BME A 300 coo 15.00 94.38 6.97 13.00 93.59 6.99 79.23 53.21 23.13 80.31 54.07 21.53 coo 19.48 94.04 5.03 19.26 94.00 5.78 77.25 49.87 20.59 77.72 50.53 20.70 coo 20.23 95.69 9.16 21.55 97.37 9.20 76.46 53.84 16.90 77.36 53.44 18.78 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 8 3 # 8 A 459 ASN B 92 ASN.? 17.15 C2 BME A 300 A 460 GLY B 93 GLY.? 15.48 C2 BME A 300 A 461 ASN B 88 ASN.? 14.13 C2 BME A 300 coo 15.00 94.38 6.97 13.00 93.59 6.99 79.23 53.21 23.13 80.31 54.07 21.53 coo 19.48 94.04 5.03 19.26 94.00 5.78 75.52 55.36 20.96 75.34 54.55 20.70 coo 20.23 95.69 9.16 21.55 97.37 9.20 76.46 53.84 16.90 77.36 53.44 18.78 2qv4_p00 source 2qv4 PANCREATIC ALPHA-AMYLASE : 8 hits 2qv4_p00 naa= 3 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 1 3 # 1 A 270 ASN A 16 ASN~? 32.74 O1 BME A 300 A 384 ASN B 40 ASN~? 22.06 C2 BME B 301 A 385 GLU B 38 GLU^? 31.80 C2 BME B 301 coo 22.28 63.17 110.61 22.47 65.06 111.53 81.19 57.34 -27.42 83.03 56.27 -27.56 coo 7.06 50.07 96.17 8.50 48.54 96.31 59.67 59.12 -17.42 60.89 58.88 -15.71 coo 11.59 49.83 99.41 10.92 47.97 100.16 61.52 60.14 -24.13 60.63 59.15 -25.77 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 2 3 # 2 A 270 ASN B 16 ASN~? 33.06 S2 BME B 301 A 384 ASN B 40 ASN~? 22.06 C2 BME B 301 A 385 GLU B 38 GLU^? 31.80 C2 BME B 301 coo 22.28 63.17 110.61 22.47 65.06 111.53 73.64 74.63 -26.43 74.05 74.83 -24.34 coo 7.06 50.07 96.17 8.50 48.54 96.31 59.67 59.12 -17.42 60.89 58.88 -15.71 coo 11.59 49.83 99.41 10.92 47.97 100.16 61.52 60.14 -24.13 60.63 59.15 -25.77 2v3r_p00 source 2v3r EXOGLUCANASE 1 : 2 hits 2v3r_p00 naa= 3 ULMN 3 1b01_d00 GENE REGULATION/DNA user 1 3 # 1 B 4 ARG B 103 ARG.? 9.89 C2 BME B 301 B 6 THR B 101 THR.? 7.80 C2 BME B 301 B 8 THR B 77 THR~? 5.05 S2 BME B 301 coo 40.52 16.08 100.90 37.97 16.41 102.60 63.00 51.98 -1.39 64.93 51.92 1.00 coo 36.11 13.64 95.03 34.54 14.86 95.91 62.74 59.71 -1.20 64.09 61.32 -1.60 coo 32.72 8.05 92.39 31.25 9.11 91.35 61.38 64.71 4.62 63.06 63.57 3.91 1b01_d00 source 1b01 GENE REGULATION/DNA : 1 hits 1b01_d00 naa= 3 ULMN 3 2bsq_d00 TRANSCRIPTION user 1 3 # 1 E 3 SER A 57 SER~? 13.02 O1 BME A 300 E 5 VAL A 60 VAL~? 16.82 O1 BME A 300 E 7 ARG A 123 ARG~? 17.98 O1 BME A 300 coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 71.70 44.22 4.13 69.75 45.17 3.03 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 73.48 40.52 8.75 75.29 41.74 8.64 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 79.32 40.68 12.01 79.04 43.03 13.95 ULMN 3 2bsq_d00 TRANSCRIPTION user 2 3 # 2 E 3 SER B 42 SER~? 17.88 C2 BME B 301 E 5 VAL B 106 VAL~? 18.80 C2 BME B 301 E 7 ARG B 105 ARG~? 19.36 C2 BME B 301 coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 59.65 59.95 -12.07 60.68 58.03 -11.04 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 53.95 59.99 -6.05 53.16 60.05 -8.08 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 52.95 54.23 -2.38 52.26 51.27 -1.82 ULMN 3 2bsq_d00 TRANSCRIPTION user 3 3 # 3 E 3 SER B 57 SER~? 14.27 S2 BME B 301 E 5 VAL B 60 VAL~? 17.79 S2 BME B 301 E 7 ARG B 123 ARG~? 19.27 S2 BME B 301 coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 70.33 75.49 -0.10 72.36 74.24 -0.48 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 68.29 80.07 3.08 66.20 79.59 3.53 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 62.37 80.29 5.08 62.68 80.61 8.15 2bsq_d00 source 2bsq TRANSCRIPTION : 3 hits 2bsq_d00 naa= 3 ULMN 3 2er8_d00 TRANSCRIPTION ACTIVATOR/DNA user 1 3 # 1 C 43 GLN B 45 GLN~? 17.54 C2 BME B 301 C 44 LYS B 48 LYS~? 21.20 S2 BME B 301 C 75 ARG B 47 ARG~? 23.93 S2 BME B 301 coo 34.33 34.01 1.06 32.24 34.35 1.22 58.11 63.39 -9.85 57.06 62.02 -8.57 coo 36.27 30.15 5.40 32.93 24.83 5.96 62.47 69.43 -9.84 56.65 72.06 -9.69 coo 30.88 29.31 6.12 29.39 29.02 3.47 65.24 66.71 -15.28 63.33 68.13 -17.26 2er8_d00 source 2er8 TRANSCRIPTION ACTIVATOR/DNA : 1 hits 2er8_d00 naa= 3 ULMN 3 2ky8_d00 TRANSCRIPTION/DNA user 1 3 # 1 A 24 ARG B 47 ARG~? 23.93 S2 BME B 301 A 32 LYS B 48 LYS~? 21.20 S2 BME B 301 A 46 ARG B 9 ARG.? 31.92 S2 BME B 301 coo -8.00 4.27 27.74 -7.09 2.66 30.09 65.24 66.71 -15.28 63.33 68.13 -17.26 coo -5.15 8.65 26.69 -4.26 5.48 32.02 62.47 69.43 -9.84 56.65 72.06 -9.69 coo -0.17 -5.20 27.14 -1.15 -5.34 29.97 61.30 71.84 -25.56 62.82 73.83 -23.80 2ky8_d00 source 2ky8 TRANSCRIPTION/DNA : 1 hits 2ky8_d00 naa= 3 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 1 3 # 1 B 34 SER A 42 SER~? 18.41 C1 BME A 300 B 37 ASN A 46 ASN~? 11.04 O1 BME A 300 B 45 THR A 77 THR~? -3.44 C2 BME A 300s coo -19.49 41.97 71.08 -17.37 40.80 71.17 83.78 56.74 -9.93 84.51 54.83 -11.21 coo -23.05 39.62 69.74 -22.86 39.59 67.61 78.74 53.91 -7.24 78.48 55.71 -6.12 coo -30.87 34.84 80.57 -28.94 34.51 81.49 79.06 56.59 7.66 78.46 57.92 6.11 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 2 3 # 2 B 34 SER A 42 SER~? 18.41 C1 BME A 300 B 37 ASN A 46 ASN~? 11.04 O1 BME A 300 B 45 THR B 35 THR^? 22.22 O1 BME A 300 coo -19.49 41.97 71.08 -17.37 40.80 71.17 83.78 56.74 -9.93 84.51 54.83 -11.21 coo -23.05 39.62 69.74 -22.86 39.59 67.61 78.74 53.91 -7.24 78.48 55.71 -6.12 coo -30.87 34.84 80.57 -28.94 34.51 81.49 73.34 60.50 -20.06 72.90 60.27 -17.95 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 3 3 # 3 B 34 SER B 42 SER~? 17.88 C2 BME B 301 B 37 ASN B 40 ASN~? 22.06 C2 BME B 301 B 45 THR A 5 THR^? 22.15 O1 BME A 300 coo -19.49 41.97 71.08 -17.37 40.80 71.17 59.65 59.95 -12.07 60.68 58.03 -11.04 coo -23.05 39.62 69.74 -22.86 39.59 67.61 59.67 59.12 -17.42 60.89 58.88 -15.71 coo -30.87 34.84 80.57 -28.94 34.51 81.49 75.17 56.47 -20.22 74.93 56.17 -18.10 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 4 3 # 4 B 34 SER B 42 SER~? 17.88 C2 BME B 301 B 37 ASN B 40 ASN~? 22.06 C2 BME B 301 B 45 THR A 29 THR.? 37.71 C2 BME B 301 coo -19.49 41.97 71.08 -17.37 40.80 71.17 59.65 59.95 -12.07 60.68 58.03 -11.04 coo -23.05 39.62 69.74 -22.86 39.59 67.61 59.67 59.12 -17.42 60.89 58.88 -15.71 coo -30.87 34.84 80.57 -28.94 34.51 81.49 56.50 67.70 -28.08 55.75 66.85 -29.96 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 5 3 # 5 B 34 SER B 42 SER~? 17.88 C2 BME B 301 B 37 ASN B 40 ASN~? 22.06 C2 BME B 301 B 45 THR A 35 THR^? 22.22 O1 BME A 300 coo -19.49 41.97 71.08 -17.37 40.80 71.17 59.65 59.95 -12.07 60.68 58.03 -11.04 coo -23.05 39.62 69.74 -22.86 39.59 67.61 59.67 59.12 -17.42 60.89 58.88 -15.71 coo -30.87 34.84 80.57 -28.94 34.51 81.49 72.00 65.36 -18.45 71.15 64.17 -16.85 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 6 3 # 6 B 34 SER B 42 SER~? 17.88 C2 BME B 301 B 37 ASN B 40 ASN~? 22.06 C2 BME B 301 B 45 THR B 5 THR.? 22.65 S2 BME B 301 coo -19.49 41.97 71.08 -17.37 40.80 71.17 59.65 59.95 -12.07 60.68 58.03 -11.04 coo -23.05 39.62 69.74 -22.86 39.59 67.61 59.67 59.12 -17.42 60.89 58.88 -15.71 coo -30.87 34.84 80.57 -28.94 34.51 81.49 70.08 69.00 -17.47 68.54 67.93 -16.36 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 7 3 # 7 B 34 SER B 42 SER~? 17.88 C2 BME B 301 B 37 ASN B 40 ASN~? 22.06 C2 BME B 301 B 45 THR B 35 THR^? 22.22 O1 BME A 300 coo -19.49 41.97 71.08 -17.37 40.80 71.17 59.65 59.95 -12.07 60.68 58.03 -11.04 coo -23.05 39.62 69.74 -22.86 39.59 67.61 59.67 59.12 -17.42 60.89 58.88 -15.71 coo -30.87 34.84 80.57 -28.94 34.51 81.49 73.34 60.50 -20.06 72.90 60.27 -17.95 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 8 3 # 8 B 34 SER B 42 SER~? 17.88 C2 BME B 301 B 37 ASN B 46 ASN~? 13.59 C2 BME B 301 B 45 THR B 35 THR^? 22.22 O1 BME A 300 coo -19.49 41.97 71.08 -17.37 40.80 71.17 59.65 59.95 -12.07 60.68 58.03 -11.04 coo -23.05 39.62 69.74 -22.86 39.59 67.61 64.66 62.99 -9.32 64.25 61.47 -7.89 coo -30.87 34.84 80.57 -28.94 34.51 81.49 73.34 60.50 -20.06 72.90 60.27 -17.95 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 9 3 # 9 B 34 SER B 42 SER~? 17.88 C2 BME B 301 B 37 ASN B 46 ASN~? 13.59 C2 BME B 301 B 45 THR B 77 THR~? 5.05 S2 BME B 301 coo -19.49 41.97 71.08 -17.37 40.80 71.17 59.65 59.95 -12.07 60.68 58.03 -11.04 coo -23.05 39.62 69.74 -22.86 39.59 67.61 64.66 62.99 -9.32 64.25 61.47 -7.89 coo -30.87 34.84 80.57 -28.94 34.51 81.49 61.38 64.71 4.62 63.06 63.57 3.91 2z3x_d00 source 2z3x DNA BINDING PROTEIN/DNA : 9 hits 2z3x_d00 naa= 3 ULMN 3 3s57_d00 OXIDOREDUCTASE/DNA user 1 3 # 1 A 101 VAL A 85 VAL^? 11.76 O1 BME B 301 A 102 PHE A 94 PHE^? 15.72 S2 BME B 301 A 169 CYH B 74 CYH~? -2.15 S2 BME B 301s coo -0.48 2.03 12.21 0.64 0.32 12.97 72.11 67.89 14.36 71.58 67.18 16.33 coo 0.51 5.20 15.97 0.26 4.09 18.50 66.81 69.50 17.94 66.87 71.80 19.56 coo 4.56 -7.03 18.26 5.32 -4.76 16.88 66.79 65.33 5.35 68.26 63.59 7.03 ULMN 3 3s57_d00 OXIDOREDUCTASE/DNA user 2 3 # 2 A 101 VAL A 86 VAL^? 11.39 S2 BME B 301 A 102 PHE A 94 PHE^? 15.72 S2 BME B 301 A 169 CYH B 74 CYH~? -2.15 S2 BME B 301s coo -0.48 2.03 12.21 0.64 0.32 12.97 69.88 70.78 13.37 69.55 71.35 11.30 coo 0.51 5.20 15.97 0.26 4.09 18.50 66.81 69.50 17.94 66.87 71.80 19.56 coo 4.56 -7.03 18.26 5.32 -4.76 16.88 66.79 65.33 5.35 68.26 63.59 7.03 ULMN 3 3s57_d00 OXIDOREDUCTASE/DNA user 3 3 # 3 A 101 VAL B 85 VAL^? 10.94 O1 BME B 301 A 102 PHE B 94 PHE^? 12.77 O1 BME B 301 A 169 CYH A 74 CYH~? 2.95 S2 BME A 300s coo -0.48 2.03 12.21 0.64 0.32 12.97 67.07 55.19 15.28 67.42 56.60 16.94 coo 0.51 5.20 15.97 0.26 4.09 18.50 71.58 57.30 18.86 71.41 60.08 19.10 coo 4.56 -7.03 18.26 5.32 -4.76 16.88 74.14 55.73 7.46 71.82 57.29 7.21 ULMN 3 3s57_d00 OXIDOREDUCTASE/DNA user 4 3 # 4 A 101 VAL B 86 VAL^? 11.52 O1 BME B 301 A 102 PHE B 94 PHE^? 12.77 O1 BME B 301 A 169 CYH A 74 CYH~? 2.95 S2 BME A 300s coo -0.48 2.03 12.21 0.64 0.32 12.97 69.24 52.05 15.38 69.41 51.59 13.25 coo 0.51 5.20 15.97 0.26 4.09 18.50 71.58 57.30 18.86 71.41 60.08 19.10 coo 4.56 -7.03 18.26 5.32 -4.76 16.88 74.14 55.73 7.46 71.82 57.29 7.21 3s57_d00 source 3s57 OXIDOREDUCTASE/DNA : 4 hits 3s57_d00 naa= 3 ULMN 3 4er8_d00 DNA BINDING PROTEIN/DNA user 1 3 # 1 A 78 ARG B 47 ARG~? 23.93 S2 BME B 301 A 82 LYS B 48 LYS~? 21.20 S2 BME B 301 A 97 ARG B 9 ARG.? 31.92 S2 BME B 301 coo 16.80 -30.32 -16.38 19.04 -32.25 -17.14 65.24 66.71 -15.28 63.33 68.13 -17.26 coo 13.73 -24.92 -13.04 16.51 -30.06 -12.17 62.47 69.43 -9.84 56.65 72.06 -9.69 coo 12.19 -29.83 -26.51 14.22 -31.21 -28.36 61.30 71.84 -25.56 62.82 73.83 -23.80 4er8_d00 source 4er8 DNA BINDING PROTEIN/DNA : 1 hits 4er8_d00 naa= 3 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 1 3 # 1 A 130 SER B 71 SER~? 8.60 S2 BME B 301 A 166 PHE B 76 PHE~? 11.05 S2 BME B 301 A 182 PHE B 119 PHE~? 15.49 S2 BME B 301 coo -46.28 37.24 81.97 -44.96 39.32 82.40 71.04 68.14 4.29 73.26 68.66 5.07 coo -36.62 39.62 84.60 -38.76 41.24 85.25 62.48 70.31 3.16 62.78 73.09 2.84 coo -36.55 45.66 79.22 -38.34 43.94 80.53 60.93 76.25 3.98 63.24 76.98 5.43 2r11_o00 source 2R11 CARBOXYLESTERASE NP : 1 hits 2r11_o00 naa= 3 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 1 3 # 1 B 130 SER B 71 SER~? 8.60 S2 BME B 301 B 166 PHE B 76 PHE~? 11.05 S2 BME B 301 B 182 PHE B 119 PHE~? 15.49 S2 BME B 301 coo -19.94 46.29 97.83 -22.38 46.56 97.60 71.04 68.14 4.29 73.26 68.66 5.07 coo -29.59 43.40 95.66 -28.22 45.54 94.50 62.48 70.31 3.16 62.78 73.09 2.84 coo -32.72 50.15 98.46 -30.32 48.85 97.77 60.93 76.25 3.98 63.24 76.98 5.43 2r11_o01 source 2R11 CARBOXYLESTERASE NP : 1 hits 2r11_o01 naa= 3 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 1 3 # 1 C 130 SER B 71 SER~? 8.60 S2 BME B 301 C 166 PHE B 76 PHE~? 11.05 S2 BME B 301 C 182 PHE B 119 PHE~? 15.49 S2 BME B 301 coo -2.19 64.27 51.12 -3.34 62.10 50.60 71.04 68.14 4.29 73.26 68.66 5.07 coo -11.14 61.91 46.89 -9.88 60.30 48.76 62.48 70.31 3.16 62.78 73.09 2.84 coo -7.71 55.92 42.70 -7.18 57.60 44.85 60.93 76.25 3.98 63.24 76.98 5.43 2r11_o02 source 2R11 CARBOXYLESTERASE NP : 1 hits 2r11_o02 naa= 3 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 1 3 # 1 D 130 SER A 71 SER~? 8.26 C1 BME B 301 D 166 PHE A 76 PHE~? 9.74 O1 BME A 300 D 182 PHE A 119 PHE~? 14.57 O1 BME A 300 coo -32.42 55.27 46.18 -30.51 54.94 47.67 70.10 52.54 6.16 67.71 52.03 6.39 coo -23.62 58.20 50.84 -23.76 56.14 48.96 78.83 50.67 7.29 78.71 47.88 7.60 coo -23.08 51.44 54.96 -24.43 52.71 52.88 80.27 45.41 9.73 77.88 44.61 10.94 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 2 3 # 2 D 130 SER B 71 SER~? 8.60 S2 BME B 301 D 166 PHE B 76 PHE~? 11.05 S2 BME B 301 D 182 PHE B 119 PHE~? 15.49 S2 BME B 301 coo -32.42 55.27 46.18 -30.51 54.94 47.67 71.04 68.14 4.29 73.26 68.66 5.07 coo -23.62 58.20 50.84 -23.76 56.14 48.96 62.48 70.31 3.16 62.78 73.09 2.84 coo -23.08 51.44 54.96 -24.43 52.71 52.88 60.93 76.25 3.98 63.24 76.98 5.43 2r11_o03 source 2R11 CARBOXYLESTERASE NP : 2 hits 2r11_o03 naa= 3 ULMN 3 3hde_o00 LYSOZYME user 1 3 # 1 A 35 GLU A 7 GLU^? 21.08 O1 BME A 300 A 44 ASP B 27 ASP.? 24.30 C1 BME A 300 A 50 THR B 29 THR.? 22.09 C1 BME A 300 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 82.55 57.05 -16.50 82.95 55.46 -15.17 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 90.17 63.25 -14.89 91.44 62.76 -13.27 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 89.91 59.73 -11.40 91.72 60.29 -10.32 ULMN 3 3hde_o00 LYSOZYME user 2 3 # 2 A 35 GLU B 7 GLU^? 27.97 S2 BME B 301 A 44 ASP A 27 ASP.? 37.00 C2 BME B 301 A 50 THR A 29 THR.? 37.71 C2 BME B 301 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 64.21 70.19 -21.03 62.19 70.66 -20.57 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 61.08 65.65 -30.46 59.02 65.16 -30.45 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 56.50 67.70 -28.08 55.75 66.85 -29.96 ULMN 3 3hde_o00 LYSOZYME user 3 3 # 3 A 35 GLU B 38 GLU^? 31.80 C2 BME B 301 A 44 ASP A 27 ASP.? 37.00 C2 BME B 301 A 50 THR A 29 THR.? 37.71 C2 BME B 301 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 61.52 60.14 -24.13 60.63 59.15 -25.77 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 61.08 65.65 -30.46 59.02 65.16 -30.45 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 56.50 67.70 -28.08 55.75 66.85 -29.96 3hde_o00 source 3HDE LYSOZYME : 3 hits 3hde_o00 naa= 3 ULMN 3 3hde_o01 LYSOZYME user 1 3 # 1 B 35 GLU A 7 GLU^? 21.08 O1 BME A 300 B 44 ASP B 27 ASP.? 24.30 C1 BME A 300 B 50 THR B 29 THR.? 22.09 C1 BME A 300 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 82.55 57.05 -16.50 82.95 55.46 -15.17 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 90.17 63.25 -14.89 91.44 62.76 -13.27 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 89.91 59.73 -11.40 91.72 60.29 -10.32 ULMN 3 3hde_o01 LYSOZYME user 2 3 # 2 B 35 GLU A 38 GLU^? 20.48 C1 BME A 300 B 44 ASP B 27 ASP.? 24.30 C1 BME A 300 B 50 THR B 29 THR.? 22.09 C1 BME A 300 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 80.67 68.42 -11.46 82.73 68.27 -11.88 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 90.17 63.25 -14.89 91.44 62.76 -13.27 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 89.91 59.73 -11.40 91.72 60.29 -10.32 ULMN 3 3hde_o01 LYSOZYME user 3 3 # 3 B 35 GLU B 7 GLU^? 27.97 S2 BME B 301 B 44 ASP A 27 ASP.? 37.00 C2 BME B 301 B 50 THR A 29 THR.? 37.71 C2 BME B 301 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 64.21 70.19 -21.03 62.19 70.66 -20.57 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 61.08 65.65 -30.46 59.02 65.16 -30.45 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 56.50 67.70 -28.08 55.75 66.85 -29.96 3hde_o01 source 3HDE LYSOZYME : 3 hits 3hde_o01 naa= 3 ULMN 3 3hde_o02 LYSOZYME user 1 3 # 1 C 35 GLU A 38 GLU^? 20.48 C1 BME A 300 C 44 ASP B 27 ASP.? 24.30 C1 BME A 300 C 50 THR B 29 THR.? 22.09 C1 BME A 300 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 80.67 68.42 -11.46 82.73 68.27 -11.88 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 90.17 63.25 -14.89 91.44 62.76 -13.27 coo 25.48 4.87 1.60 23.90 4.95 0.15 89.91 59.73 -11.40 91.72 60.29 -10.32 ULMN 3 3hde_o02 LYSOZYME user 2 3 # 2 C 35 GLU B 7 GLU^? 27.97 S2 BME B 301 C 44 ASP A 27 ASP.? 37.00 C2 BME B 301 C 50 THR A 29 THR.? 37.71 C2 BME B 301 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 64.21 70.19 -21.03 62.19 70.66 -20.57 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 61.08 65.65 -30.46 59.02 65.16 -30.45 coo 25.48 4.87 1.60 23.90 4.95 0.15 56.50 67.70 -28.08 55.75 66.85 -29.96 3hde_o02 source 3HDE LYSOZYME : 2 hits 3hde_o02 naa= 3 ULMN 3 3uao_o00 PUTATIVE ISOCHORISMATASE user 1 3 # 1 A 29 ASP A 129 ASP~? 19.06 O1 BME A 300 A 117 LYS A 126 LYS.? 26.12 O1 BME A 300 A 150 CYH A 52 CYH~? 13.74 O1 BME A 300 coo 37.97 47.82 5.46 38.65 48.02 7.40 80.80 42.21 -6.02 80.73 43.57 -7.63 coo 41.02 51.33 13.36 40.18 47.06 9.99 79.50 36.17 1.43 79.74 32.57 -2.57 coo 39.17 42.30 8.54 40.94 44.26 7.78 78.45 45.58 -0.24 81.07 46.23 -0.72 3uao_o00 source 3UAO PUTATIVE ISOCHORISMATASE : 1 hits 3uao_o00 naa= 3 ULMN 3 3uao_o01 PUTATIVE ISOCHORISMATASE user 1 3 # 1 B 29 ASP A 129 ASP~? 19.06 O1 BME A 300 B 117 LYS A 126 LYS.? 26.12 O1 BME A 300 B 150 CYH A 52 CYH~? 13.74 O1 BME A 300 coo 33.94 43.16 45.29 35.02 43.05 43.47 80.80 42.21 -6.02 80.73 43.57 -7.63 coo 38.53 39.60 38.22 36.76 43.89 41.37 79.50 36.17 1.43 79.74 32.57 -2.57 coo 35.77 48.61 42.57 37.40 46.62 43.48 78.45 45.58 -0.24 81.07 46.23 -0.72 3uao_o01 source 3UAO PUTATIVE ISOCHORISMATASE : 1 hits 3uao_o01 naa= 3 ULMN 3 3uao_o02 PUTATIVE ISOCHORISMATASE user 1 3 # 1 C 29 ASP A 129 ASP~? 19.06 O1 BME A 300 C 117 LYS A 126 LYS.? 26.12 O1 BME A 300 C 150 CYH A 52 CYH~? 13.74 O1 BME A 300 coo 54.62 -9.81 68.84 52.97 -9.23 67.61 80.80 42.21 -6.02 80.73 43.57 -7.63 coo 46.74 -10.34 64.36 51.80 -7.96 65.19 79.50 36.17 1.43 79.74 32.57 -2.57 coo 55.78 -5.03 64.48 55.52 -7.79 64.07 78.45 45.58 -0.24 81.07 46.23 -0.72 3uao_o02 source 3UAO PUTATIVE ISOCHORISMATASE : 1 hits 3uao_o02 naa= 3 ULMN 3 3uao_o03 PUTATIVE ISOCHORISMATASE user 1 3 # 1 D 29 ASP A 129 ASP~? 19.06 O1 BME A 300 D 117 LYS A 126 LYS.? 26.12 O1 BME A 300 D 150 CYH A 52 CYH~? 13.74 O1 BME A 300 coo 25.05 13.27 54.10 26.66 12.10 53.60 80.80 42.21 -6.02 80.73 43.57 -7.63 coo 33.45 10.03 51.76 28.31 9.37 53.37 79.50 36.17 1.43 79.74 32.57 -2.57 coo 24.32 7.20 55.59 24.80 8.07 53.08 78.45 45.58 -0.24 81.07 46.23 -0.72 3uao_o03 source 3UAO PUTATIVE ISOCHORISMATASE : 1 hits 3uao_o03 naa= 3 ULMN 3 3uao_o04 PUTATIVE ISOCHORISMATASE user 1 3 # 1 E 29 ASP A 129 ASP~? 19.06 O1 BME A 300 E 117 LYS A 126 LYS.? 26.12 O1 BME A 300 E 150 CYH A 52 CYH~? 13.74 O1 BME A 300 coo 54.17 11.77 49.20 52.64 11.40 50.63 80.80 42.21 -6.02 80.73 43.57 -7.63 coo 45.83 11.66 53.42 50.97 10.25 52.77 79.50 36.17 1.43 79.74 32.57 -2.57 coo 55.28 7.50 53.67 54.71 10.14 54.01 78.45 45.58 -0.24 81.07 46.23 -0.72 3uao_o04 source 3UAO PUTATIVE ISOCHORISMATASE : 1 hits 3uao_o04 naa= 3 ULMN 3 3uao_o05 PUTATIVE ISOCHORISMATASE user 1 3 # 1 F 29 ASP A 129 ASP~? 19.06 O1 BME A 300 F 117 LYS A 126 LYS.? 26.12 O1 BME A 300 F 150 CYH A 52 CYH~? 13.74 O1 BME A 300 coo 41.67 65.37 28.64 40.76 63.70 27.74 80.80 42.21 -6.02 80.73 43.57 -7.63 coo 38.34 58.97 23.05 39.26 61.42 28.02 79.50 36.17 1.43 79.74 32.57 -2.57 coo 39.64 61.25 32.92 38.08 62.62 31.22 78.45 45.58 -0.24 81.07 46.23 -0.72 3uao_o05 source 3UAO PUTATIVE ISOCHORISMATASE : 1 hits 3uao_o05 naa= 3 ULMN 3 3uao_o06 PUTATIVE ISOCHORISMATASE user 1 3 # 1 G 29 ASP A 129 ASP~? 19.06 O1 BME A 300 G 117 LYS A 126 LYS.? 26.12 O1 BME A 300 G 150 CYH A 52 CYH~? 13.74 O1 BME A 300 coo 26.53 -14.13 63.27 28.07 -12.63 63.49 80.80 42.21 -6.02 80.73 43.57 -7.63 coo 34.28 -10.03 65.81 29.08 -9.98 63.85 79.50 36.17 1.43 79.74 32.57 -2.57 coo 25.24 -8.30 61.46 25.55 -9.17 63.98 78.45 45.58 -0.24 81.07 46.23 -0.72 3uao_o06 source 3UAO PUTATIVE ISOCHORISMATASE : 1 hits 3uao_o06 naa= 3 ULMN 3 3uao_o07 PUTATIVE ISOCHORISMATASE user 1 3 # 1 H 28 VAL A 56 VAL~? 13.57 O1 BME A 300 H 117 LYS A 73 LYS~? -2.81 O1 BME A 300s H 150 CYH A 52 CYH~? 13.74 O1 BME A 300 coo 45.82 27.58 23.40 45.30 28.87 21.66 75.32 43.18 4.45 76.59 44.49 5.61 coo 38.01 32.08 28.20 39.46 29.85 23.57 75.23 53.47 4.59 74.97 57.96 1.35 coo 41.19 29.62 18.76 39.21 28.51 20.32 78.45 45.58 -0.24 81.07 46.23 -0.72 ULMN 3 3uao_o07 PUTATIVE ISOCHORISMATASE user 2 3 # 2 H 28 VAL A 56 VAL~? 13.57 O1 BME A 300 H 117 LYS A 126 LYS.? 26.12 O1 BME A 300 H 150 CYH A 52 CYH~? 13.74 O1 BME A 300 coo 45.82 27.58 23.40 45.30 28.87 21.66 75.32 43.18 4.45 76.59 44.49 5.61 coo 38.01 32.08 28.20 39.46 29.85 23.57 79.50 36.17 1.43 79.74 32.57 -2.57 coo 41.19 29.62 18.76 39.21 28.51 20.32 78.45 45.58 -0.24 81.07 46.23 -0.72 ULMN 3 3uao_o07 PUTATIVE ISOCHORISMATASE user 3 3 # 3 H 28 VAL A 95 VAL^? 8.15 S2 BME B 301 H 117 LYS B 81 LYS~? 11.51 C2 BME B 301 H 150 CYH B 74 CYH~? -2.15 S2 BME B 301s coo 45.82 27.58 23.40 45.30 28.87 21.66 66.62 66.55 13.00 66.48 67.46 11.01 coo 38.01 32.08 28.20 39.46 29.85 23.57 58.04 61.64 8.69 57.58 55.47 6.95 coo 41.19 29.62 18.76 39.21 28.51 20.32 66.79 65.33 5.35 68.26 63.59 7.03 ULMN 3 3uao_o07 PUTATIVE ISOCHORISMATASE user 4 3 # 4 H 28 VAL B 56 VAL~? 15.27 S2 BME B 301 H 117 LYS B 73 LYS~? 5.56 C2 BME B 301 H 150 CYH B 52 CYH~? 17.21 S2 BME B 301 coo 45.82 27.58 23.40 45.30 28.87 21.66 66.84 76.74 -0.76 65.26 75.74 0.33 coo 38.01 32.08 28.20 39.46 29.85 23.57 66.37 67.01 1.95 66.56 61.98 -0.01 coo 41.19 29.62 18.76 39.21 28.51 20.32 64.37 73.52 -5.35 61.67 73.37 -6.12 ULMN 3 3uao_o07 PUTATIVE ISOCHORISMATASE user 5 3 # 5 H 28 VAL B 56 VAL~? 15.27 S2 BME B 301 H 117 LYS B 126 LYS.? 28.14 S2 BME B 301 H 150 CYH B 52 CYH~? 17.21 S2 BME B 301 coo 45.82 27.58 23.40 45.30 28.87 21.66 66.84 76.74 -0.76 65.26 75.74 0.33 coo 38.01 32.08 28.20 39.46 29.85 23.57 64.27 82.78 -6.16 67.59 84.99 -10.95 coo 41.19 29.62 18.76 39.21 28.51 20.32 64.37 73.52 -5.35 61.67 73.37 -6.12 ULMN 3 3uao_o07 PUTATIVE ISOCHORISMATASE user 6 3 # 6 H 28 VAL B 95 VAL^? 8.62 S2 BME A 300 H 117 LYS A 81 LYS~? 9.69 C2 BME A 300 H 150 CYH A 74 CYH~? 2.95 S2 BME A 300s coo 45.82 27.58 23.40 45.30 28.87 21.66 72.58 56.58 14.56 73.15 55.08 13.07 coo 38.01 32.08 28.20 39.46 29.85 23.57 81.93 61.05 10.82 83.04 64.25 6.21 coo 41.19 29.62 18.76 39.21 28.51 20.32 74.14 55.73 7.46 71.82 57.29 7.21 3uao_o07 source 3UAO PUTATIVE ISOCHORISMATASE : 6 hits 3uao_o07 naa= 3